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Abstract 
A common strategy within the fields of biofabrication and tissue engineering 
(TE) involves combining cells with three-dimensional (3D) scaffolds, which provide 
a structural template for regeneration. Extrusion-based additive manufacturing 
techniques like fused deposition modelling (FDM) are often used to fabricate these 
porous scaffolds. However, one of the major challenges in the progress of 
biofabrication research has been the lack of suitable 3D-printing materials. The 
majority of research involving 3D-printing of scaffolds has been conducted using a 
limited range of hydrophobic polymers, which often require pre- or post-fabrication 
modification to reduce surface hydrophobicity and improve cellular interactions. 
Therefore, there is still a need for more hydrophilic and highly tuneable polymers 
suited for extrusion-based additive manufacturing techniques. As such, this project 
sought to expand on the minimal 3D-printing work reported with hydrophilic 
polymers by using poly(2-ethyl-2-oxazoline) (PEtOx), a novel polymer ink that has 
shown immense potential as a biomaterial. An optimisation study was performed 
using a BioExtruder system to determine the prime scaffold printing parameters, and 
showed for the first time that PEtOx could be 3D-printed into scaffold structures 
using a FDM technique. In order to explore whether the hydrophilic polymer could 
be rendered insoluble to increase its suitability for TE applications, chemical 
crosslinking was also investigated. In a proof of concept experiment, partial 
hydrolysis of PEtOx was performed to yield a copolymer containing 
poly(ethylenimine) (PEI) with reactive secondary amine groups, which was then 
melt-pressed into films and chemically crosslinked using glutaraldehyde (GA) 
vapour or solution to form insoluble structures. Ultimately, this thesis showed that 
PEtOx is a promising hydrophilic polymer ink for extrusion-based 3D-printing in 
TE, and paves the way for future work investigating the printability of the partially 
hydrolysed polymer to form scaffolds that can be crosslinked independent of time to 
form insoluble structures.  
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Chapter 1: Introduction 
This chapter outlines the background (section 1.1) of the research, and its 
significance and scope (section 1.2). Section 1.3 includes an outline of the remaining 
chapters of the thesis. 
1.1 BACKGROUND 
Issues associated with the current approaches to replacing damaged or 
degenerated tissue, in particular the shortage of donor tissues and organs and the 
associated risk of rejection, have led to the need for an alternative. Within the fields 
of tissue engineering (TE) and regenerative medicine, biofabrication has emerged as 
a rapidly growing area of research that aims to use automated processes to build or 
pattern cell-biomaterial constructs with fine-tuned internal and external spatial 
arrangements that may enable maturation into functional tissue equivalents [1, 2]. 
Biofabrication, also known as additive biomanufacturing, has the potential to be the 
manufacturing paradigm of the 21st century [3]. 
One approach to building three-dimensional (3D) scaffolds for biofabrication is 
an additive manufacturing technique known as fused deposition modelling (FDM). 
FDM builds scaffolds in a layer-by-layer fashion using molten thermoplastic 
materials that are extruded through a nozzle onto a moving building platform. 
Material selection plays a key role in the success of 3D-printed constructs, with 
synthetic polymers often used due to their reproducibility and adjustable properties. 
Furthermore, materials used in FDM techniques must typically exhibit suitable 
mechanical and processing properties. Consequently the majority of research 
involving 3D-printing of scaffolds has been conducted using a limited range of 
hydrophobic polymers, including poly(lactic-co-glycolic acid) (PLGA) [4],  
poly(lactic acid) (PLA) [5], and most commonly, poly(ɛ-caprolactone) (PCL) [6-10]. 
1.2 SIGNIFICANCE AND SCOPE 
One of the major challenges in the progress of biofabrication research has been 
the lack of suitable printing materials. Hydrophilic polymers often possess greater 
biocompatibility over their hydrophobic counterparts, however, inferior mechanical 
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strength and water stability issues have limited their use in additive biomanufacturing 
research, in particular with FDM techniques. This project seeks to expand on the 
minimal 3D-printing work reported using hydrophilic polymers, by using a novel 
polymer ink that has shown immense potential as a biomaterial. Issues with water 
stability will also be addressed by hydrolysis, and subsequent crosslinking of the 
polymer chains. It is envisioned that the hydrogels could be used for cell delivery, or 
find applications in surface modification. 
1.3 RESEARCH OBJECTIVES 
The main objective of this research is to investigate commercially available  
poly(2-ethyl-2-oxazoline) as a new hydrophilic polymer ink for 3D-printing, for 
eventual use in biofabrication and TE applications. In order to optimise printability, 
the effects of liquefier temperature, extrusion rate, nozzle diameter, and deposition 
velocity on scaffold morphology are investigated. Furthermore, this research aims to 
investigate an approach towards reducing the water solubility of the hydrophilic 
polymer, utilising partial hydrolysis to enable subsequent chemical crosslinking. 
1.4 THESIS OUTLINE 
Chapter 2 is a literature review covering extrusion-based additive 
manufacturing techniques, with a particular focus on previous work conducted with 
similar melt-extrusion methods or FDM systems to that used in this study. A review 
of the relevant research conducted on the polymer of interest in this study,  
poly(2-ethyl-2-oxazoline), is also included, in addition to scaffold crosslinking 
methods used in the field of TE. The materials and methods used in this project are 
covered in chapter 3. Chapters 4 and 5 include the results and discussion from the 
scaffold fabrication optimisation study, and the partial hydrolysis and crosslinking 
experiments, respectively. Conclusions from the research are detailed in chapter 6. 
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Chapter 2: Literature Review 
This chapter reviews literature on the following topics: extrusion-based additive 
manufacturing techniques (section 2.1), a fabrication process commonly used in TE; 
poly(2-ethyl-2-oxazoline) (section 2.2), a polymer gaining interest in the field and 
the focus of this thesis; hydrolysis of poly(2-ethyl-2-oxazoline) (section 2.3) to 
render the polymer crosslinkable, and the various protocols used in the literature; 
scaffold crosslinking techniques (section 2.4) that have been used to improve water 
stability and mechanical strength. Section 2.5 highlights the implications from the 
literature and develops the conceptual framework for the study. 
2.1 EXTRUSION-BASED ADDITIVE MANUFACTURING TECHNIQUES 
2.1.1 Fused Deposition Modelling 
Fused deposition modelling (FDM) is an additive extrusion-based technique 
developed in the late 1980s. It involves the passage of a molten thermoplastic 
material through the nozzle of an extrusion head controlled by a computer that 
deposits the semi-molten material in a layer-by-layer fashion. Extrusion-based 
techniques have been successfully applied in the fabrication of 3D structures for TE, 
particularly in the areas of bone and cartilage regeneration. In 2002, Xiong et al. 
reported a novel low-temperature deposition process to manufacture BMP-loaded 
poly-ʟ-lactide acid/tricalcium phosphate scaffolds [11]. The scaffolds displayed 
morphological and mechanical properties that were suitable for bone TE, and the low 
temperature used enabled preservation of scaffold material bioactivities. Zein et al. 
used an FDM machine to fabricate poly(ɛ-caprolactone) (PCL) scaffolds with a range 
of filament diameters, porosities and channel sizes [12]. In 2008, Rath et al. reported 
the fabrication of PCL-polyethylene scaffolds using a robotic dispensing system, 
which were seeded with porcine articular chondrocytes and showed cellular 
proliferation and deposition of extracellular matrix [13].  
2.1.2 BioExtruder Optimisation Studies 
In 2009, Domingos et al. presented the BioExtruder as a novel melt extrusion-
based deposition system for fabricating 3D porous PCL scaffolds with well-defined 
internal geometry [9] (Figure 2.1). The BioExtruder is an additive biomanufacturing 
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system developed at the Polytechnic Institute of Leiria, Portugal. Polymer is heated 
until molten, and then solidifies upon extrusion onto a moving building platform to 
fabricate scaffolds in a layer-by-layer process. Single-material deposition is 




Figure 2.1. BioExtruder single-material extrusion system [9]. Reprinted with permission under the 
Creative Commons Attribution License. 
 
Using a 0°/90° lay-down pattern, scaffolds with interconnected square pores of 
uniform dimensions and distribution were produced (Figure 2.2). Cell seeding 
studies demonstrated low fibroblast proliferation overall due to the large pore size 
(~600 x 600 µm), however, significant cell adhesion and proliferation were observed 
on the filaments.  
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Figure 2.2. Square PCL scaffold produced by Domingos et al. using the BioExtruder [9]. Reprinted 
with permission under the Creative Commons Attribution License. 
 
A more detailed study on the influence of BioExtruder process parameters on 
PCL scaffold morphology and mechanical properties was reported by the same group 
in 2012 [8]. By iteratively varying the values of liquefier temperature (LT), screw 
rotation velocity (SRV), deposition velocity (DV) and slice thickness (ST) to 
produce a range of scaffolds, Domingos et al. determined that DV and SRV had the 
greatest effect on filament width and scaffold porosity, and subsequently mechanical 
properties. Overall, the study was successful in demonstrating the high degree of 
control over scaffold structural characteristics provided by the BioExtruder. The 
BioExtruder system has also been used to fabricate PCL scaffolds to correct spine 
deformities in sheep models [10, 14]. 
Despite the extensive scaffold fabrication work performed with the 
BioExtruder system using PCL, the hydrophobic nature of the polymer results in 
limited cell adhesion and proliferation. Modification strategies have therefore been 
employed to reduce its surface hydrophobicity and improve cellular interactions after 
scaffold fabrication, including mineralisation [15], sodium hydroxide treatment [16], 
attachment of biomacromolecules [17, 18], and surface immobilisation of bioactive 
peptides [19]. Furthermore, other components have been incorporated with PCL 
during printing to increase its suitability to TE applications, including hydroxyapatite 
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[20], eggshell powder [21], TCP20 bioglass [22], and polylactide [23]. Although these 
pre- and post-fabrication modification techniques have demonstrated improved cell 
attachment and functional properties, there is still a need for more hydrophilic and 
highly tuneable polymers suited for extrusion-based additive manufacturing 
techniques. 
2.2 POLY(2-ETHYL-2-OXAZOLINE) AS A BIOMATERIAL 
2.2.1 Background 
Poly(2-oxazoline)s (PAOx) are a polymer class gaining attention as 
biomaterials due to their biocompatibility and stealth properties (Figure 2.3). The 
cationic ring-opening polymerisation of 2-oxazoline monomers, combined with end-
group and side-chain modification, allows a wide range of structural and functional 
variations to be achieved. Poly(2-ethyl-2-oxazoline) (PEtOx) is a commercially 
available member of the PAOx group that is hydrophilic at body temperature with a 
lower critical solution temperature of 60 °C. As such, PEtOx has been explored for 
use in drug delivery systems and other biomedical applications to mask materials 
from the immune system [24-26]. PEtOx has also been used to successfully enhance 
transmucosal drug delivery, termed POZylation, where it showed comparable 
properties to the more widely used PEGylation strategy [27]. 
 
Figure 2.3. Chemical structure of poly(2-oxazoline) (PAOx). 
 
2.2.2 Electrospinning with PEtOx 
In a 2009 publication, Buruaga et al. produced fibres of PEtOx with micron 
diameters using a technique known as solution electrospinning, where an electrical 
charge is used to draw a stable liquid jet of polymer from a spinneret onto a collector 
[28]. Solution electrospinning requires the preliminary dissolution of the polymer in 
a solvent that is evaporated as the jet travels through the air, leaving behind a random 
arrangement of polymeric fibres on the collector plate. The researchers 
predominantly used water as the solvent for PEtOx, as this was found to produce the 
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greatest number of fibres and the highest uniformity. The ability to produce fibre 
diameters in the 200 – 800 nm range, combined with its suitability for a water-based 
electrospinning system, highlights the great potential for PEtOx as a material for TE 
applications.  
More recently, Hochleitner et al. [29] used a similar technique known as melt 
electrospinning writing (MEW) to produce fibrous PEtOx scaffolds. By using molten 
polymers instead of polymer solutions, and combining the system with a computer-
controlled moving collector plate, MEW can be used to fabricate 3D structures with 
fibre diameters in the micron range. The optimisation study was the first of its kind 
using PEtOx, and focussed on key process parameters such as heating temperature, 
accelerating voltage, feeding pressure, collector distance, and spinneret diameter. It 
was found that an increase in feeding pressure and heating temperature led to 
significantly wider fibres, while extending the collector distance reduced fibre width. 
The researchers were able to fabricate 3D PEtOx scaffolds with fibre diameters 
ranging 8 – 138 µm using processing temperatures of 200 to 220 °C, with possible 
applications in TE. However, no cell studies were performed, and the solubility of 
the hydrophilic structures or any potential issues with rapid dissolution upon 
implantation were not discussed. 
2.2.3 PEtOx Hot Melt-Extrusion 
PEtOx has also demonstrated suitability for hot-melt extrusion (HME) in the 
production of controlled release drug formulations [30]. By coupling HME with 
injection moulding, De Geest and co-workers produced tablets containing PEtOx of 
various molecular weights as a matrix excipient, combining it with highly and poorly 
soluble drugs. The optimal processing temperature for HME of pure PEtOx using a 
twin screw extruder was determined to be 160 °C, which enabled the production of 
transparent PEtOx tablets. Solubility studies on pure PEtOx tablets revealed that 
dissolution rate decreased with increasing polymer molecular weight. These results 
confirm that PEtOx of varying molecular weights are suitable for processing by 
HME, and that dissolution rate in HME-processed polymer is determined by chain 
length. 
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2.3 POLY(2-ETHYL-2-OXAZOLINE) HYDROLYSIS 
2.3.1 Background 
PAOx is chemically inert, and therefore crosslinking requires modification to 
introduce reactive groups. One method involves hydrolysis of the amide group to the 
secondary amine. When PAOx is fully hydrolysed, it forms linear poly(ethylenimine) 
(L-PEI) (Figure 2.4), a semi-crystalline polymer that has many applications, 
particularly in the textile industry [31], and more recently in gene delivery and 
transfection with lower cytotoxicity noted than for the gold-standard branched PEI 
[32, 33]. The first detailed report of the hydrolysis of PAOx into L-PEI was in 1973, 
using alkaline conditions [34]. Follow up reports have used either alkaline [35] or 
acid [36, 37] hydrolysis conditions to yield L-PEI from PAOx, with another study 
using enzymatic degradation to achieve partial hydrolysis [38]. Acidic conditions 
have shown to be preferable, as hydrolysis occurs at a faster and more controlled 
manner [39], while basic conditions result in polymer degradation [40]. Despite 
advances in L-PEI research in biomedical applications, its cytotoxicity remains a 
problem. 
 
Figure 2.4. Chemical structure of poly(ethylenimine) (PEI). 
 
2.3.2 Partial Hydrolysis of PAOx 
Recent publications by the Hoogenboom group and others have also focussed 
on partial hydrolysis of PAOx to yield poly[(2-alkyl-2-oxazoline)-co-ethylenimine] 
copolymers, in an effort to combine the tuneable and biocompatible properties of 
PAOx with the gene delivery properties of L-PEI, limiting its cytotoxicity and 
ultimately increasing its in vivo applications. In 2012, an ethanol-water solvent 
mixture was reported to control the degree of acid hydrolysis of a range of PAOx, 
including PEtOx [41]. It was found that the hydrolysis rate of PEtOx in the ethanol-
water solvent was approximately 8 times slower than that reported with pure water. 
This was thought to be due to a shielding effect of the ethanol molecules over the 
hydrophobic side chains, hindering the access of water molecules to the amide 
carbonyl group, which is essential for the hydrolysis reaction. More recently, 
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Hoogenboom and co-workers found that decreasing the acid concentration and 
increasing the reaction temperature allowed tailored poly[(2-ethyl-2-oxazoline)-co-
ethylenimine] (PEtOx-EI) copolymers to be obtained in a reproducible and fast 
manner [42] (Figure 2.5). It has also been found that only a very high degree of 
hydrolysis could limit biomedical applications, due to issues with insolubility at low 
temperatures due to crystallisation [43]. The facile route to partially hydrolysed 
PAOx makes this an attractive strategy to making polymers containing free amine 
groups for crosslinking following extrusion. 
   
Figure 2.5. Schematic representation of the partial hydrolysis of poly(2-ethyl-2-oxazoline) (PEtOx) 
leading to poly[(2-ethyl-2-oxazoline)-co-ethylenimine] (PEtOx-EI).   
 
2.4 SCAFFOLD CROSSLINKING TECHNIQUES  
2.4.1 Background 
Although natural and synthetic hydrophilic polymers typically possess superior 
biocompatibility, TE applications often require materials with mechanical and 
degradation criteria that are better fulfilled by hydrophobic polymers. Chemical or 
physical crosslinking are common methods for rendering hydrophilic polymers 
insoluble and increasing mechanical strength. By forming bonds between polymer 
chains, the stability of water-soluble polymers in aqueous media can be greatly 
improved. Physical methods, including heat and radiation, are generally considered 
less efficient than chemical methods. The majority of literature on crosslinking used 
in TE is focussed on electrospun hydrophilic fibres, as these would otherwise 
undergo rapid dissolution in water and exhibit poor mechanical properties.  
2.4.2 In situ Crosslinking 
In situ crosslinking is a one-step process wherein crosslinking and processing 
occur simultaneously, most commonly during electrospinning. One such approach 
involves incorporating a crosslinking agent into the electrospinning solution 
immediately before processing, enabling the production of insoluble nanofibres. 
Tang et al. used this technique to electrospin insoluble poly(vinyl alcohol) (PVA) 
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nanofibres by mixing glutaraldehyde (GA) and hydrochloric acid (HCl) into the 
electrospinning syringe to act as the crosslinker and catalyst, respectively [44]. A 
similar approach was used by Jiang et al. to generate water-stable electrospun 
collagen fibres [45]. By combining collagen, ethanol and water with citric acid as the 
crosslinker, and sodium hypophosphite as the catalyst, crosslinked electrospun 
scaffolds were fabricated. An adaptation of this technique was reported by Lin and 
Tsai in 2013, wherein a mixture of gelatin and phenylazide-conjugated poly(acrylic 
acid) was electrospun under UV irradiation to initiate the crosslinking reaction [46]. 
All of these studies demonstrated water insolubility, uniform fibre morphology, and 
improved mechanical properties in the crosslinked structures.  
A similar in situ approach involves the use of a dual-syringe technique, where 
the polymer solution and a crosslinking agent are mixed immediately prior to 
reaching the electrospinning jet. This enables the reaction to occur within the fibres 
shortly after formation, preventing clogs associated with premature crosslinking in 
the syringe. This technique was employed by Ji et al., where a hyaluronic acid (HA) 
derivative was electrospun with a homobifunctional crosslinker, poly(ethylene 
glycol) diacrylate [47]. The resulting crosslinked HA nanofibrous structures were 
well preserved after hydration, and were shown to support cell migration. In 2015, a 
similar technique was reported for in situ crosslinking of gelatin, with a diisocyanate 
crosslinker loaded into an attached mixing syringe [48]. The crosslinked gelatin 
meshes demonstrated improved fibre morphology retention after implantation, 
dependent on the ratio of crosslinker to gelatin used.  
2.4.3 Two-Step GA Crosslinking 
Another approach to crosslinking hydrophilic polymers involves a two-step 
method. Although potentially more time laborious, the greater control over the areas 
to be crosslinked, and the ability to crosslink independent of time afforded by the 
technique are advantageous. Due to its high vapour pressure, GA can be used in its 
vapour-phase to crosslink structures that would otherwise dissolve in an aqueous 
crosslinking solution, although cytotoxicity above certain concentrations is a limiting 
factor. Commonly used to fix tissues samples for histological analysis, GA contains 
aldehydes that readily react with amines or alcohols to form an insoluble network. 
Studies involving GA vapour crosslinking of electrospun natural polymers 
including fibrinogen, gelatin, and collagen have been reported. GA vapour 
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crosslinking failed to produce any significant improvement on fibrinogen scaffold 
mechanical integrity when exposed to a 50% GA vapour chamber at room 
temperature for 1 hour, possibly due to insufficient exposure time [49]. Nanofibrous 
gelatin mats placed inside a desiccator filled with saturated GA vapour for 3 days 
demonstrated enhanced thermal stability and mechanical properties, with fibre 
morphology generally preserved after immersion in 37 °C water for 6 days [50]. 
Yang et al. crosslinked electrospun collagen fibres using 25 wt% GA in a sealed 
beaker for 24 hours at room temperature, which preserved their fibrous structure after 
immersion in water for 4 hours [51].  
Vapour-phase GA has also been used to crosslink hydrophilic synthetic 
polymers, including PVA (Figure 2.6) [52]. After incorporating HCl into the 
electrospinning solution to provide an acid catalyst, PVA nanofibrous mats were 
crosslinked using different concentrations of GA solution in a sealed vessel, with 
four different exposure times ranging 6 – 48 hours. The structures were rendered 
insoluble, although the authors reported some entanglement and interfibre fusion 
following GA exposure, most likely due to the water vapour contained in the 
aqueous 25 wt% GA. It should be noted that because GA is highly toxic, this method 
cannot be used with cells present. 
 
Figure 2.6. Schematic illustration of the reaction of PVA with GA and its intermolecular and/or 
intramolecular crosslinking product and the unreacted end of the aldehyde. Reprinted with permission 
from [52]. Copyright 2013 American Chemical Society (see Appendix). 
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2.5 SUMMARY AND IMPLICATIONS 
From the reviewed literature, it is evident that there is a lack of biocompatible 
hydrophilic polymers suited for melt-based FDM techniques. PEtOx is a polymer 
that fits these criteria, and has been shown to be suitable for melt-extrusion and 
MEW. Furthermore, partial hydrolysis of PEtOx yields a copolymer containing PEI 
with reactive secondary amine groups. Therefore, it is hypothesised that PEtOx could 
be partially hydrolysed and then fabricated into scaffolds using the BioExtruder 
system, followed by GA crosslinking to render the structure water insoluble. 
Additionally, crosslinking scaffolds independent of time and printing could prove to 
be more practical and convenient than currently used techniques, as the difficulties 
typically associated with the matching of extrusion rate and crosslinking can be 
avoided. These proof of concept experiments will pave the way for exploring similar 
methods for printing 3D crosslinked structures based on PAOx, but using less toxic 
conditions. Overall, this study aims to broaden the range of hydrophilic polymers 
used in FDM for biofabrication, enabling further progress in the field. 
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Chapter 3: Materials and Methods 
This chapter describes the materials and methods adopted by this research to 
achieve the aims and objectives stated in section 1.2 of Chapter 1. Section 3.1 lists 
the materials used in the study; section 3.2 discusses the methodology used in the 
optimisation of scaffold fabrication parameters; section 3.3 details the protocol used 
for the partial hydrolysis of PEtOx and the characterisation studies undertaken; 
section 3.4 outlines the methodologies used for the crosslinking of the partially 
hydrolysed PEtOx; section 3.5 lists the collaborations that enabled this research to 
occur; section 3.6 discusses the problems and limitations associated with the 
research; finally, section 3.7 outlines a timeline for the completion of each stage of 
the research. 
3.1 MATERIALS 




(Poly(2-ethyl-2-oxazoline), ~5 kDa)  
Polymer Chemistry Innovations 
Aquazol® 50 
(Poly(2-ethyl-2-oxazoline), ~50 kDa) 
Polymer Chemistry Innovations 
Hydrochloric Acid (32 wt%) Sigma Aldrich 
Sodium Hydroxide Sigma Aldrich 
SnakeSkin™ dialysis tubing  
(MWCO 3,500) 
Sigma Aldrich 
Glutaraldehyde (25 wt%) ProSciTech 
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3.2 OPTIMISATION OF PETOX BIOEXTRUSION PARAMETERS 
3.2.1 Scaffold Fabrication Parameters 
There are many interdependent parameters that control the BioExtruder and 
ultimately determine scaffold morphology (Table 3.2). Process parameters such as 
deposition velocity (DV) and slice thickness (ST) dictate the speed at which the 
building platform moves in the XY direction, and the Z-axis increment between 
layers, respectively. Polymer flow rate is largely determined by the temperature at 
which the polymer is melted during extrusion, known as the liquefier temperature 
(LT), and the screw rotation velocity (SRV). The diameter of extruded filaments in 
the scaffold is dependent on the internal diameter of the nozzle (ND) attached. The 
filament distance (FD) and lay-down pattern are determined during the design of the 
scaffold g-code and are chosen for a desired geometry and porosity.  
 
Table 3.2 Scaffold design and fabrication parameters (reproduced from Domingos et al. [8]) 
 Process Parameters Instrument Parameters Design Parameters 
    
 Deposition Velocity Liquefier Temperature Filament Distance 
 Slice Thickness Screw Rotation Velocity Lay-down Pattern 
  Nozzle Internal Diameter  
 
3.2.2 Scaffold Design 
G-code for a simple lattice (12 x 12 mm2) consisting of 2 layers was written 
with a 0°/90° lay-down pattern to obtain square-shaped pores (Figures 3.1 and 3.2). 
FD was set to 2 mm and kept constant throughout all printing. 





















Figure 3.1. G-code written for the BioExtruder to fabricate a 2-layer 12 x 12 mm2 square scaffold 
with a 0°/90° lay-down pattern. (DV = 150 mm/min; FD = 2 mm; ST = 300 µm) 
 
G17 G21 G40 G49 G54 G80 G90 G94 F150  
 
(Start of part) 
G1 Z-14.7  
G1 X-12 Y0 Z-14.7  
G1 X0 Y0 Z-14.7  
G1 X0 Y2 Z-14.7  
G1 X-12 Y2 Z-14.7  
G1 X-12 Y4 Z-14.7  
G1 X0 Y4 Z-14.7  
G1 X0 Y6 Z-14.7  
G1 X-12 Y6 Z-14.7  
G1 X-12 Y8 Z-14.7  
G1 X0 Y8 Z-14.7  
G1 X0 Y10 Z-14.7  
G1 X-12 Y10 Z-14.7  
G1 X-12 Y12 Z-14.7  
G1 X0 Y12 Z-14.7  
 
G1 Z-14.4  
G1 X0 Y0 Z-14.4  
G1 X-2 Y0 Z-14.4  
G1 X-2 Y12 Z-14.4  
G1 X-4 Y12 Z-14.4  
G1 X-4 Y0 Z-14.4  
G1 X-6 Y0 Z-14.4  
G1 X-6 Y12 Z-14.4 
G1 X-8 Y12 Z-14.4  
G1 X-8 Y0 Z-14.4  
G1 X-10 Y0 Z-14.4  
G1 X-10 Y12 Z-14.4  
G1 X-12 Y12 Z-14.4  
G1 X-12 Y0 Z-14.4  
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Figure 3.2. Representation of the scaffold lay-down pattern as plotted by the BioExtruder. 
 
3.2.3 BioExtruder System Set-up 
The BioExtruder system used in this study is located at the Institute of Health 
and Biomedical Innovation (IHBI), QUT (Figure 3.3). Poly(2-ethyl-2-oxazoline) 
(PEtOx) with a molecular weight of approximately 50 kDa (Aquazol® 50) was 
loaded into the material chamber of the BioExtruder and heated to 150 or 160 °C 
until molten. A plunger was inserted into the chamber, acted on by pneumatic 
pressure (0.8 MPa) to assist with the movement of polymer into the rotating 
extrusion screw mechanism, which was heated to the same temperature as the 
material chamber. Extrusion was allowed to occur prior to printing until consistent 
polymer flow was achieved. 
 
Figure 3.3. The BioExtruder system used in this study. 
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3.2.4 Optimisation Experiments 
Initially, SRV was varied by changing the voltage applied to the BioExtruder 
screw mechanism to ascertain its effect on scaffold morphology for a range of DV 
(50, 100, 150 and 200 mm/min) with fixed ND (410 µm), LT (160 °C) and ST  
(300 µm). Due to the nonlinear relationship observed between SRV and actual 
polymer flow rate, the set-up of the BioExtruder system was deemed unsuitable for 
optimisation of polymer flow rate to an exact value. Therefore, subsequent scaffold 
fabrication optimisation studies were performed by setting the voltage applied to the 
screw mechanism to the minimum value that produced consistent polymer flow, then 
iteratively varying each of the remaining parameters.  
The values tested for each parameter are listed in Table 3.3, with the values 
that were fixed during the testing of other parameters underlined; for example, when 
optimising ND, scaffolds were produced with LT, DV and ST values of 160 °C,  
150 mm/min and 300 µm, respectively, for each of the 340 and 410 µm internal 
nozzle diameters. All scaffolds were fabricated in duplicate to allow for sample 
damage during SEM imaging. 
 
Table 3.3 Parameters iteratively tested during optimisation of scaffold fabrication.  
 Parameters Tested          
    
 Nozzle Internal Diameter (µm) 340, 410  
 Liquefier Temperature (°C) 150, 160  
 Deposition Velocity (mm/min) 50, 100, 150, 200  
 Slice Thickness (µm) 100, 200, 300  
 
3.2.5 Scaffold Characterisation 
Scaffolds were viewed and photographed using a light microscope to evaluate 
the structure at low magnification. Morphological analysis of the filament integrity 
and interlayer adhesion was carried out using scanning electron microscopy (SEM; 
Jeol JSA 6360A, Tokyo, Japan) following gold sputtering (Leica EM SCD005A, 
Germany). Strut width (SW) (Figure 3.4) was measured from the SEM micrographs 
using image analysis software (ImageJ, National Institutes of Health, USA). 
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Measurements were taken at 8 filament and junction regions in samples printed 
within the same run, with the mean and standard error of the mean calculated. 
 
Figure 3.4. Schematic cross-section of a 4-layered scaffold viewed in the XZ plane, demonstrating 
strut width (SW), filament distance (FD), and slice thickness (ST). 
 
3.3 PARTIAL HYDROLYSIS OF PETOX 
3.3.1 Acid Hydrolysis of PEtOx 
PEtOx with an approximate molecular weight of 5 kDa (Aquazol® 5; 2.38 g) 
was dissolved in MilliQ water (25 mL) in a glass beaker at room temperature using a 
magnetic stirrer. Once dissolved, a 32 wt% HCl solution in water (25 mL) was 
added. The solution was immediately heated (100 °C), and the hydrolysis was 
terminated by removing the vial from the heat after 30 minutes and adding a 
concentrated NaOH solution to neutralise the pH to between 7 and 8. The solvent 
was removed by placing the solution in dialysis tubing (SnakeSkin™, molecular 
weight cut-off 3,500), and the hydrolysed polymer solution was freeze dried.  
Aquazol® 50 was hydrolysed following the same protocol, however larger 
quantities of polymer (9.52 g), MilliQ water (100 mL), and 32 wt% HCl solution in 
water (100 mL) were used to yield a greater quantity of hydrolysed polymer. The 
hydrolysis was terminated after 30 minutes. 
3.3.2 Characterisation of Partially Hydrolysed PEtOx 
Proton nuclear magnetic resonance (1H-NMR) spectroscopy was used to 
determine the hydrolysis degree from PEtOx to PEtOx-PEI by comparing the NH 
peaks with the main chain CH2 peaks. The glass transition temperature (Tg) of the 
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partially hydrolysed PEtOx samples was determined using differential scanning 
calorimetry (DSC).  
3.4 CROSSLINKING OF PARTIALLY HYDROLYSED PETOX 
3.4.1 Film Preparation 
A film of the partially hydrolysed Aquazol® 50 (H-Aq50) sample was melt-
pressed at 150 °C, while the partially hydrolysed Aquazol® 200 (H-Aq200) sample 
required a temperature of 180 °C. H-Aq200 films of 3 thicknesses were produced:  
film A (160 µm), film B (410 µm) and film C (550 µm). Average film thickness was 
determined by measuring 5 sections of each sample using digital callipers. 
3.4.2 GA Crosslinking of H-Aq50 Film Samples 
The melt-pressed film was cut into samples of approximately equal size and 
weighed (8.7 – 12.3 mg) prior to placing inside glass vials. 25 wt% GA solution  
(10 µL) was directly pipetted onto the film samples, with approximately half 
dispensed onto each side of the film, ensuring full coverage without promoting 
dissolution. The crosslinking proceeded for 1, 3, 6 and 24 hour time periods, 
followed by observations on film appearance recorded before and after washing in 
MilliQ water for ~72 hours. Control samples were also set up without placing GA 
inside the vials. 
H-Aq50 film samples were also exposed to 25 wt% GA solution vapour to 
initiate crosslinking. Samples were weighed (10.5 – 13.0 mg) and placed inside 
screw top glass bottles. Shallow vessels containing 25 wt% GA solution (50 µL) 
were placed inside the bottles containing the film samples (Figure 3.5), which were 
then sealed and placed inside a larger sealed jar and kept at room temperature, or in a 
40 °C oven to increase vapour pressure. Reactions were allowed to proceed for 3, 4, 
5 and 24 hour time periods, followed by observing the appearance prior to and after 
submerging the samples in MilliQ water for ~72 hours.  
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Figure 3.5. Experimental set-up used for exposing films to GA vapour. 
 
3.4.3 GA Crosslinking of H-Aq200 films 
H-Aq200 was also used for crosslinking studies, as the polymer  film samples 
A and B were weighed (8.8 – 13.7 and  8.6 – 18.9 mg, respectively) and exposed to 
25 wt% GA solution at room temperature using the same protocol as described in 
section 3.4.2, however a larger volume was used (20 µL), and an additional 16 hour 
time point was added. The experiment was also repeated using 25 wt% GA solution 
vapour at 40 °C using the same protocol, with film A and B samples weighing 10.0 – 
15.1 and 6.7 – 14.9 mg, respectively. 
The study was then repeated using film C, with less sample weight variation  
(18.3 – 22.3 mg). However, both the 25 wt% GA vapour and solution experiments 
were performed at room temperature and 45 °C to enable direct comparisons 
between the two techniques and evaluate the effect of temperature. 
3.4.4 Calculating Crosslinking Yield Percentage 
After ~72 hours of submersion in MilliQ water to promote dissolution of any 
soluble material, excess water was removed and the GA-exposed samples were dried 
in an oven (60 °C) and then weighed. The crosslinking yield was then calculated 
using the following formula: 
 
 
Crosslinking Yield (%)  =         Mass (dry)         x 100 
              Mass (original) 
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3.5 COLLABORATIONS 
The H-Aq200 sample used in the crosslinking studies was obtained via 
collaboration with Prof. Dr. Richard Hoogenboom and the Supramolecular 
Chemistry Group at the University of Ghent, Belgium.   
3.6 LIMITATIONS 
Due to BioExtruder machine access becoming unexpectedly restricted during 
the project, optimisation studies were prematurely ceased before more complex and 
biologically relevant scaffold designs could be fabricated. Similarly, hydrolysed 
PEtOx was melt-pressed into films instead of 3D-printed structures as a proof of 
concept study, due to issues with machine access and time constraints. 
3.7 PROCEDURE AND TIMELINE 
A timeline outlining the completion of each stage of the project is included in 
Table 3.4. Limited research was conducted during February – June, as full-time 
coursework was undertaken. 
 
Table 3.4 Timeline for the completion of each stage of the research. 
Research Stage Time Period          
    
 Optimisation of scaffold fabrication April 2015 – September 2015  
 Scaffold characterisation August 2015 – October 2015   
 PEtOx hydrolysis and characterisation October 2015 – November 2015   
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Chapter 4: Optimisation of PEtOx 
Bioextrusion Parameters 
4.1 CHAPTER OVERVIEW 
This chapter details and discusses the results from the optimisation of PEtOx 
bioextrusion parameters study. The effect of each parameter on scaffold morphology 
is discussed and compared to the findings of previous literature.  
4.2 RESULTS AND DISCUSSION 
4.2.1 Screw Rotation Velocity (SRV) 
The amount of polymer that is extruded through the BioExtruder nozzle of set 
dimension is determined by the velocity imposed to the screw. Due to the 
configuration of the machine used in this study, SRV could only be controlled by 
varying the voltage applied to the motor, with no reliable method of measuring actual 
rotational speed. Issues with achieving repeatable polymer flow rates between print 
runs using the same voltage revealed that the relationship between voltage and SRV 
was nonlinear and inaccurate, and it was therefore only possible to test the effect of 
SRV on scaffold morphology using arbitrary values.  
While maintaining constant the liquefier temperature (LT) at 160 °C and slice 
thickness (ST) at 300 µm, and using a nozzle internal diameter (ND) of 410 µm, 
voltage was set to the machine maximum (20 V) and then decreased to the minimum 
for each given deposition velocity (DV) tested (50, 100, 150, and 200 mm/min) that 
would still enable PEtOx adhesion to the stage so scaffolds could be printed. As 
expected, it was found that for each DV, increasing the voltage applied to the screw 
mechanism led to a widening of struts, with an almost complete loss of pores in the 
50 mm/min DV samples (Figure 4.1). This is due to the higher amount of polymer 
that is extruded when the SRV is increased.  
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Figure 4.1. Photographs of PEtOx scaffolds 3D-printed with the BioExtruder Extruder system, 
showing the effect of varying SRV (by voltage) on scaffold morphology for various DV.  
(LT = 160 °C; ND = 410 µm; ST = 300 µm) 
 
Conversely, when the voltage applied to the screw approached the lower limit 
for each DV, insufficient polymer flow caused stretching of the filament between the 
nozzle and the moving building platform, resulting in thinner struts. Similarly, strut 
adhesion to the building platform was compromised when polymer flow was 
reduced, resulting in a loss of scaffold geometry and rounding of corners, eventually 
reaching a critical level where the PEtOx failed to attach to the stage and instead 
accumulated on the nozzle. Interestingly, this phenomenon was not seen in the 50 
mm/min DV scaffolds, as the minimum voltage that could be applied to the AC 
motor (4 V) was too high. Furthermore, PEtOx flow rate appeared to reach its peak at 
approximately 14 – 16 V, most likely due to insufficient feeding of polymer into the 
screw at SRV values above this level. 
This relationship between SRV and filament width is supported by findings in 
an optimisation study of bioextruded poly(ɛ-caprolactone) (PCL) scaffolds by 
Domingos et al. [8], however, a variation in machine set-up allowed for a more 
precise measurement of SRV in revolutions per minute (rpm). The researchers found 
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that an increase in SRV from 20 to 30 rpm led to a widening of filaments from  
235 ± 10 to 326 ± 9 µm. Due to the arbitrary measuring of SRV in this study, the 
effect of SRV on scaffold morphology was determined qualitatively instead of 
measuring the filament width.  
Ultimately, these results demonstrate the effect of polymer flow rate on 
scaffold morphology, and highlight the interdependent relationship between SRV 
and DV. From these results, it was decided that a DV of 150 mm/min was ideal for 
further experiments, as its optimum polymer flow rate could be achieved between the 
narrowest range of applied voltages.    
4.2.2 Internal Nozzle Diameter (ND) 
In order to determine the effect of ND on PEtOx bioextrusion, two sizes of 
needle were tested: 340 and 410 µm internal diameters (23 and 22 gauge, 
respectively). Voltage applied to the screw was set to the minimum value required to 
produce consistent polymer flow, and LT, DV and ST were fixed at 160 °C,  
150 mm/min and 300 µm, respectively.  
Measurements taken from the SEM micrographs (Figure 4.2) show that 
filament diameter increased from 369 ± 11 to 514 ± 15 µm when the ND was 
changed from 340 to 410 µm (Figure 4.3). This is to be expected, as ND determines 
the maximum amount of polymer that can be extruded at a given time, with a 
narrower diameter resulting in less material deposition.  
It is also interesting to note that strut width was most similar to ND when using 
the 340 µm nozzle and with less widening at junction regions, suggesting that 
polymer flow rate was better controlled. Future experiments using smaller NDs are 
needed to confirm this phenomenon. The optimisation study by Domingos et al. did 
not test the effect of ND, using only one size (300 µm) [8]. Despite other literature 
on the BioExtruder also using only a 300 µm nozzle for PCL scaffolds [9, 18], due to 
no known previous attempts at PEtOx bioextrusion, it was decided that larger nozzles 
would be most suitable for this optimisation study. Due to time constraints, smaller 
NDs were not able to be tested, however it is predicted that these would also be 
suitable and could produce superior results. 
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Figure 4.2. SEM micrographs of PEtOx scaffolds showing the effect of internal nozzle diameter (ND) 
on strut junctions. Scale bar is equal to 1 mm. Top and bottom row images are tilted at 0 and 50° from 
horizontal, respectively. (LT = 160 °C; DV = 150 mm/min; ST = 300 µm). 
 
 
Figure 4.3. The effect of nozzle internal diameter (ND) on strut and junction widths.  
(LT = 160 °C; DV = 150 mm/min; ST = 300 µm)  
 
4.2.3 Liquefier Temperature (LT) 
Due to the novelty of printing PEtOx with the BioExtruder, the LT values were 
determined by trial and error. Aquazol® 50 (PEtOx, ~50 kDa) is a fully amorphous 
polymer with a Tg reported by the manufacturers to be 69 – 71 °C. Qualitatively, it 
has a very high melt viscosity, and therefore a processing temperature significantly 
above the Tg was chosen. Upon loading the Aquazol® 50 into the material chamber, 
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to extrude after a period of time. The Aquazol® 50 began to extrude at 150 °C, so this 
was set as the minimum LT value, with 160 °C also tested to determine the effect of 
temperature on scaffold morphology. The values of DV, ST, and ND (150 mm/min, 
300 µm, and 340 µm, respectively) were kept constant while setting the LT to 150 
and 160 °C. SRV was set to the minimum required for homogenous polymer flow 
and also maintained constant. 
By analysing the SEM images (Figure 4.4), it was found that an increase in LT 
from 150 to 160 °C corresponded to a decrease in filament diameter from 459 ± 6 to 
369 ± 11 µm (Figure 4.5). This is opposite to what has been observed with PCL, 
where strut width increased with LT [8]. Further experimentation is required to 
confirm this finding, however it is likely to be a result of differences between PCL 
and PEtOx flow properties, and also issues with the protocol for setting SRV due to 
the configuration of the BioExtruder. PEtOx flow was greatly increased at 160 °C, 
resulting in a necessary reduction in voltage applied to the screw mechanism to 
ensure it was set to the minimum value to produce consistent polymer flow. It is 
therefore possible that the voltage was excessively reduced, causing a reduction in 
strut width, however this can only be confirmed and rectified with modification of 
the BioExtruder to enable measuring of SRV. There was also less widening of 
filaments at junction sites observed when the LT was increased from 150 to 160 °C, 
with junction width decreasing from 642 ± 20 to 429 ± 14 µm. This is likely due to 
the aforementioned causes for the decrease in filament width. 
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Figure 4.4. SEM micrographs of PEtOx scaffolds showing the effect of internal nozzle diameter (ND) 
on strut junctions. Scale bar is equal to 1 mm. Top and bottom row images are tilted at 0 and 50° from 
horizontal, respectively. (LT = 160 °C; DV = 150 mm/min; ST = 300 µm). 
 
 
Figure 4.5. The effect of liquefier temperature (LT) on strut and junction widths.  
(ND = 340 µm; DV = 150 mm/min; ST = 300 µm) 
 
Overall, these results indicate that of the LT values tested, 160 °C was most 
suitable for bioextrusion of Aquazol® 50, as the average strut width was closest to 
ND and the junction regions displayed the least widening. This finding is in line with 
the work of De Geest and colleagues, who found 160 °C to be suitable for HME of 
PEtOx with the same molecular weight into tablets with a smooth surface [30]. The 
authors also noted that this temperature was below the decomposition temperature of 
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required for the bioextrusion of PCL (70 – 80 °C) [8, 9, 18], this temperature is 
readily achievable and within the heating capabilities of the BioExtruder system. 
4.2.4 Deposition Velocity (DV) 
By controlling the speed at which the building platform moves in the XY 
direction, DV has a profound effect on scaffold morphology. To determine the 
optimal DV for PEtOx extrusion, the values of LT, ST, and ND (160 °C, 300 µm, 
and 340 µm, respectively) were fixed while four different DV values were tested: 50, 
100, 150, and 200 mm/min. As per previous experiments, voltage applied to the 
screw mechanism was fixed to the minimum value required to enable consistent 
polymer flow. 
The SEM micrographs showed that increasing DV from 50 to  
150 mm/min led to a narrowing of filament diameters from 435 ± 10 to 369 ± 11 µm 
(Figure 4.6). This is due to the stretching and subsequent narrowing of filaments that 
occurs when DV is increased in the XY plane. A decrease in strut width with 
increasing DV has also been reported during bioextrusion of PCL [8].  
 
Figure 4.6. The effect of deposition velocity (DV) on strut width.  
(LT = 160 °C; ND = 340 µm; ST = 300 µm) 
 
Unexpectedly, increasing the DV from 150 to 200 mm/min resulted in a 
widening of filaments. BioExtruder system modifications and further 
experimentation are required to determine if this is a true phenomenon, or due to 
excessively increasing the voltage applied to the screw mechanism in an effort to 
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These findings ultimately show that DV has a significant effect on scaffold 
morphology, with 150 mm/min the optimum DV for PEtOx bioextrusion, as this 
produced strut widths that were closest to the ND. While the DV used for 
bioextrusion of PCL is typically 480 – 600 mm/min [8, 9], this speed is still within 
the capabilities of the machine, but the time required to fabricate scaffolds would be 
significantly longer. However, this issue may be overcome by increasing SRV to 
enable a more comparable DV to PCL. 
4.2.5 Slice Thickness (ST) 
The increment that the extrusion head moves up the Z-axis between layers is 
determined by the ST, which ultimately affects the interlayer strut adhesion in 
scaffolds. To ascertain the optimum ST for PEtOx bioextrusion, the values of LT, 
ND and DV were fixed (160 °C, 340 µm, and 150 mm/min, respectively) while the 
ST was varied between 100, 200 and 300 µm. Following the same principle of the 
previous experiments, the voltage applied to the BioExtruder screw mechanism was 
set to the minimum value required to give consistent polymer flow. 
By measuring the SEM micrographs, it was found that ST had little effect on 
strut width, as when increased from 100 µm to 300 µm the strut width only slightly 
decreased from 393 ± 7 to 369 ± 11 µm. However, the effect of increasing ST from 
100 to 300 µm had a much greater effect on the width of struts at junctions, 
decreasing from 603 ± 9 to 429 ± 14 µm (Figure 4.7).   
 
Figure 4.7. The effect of slice thickness (ST) on strut width at junction sites.  
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          The inverse correlation between junction width and ST can be explained by the 
SEM micrographs tilted at 50° from the horizontal (Figure 4.8). When ST is too low 
for the filament diameter, compression of the struts at the junction sites occurs, 
resulting in widening and a change to a more elliptical shape. These results are 
supported by the findings of Domingos et al., who found lesser strut widths when 
increasing ST [8].  
 
 
Figure 4.8. SEM micrographs of PEtOx scaffolds showing the effect of slice thickness (ST) on strut 
junctions. Scale bar is equal to 1 mm. Top and bottom row images are tilted at 0 and 50° from 
horizontal, respectively. (LT = 160 °C; ND = 340 µm; DV = 150 mm/min). 
 
Overall, increasing ST resulted in less adhesion between the layers and 
minimised strut widening at crossover regions. For this study, minimising strut 
widening at junction regions was a priority, and therefore 300 µm was deemed the 
most suitable ST, which has also been observed during the optimisation of PCL 
bioextrusion conditions [8]. Further experimentation using other ST values would 
likely find that the optimal value is slightly below 300 µm, as some slackness of top 
layer filaments between crossover regions was observed. However, as with PCL, the 
optimum ST for PEtOx bioextrusion will ultimately depend on the interlayer 
adhesion and mechanical properties required for its intended applications, and also 
the ND used.  
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4.2.6 Summary 
Experimental results highlight a direct influence of the BioExtruder process 
conditions on PEtOx scaffold morphology. Moreover, the majority of the parameters 
are interdependent, in particular SRV and DV. The greatest influence on filament 
thickness is exerted by SRV and ND, while ST had a major effect on strut junctions 
and interlayer adhesion, which is an important determinant of the mechanical 
properties. To find the optimal set of process and instrument parameters to fabricate 
PEtOx scaffolds of predictable and reproducible morphology, all parameters were 
evaluated on their ability to produce filaments of homogenous width equivalent to 
the ND. The combination of process conditions determined by morphological 
analysis that enable the production of PEtOx scaffolds with strut width closest to the 
ND are listed in Table 4.1. 
 









340 160 150 300 
 
Ultimately, this study has shown for the first time that Aquazol® 50 is suitable 
for bioextrusion into scaffold structures. The effects of BioExtruder process 
parameters on scaffold morphology are similar to those observed with PCL, with the 
exception of LT, which is likely a result of variations in machine configurations or 
human error. Therefore, PEtOx could be a suitable hydrophilic alternative to PCL 
only requiring minor alterations to current process conditions, in particular increasing 
LT and decreasing DV.  
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Chapter 5: Partial Hydrolysis of PEtOx and 
Crosslinking Studies 
5.1 CHAPTER OVERVIEW 
Chapter 5 describes and discusses the results from the partial hydrolysis of 
PEtOx and the effectiveness of the crosslinking studies. Comparisons are made 
between the PEtOx hydrolysed as part of this study and the sample obtained from 
collaborators, as well as the results of other relevant literature. The effectiveness of 
the GA crosslinking is also discussed and compared, with an emphasis on the 
crosslinking yield achieved by each technique. 
5.2 RESULTS AND DISCUSSION 
For initial proof of concept experiments, Aquazol® 5 was partially hydrolysed 
and characterised due to a more abundant supply available than Aquazol® 50. The 
research group of Prof. Dr. Richard Hoogenboom, who have multiple publications on 
partial hydrolysis of PEtOx, also provided a more refined co-polymer, Aquazol® 200 
(H-Aq200), and accompanying 1H-NMR data for this project. 1H-NMR spectroscopy 
was also performed to determine the degree of hydrolysis from PEtOx to PEtOx-EI 
of the Aquazol® 5 sample, using the ratio of the NH peak of PEI with the CH2 peaks 
of the PEtOx sidechain and backbone. It is evident that the partially hydrolysed 
Aquazol® 5 (H-Aq5) sample was hydrolysed to a much greater degree than the H-
Aq200 due to the much higher relative PEI peak, indicating a greater quantity of 
PEtOx-EI present in the sample (Figures 5.1 and 5.2). This is likely due to 
inexperience and unfamiliarity with performing the hydrolysis procedure, and 
subsequently performing a much harsher acid hydrolysis treatment than the more 
refined technique used by collaborators on the H-Aq200 sample. 1H-NMR 
spectroscopy was not performed on the H-Aq50 sample, however the similar 
processing conditions used would likely render a comparable degree of hydrolysis. 
 










Figure 5.1. 1H-NMR spectrum of partially hydrolysed Aquazol® 5 (H-Aq5), with  




Figure 5.2. 1H-NMR spectrum of partially hydrolysed Aquazol® 200 (H-Aq200), with  
poly(2-ethyl-2-oxazoline) (PEtOx) backbone (bb) and sidechain (sc), and poly(ethylenimine) (PEI) 
peaks identified. Note: 1H-NMR spectroscopy was performed by the the Hoogenboom group, who 
also provided the sample for the studies in this thesis.  
 
The effect of partial hydrolysis of PEtOx on the thermal properties is important 
for applications in FDM. Therefore, DSC was performed on the PEtOx-EI samples to 
determine and compare the glass transition temperatures (Tg) (Figure 5.3). Aquazol® 
is an amorphous polymer with a Tg between 69 – 71 °C as reported by the 
manufacturers, while L-PEI is semi-crystalline with a Tg of -29.5 °C. To render the 
results more relevant to the 3D-printing study, H-Aq50 was tested. During the 2nd 
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heating phase of DSC, the slight downward shift in heat flow of the H-Aq50 
represented a Tg of approximately 25 °C. Similarly, the Tg of the H-Aq200 was 
found to be approximately 50 °C. These results are indicative of PEtOx-EI, with both 
Tg values intermediary between that of PEtOx and L-PEI homopolymers. 
Furthermore, these results confirm the findings of the 1H-NMR spectra, with the Tg 
of the H-Aq200 closer to that of PEtOx, indicating a lesser degree of hydrolysis in 
the sample. Similar findings were reported by Hoogenboom and colleagues, where 6, 
25, 43 and 71% hydrolysed PEtOx samples were amorphous materials with 
intermediate Tg values of 62.3, 58.9, 47.6 and 5.1 °C, respectively [43]. Interestingly, 
the PEtOx-EI with up to 25% hydrolysis had a Tg close to that of the PEtOx 
homopolymer, indicating hydrogen bonding between the secondary amine groups of 
the PEI with the tertiary amide groups of PEtOx.  
 
 
Figure 5.3. DSC of partially hydrolysed Aquazol® 50 (A) and 200 (B) showing only the 2nd heating 
phase, with the Tg at approximately 25 and 50°C, respectively. 
 
Overall, the hydrolysis performed in this study proved to be a harsher treatment 
than that used by collaborators. As such, the proportion of PEI present in the  
PEtOx-EI copolymer is much higher. This has important implications for GA 
crosslinking of PEtOx-EI, which is dependent on the presence of reactive secondary 
amine groups produced by the hydrolysis reaction.  
5.2.1 Preparation of Partially Hydrolysed PEtOx Films 
Partially hydrolysed PEtOx films were melt-pressed as an initial model for 
proof of concept crosslinking experiments. The H-Aq50 sample was readily melted 
and pressed into films at 150 °C, while the H-Aq200 required a temperature of  
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180 °C. Due to minimal sample quantity and the rudimentary nature of the 
experiments, only one H-Aq50 film was melt-pressed. The film was pliable and 
sticky to touch, and of a light yellow colour.  
The majority of crosslinking experiments were performed using the more 
refined and less hydrolysed H-Aq200 sample, which was melt-pressed into 3 films, 
hereafter referred as films A, B, and C. To render the proof of concept film 
crosslinking experiments relevant to the study, the aim was to test thicknesses similar 
to the strut widths that could be achieved by 3D-printing with the BioExtruder or 
similar FDM techniques. However, due to the set-up of the melt-press machine used, 
it was difficult to accurately produce films of a desired thickness. The H-Aq200 
films had a markedly different appearance and mechanical properties compared to 
the H-Aq50 film; the H-Aq200 films were brittle and much lighter in colour, shinier 
and less sticky to touch. The films also contained a large number of air bubbles, 
which could not be avoided despite modifications to the melt-pressing technique 
(Figure 5.4).  
 
 
Figure 5.4. Photograph of a partially hydrolysed Aquazol® 200 (H-Aq200) film sample used for 
crosslinking studies. 
 
5.2.2 Glutaraldehyde Crosslinking of Partially Hydrolysed Aquazol® 50 Films 
H-Aq50 film samples were exposed to GA solution at room temperature for 1, 
3, 6 and 24 hours prior to washing in MilliQ water. Following exposure to GA, the 
film samples appeared yellow in colour, unlike the control sample that had not been 
exposed to GA. This colour change is indicative of successful crosslinking, as it is 
caused by the formation of aldimine linkages between the free amine groups of 
 Chapter 5: Partial Hydrolysis of PEtOx and Crosslinking Studies 37 
PEtOx-EI and GA, and has also been noted with gelatin GA crosslinking studies [50, 
53]. The GA-exposed and control H-Aq50 film samples were submerged in MilliQ 
water for approximately 72 hours to promote dissolution of any material that had not 
crosslinked, then dried and weighed to calculate the crosslinking yield (Figure 5.5). 
Following water submersion, the GA-exposed samples appeared swollen and 
deformed, and the control sample had fully dissolved. As expected, the crosslinking 
yield increased with GA exposure time, reaching a maximum of 63.2% at 24 hours.   
 
Figure 5.5. Crosslinking yield (%) of partially hydrolysed Aquazol® 50 (H-Aq50)  
melt-pressed film samples exposed to 25 wt% glutaraldehyde (GA) solution at room temperature.  
 
In an effort to minimise sample deformation during the crosslinking process, 
GA vapour crosslinking was also trialled. Following GA vapour exposure at room 
temperature for 3, 4 and 5 hours, the H-Aq50 samples showed little change in 
appearance. After approximately 72 hours of submersion in MilliQ water, the 
samples were mostly dissolved, with crosslinking yields below 10% (Figure 5.6). 
After 24 hours of GA vapour exposure at room temperature, the sample had a slight 
yellow appearance and was less soluble, but the crosslinking yield of 19.8% 
remained much lower than that of the GA solution exposed samples. In order to 
increase the vapour pressure and effectiveness of the crosslinking, H-Aq50 film 
samples were exposed to GA vapour at 40 °C. Higher crosslinking percentage yields 
were achieved with the increase in temperature for all exposure times except 3 hours, 
reaching 53.8% after 24 hours of GA exposure. After the designated time for the 
crosslinking reaction, the films had not only undergone a colour change to a darker 
yellow but also become slightly swollen, presumably due to the presence of water in 
the vapour of aqueous GA (25 wt%) solution. This sample deformation has also been 
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lower concentrations of GA were used in the PVA study, the high water content 
swelled the PVA fibres more effectively than the GA vapour could crosslink, leading 
to fibre fusion and entanglement. This undesired result was minimised by using 
higher concentrations of GA. 
 
Figure 5.6. Crosslinking yield (%) of partially hydrolysed Aquazol® 50 melt-pressed films exposed to 
25 wt% glutaraldehyde (GA) solution vapour at room temperature (RT) and 40 °C. 
 
Overall, these proof of concept experiments showed for the first time that GA 
solution and vapour could be used to successfully crosslink PEtOx-EI and modulate 
its water solubility. Despite the promising results from these studies, it was decided 
that a less hydrolysed PEtOx-EI sample was preferable for crosslinking, and 
therefore the remaining experiments were performed using the H-Aq200 sample 
obtained from collaborators at the University of Ghent, Belgium.  
5.2.3 Glutaraldehyde Crosslinking of Partially Hydrolysed Aquazol® 200 Films 
Samples of H-Aq200 films A and B of 160 and 410 µm thicknesses, 
respectively, were exposed to GA solution at room temperature using the same 
protocol as for H-Aq50, however a 16 hour time point was added due to the large 
increase in crosslinking yield observed between the 6 and 24 hour time points. 
Following GA exposure, the thinner film A samples did not swell until the 6 hour 
time point, and major deformation was only present in the 16 and 24 hour exposed 
samples. Yellowing of the films was mostly localised to the central region while the 
edges remained off-white or translucent. Following submersion in MilliQ water for 
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lost shape. The crosslinking yield reached a maximum of 56.9% at the 6 hour time 
point, but then decreased to 48.5% at 16 hours, and slightly increased to 51.6% at 24 
hours (Figure 5.7). This is thought to be due to an excessive volume of GA used, 
causing gradual dissolution of the sample during the crosslinking process, evidenced 
by the loss of shape in the sample. This trend was not observed in the samples 
exposed to GA vapour, with crosslinking yield increasing between the 6 and 24 hour 
time points. The slight decrease in yield observed during the earlier time points is 
thought to be due to differences between sample weights while using the same GA 
vapour pressure, which could be avoided by using samples of more similar weights, 
in addition to using a larger sample size. The GA-vapour exposed samples displayed 
less yellowing and deformation, and had a much lower crosslinking yield than that of 
the solution-exposed samples.  
 
Figure 5.7. Partially hydrolysed Aquazol® 200 film A (160 µm thickness) samples exposed to 25 wt% 
glutaraldehyde (GA) solution at room temperature, and vapour at 40 °C. 
 
The difference between the crosslinking yields of the solution and vapour 
techniques was less significant in the thicker H-Aq200 film C (Figure 5.8). Samples 
exposed to GA solution displayed an unexpected crosslinking yield trend. Although 
yield increased between the 1 and 3 hour time points, it then decreased before 
reaching a maximum of 71.4% at 24 hours. The decreased crosslinking during the 6 
and 16 hour time points is thought to be a result of sample dissolution, or weighing 
inaccuracies. The crosslinking yield at 24 hours was higher than that of the thinner 
film A, which is likely due to the greater thickness of the film and subsequent greater 
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samples displayed much greater crosslinking yields compared to film A when 
exposed to GA vapour at 40 °C. This is also thought to be a result of less sample 
dissolution by water vapour during the crosslinking process, due to the increased 
thickness of the films.  
 
Figure 5.8. Partially hydrolysed Aquazol® 200 film B (410 µm thickness) samples exposed to 25 wt% 
glutaraldehyde (GA) solution at room temperature, and vapour at 40 °C. 
 
Due to some unexpected crosslinking yield results that were presumed to be 
caused by large variations in sample weights while using a set volume of GA, more 
care was taken to minimise sample weight variation in the crosslinking studies using 
film C. Also, to enable direct comparisons between the solution and vapour 
crosslinking techniques, both experiments were performed at room temperature and 
at an elevated temperature of 45 °C to further increase vapour pressure. Temperature 
was shown to have minimal effect on the crosslinking yield of GA-solution exposed 
samples for most time points, except at 24 hours where the room temperature and  
45 °C samples reached maximums of 76.5% and 65.3%, respectively (Figure 5.9). 
This is possibly caused by some melting of the sample due to the temperature 
approaching the Tg of 50 °C. However the decrease between 1 and 6 hours of 
exposure was unexpected. Further experimentation is required to determine whether 
this is a result of weighing inaccuracies, as the samples displayed minimal 
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Figure 5.9. Partially hydrolysed Aquazol® 200 film C (500 µm thickness) samples exposed to 25 wt% 
glutaraldehyde (GA) solution at room temperature (RT) and 45 °C. 
 
Temperature had a much greater impact on GA vapour crosslinking. With the 
exception of the 3 hour time point, the samples exposed to GA vapour at 45 °C had 
higher crosslinking yields than those reacted at room temperature (Figure 5.10). This 
is due to increased vapour pressure inside the sealed glass bottle, subsequently 
leading to greater GA exposure of the sample.  
 
Figure 5.10. Partially hydrolysed Aquazol® 200 (H-Aq200) film C (550 µm thickness) samples 
exposed to 25 wt% glutaraldehyde (GA) vapour at room temperature (RT) and 45 °C. 
 
The samples exposed to GA vapour at 45 °C for 16 and 24 hours showed the 
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resulted in insoluble structures that maintained their shape after approximately 72 
hours of water submersion (Figure 5.11). 
 
 
Figure 5.11. Photographs of the insoluble PEtOx-EI crosslinked film structures (*) formed after 
glutaraldehyde (GA) vapour exposure at 45 °C for 16 (left panel) and 24 (right panel) hours.  
 
 Interestingly, raising the temperature from 40 to 45 °C only led to major 
increases in crosslinking yield at the 1 and 24 hour exposure periods when 
comparing films B and C, however further experiments involving films of the same 
thickness are required to confirm this effect.  
5.2.4 Summary 
Experimental results indicate for the first time that PEtOx-EI can be 
crosslinked using GA solution or vapour to create water insoluble structures. As 
expected, resistance to dissolution is dependent on the crosslinking yield, with GA 
solution typically leading to higher yields, but GA vapour causing less sample 
deformation.  
The maximum crosslinking yield was achieved using GA solution at room 
temperature for 24 hours, however the complete loss of sample shape following 
crosslinking will prevent this technique from being used on 3D-printed scaffold 
structures, which would likely suffer from the same deformation. However, the 
traditional method of GA solution crosslinking utilises an immersion technique 
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instead of pipetting the crosslinker directly onto the sample, so this could be explored 
to improve sample coverage and minimise exposure time, and thus sample 
deformation.  
The 16 and 24 hour GA vapour crosslinking at 45 °C proved to be the most 
promising set of crosslinking conditions, as the samples swelled but did not lose 
shape after soaking in water. Some GA vapour crosslinking studies involve doping 
the sample with an acid, typically HCl, to provide a catalyst for the crosslinking 
reaction [52], which could be explored for PEtOx-EI crosslinking. Higher 
concentrations of GA should also be trialled, as this has been shown to minimise 
sample deformation in PVA nanofibrous mats [52]. Longer exposure times could 
also yield greater crosslinking, as some studies have shown positive results after 72 
hours [50]. Additionally, suspending the sample in the vessel in such a manner that 
all surfaces are equally exposed to GA vapour would likely lead to superior results. 
Ultimately, this proof of concept study has shown that PEtOx-EI can be 
rendered insoluble by GA crosslinking, however, despite the similarity of the film 
thicknesses to strut widths obtainable by FDM, experiments involving the GA 
crosslinking of PEtOx-EI scaffolds must be conducted to determine strut and 
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Chapter 6: Conclusions 
Due to one of the major challenges in biofabrication research being a lack of 
suitable printing materials, this thesis aimed to develop a new crosslinkable 
hydrophilic polymer that is suitable for extrusion-based 3D-printing techniques, such 
as FDM. To achieve this, an optimisation study was conducted to determine the 
optimum processing parameters for the bioextrusion of PEtOx into scaffolds. 
Hydrolysis was performed to render PEtOx crosslinkable, followed by a series of GA 
crosslinking experiments to evaluate the effectiveness and suitability of each 
technique at forming insoluble structures.  
The often superior biocompatibility of hydrophilic materials over hydrophobic 
polymers is typically offset by inferior mechanical strength and water stability issues, 
limiting their use in FDM techniques for TE applications. This study has shown for 
the first time that PEtOx, a hydrophilic polymer that has demonstrated great potential 
as a biomaterial in drug delivery applications, can be 3D-printed into scaffold 
structures using a FDM technique. Although process parameters used were similar to 
those typically used to print with some hydrophobic polymers, further optimisation 
studies involving more complex and biologically relevant scaffold designs are 
required before PEtOx can be readily accepted as an alternative polymer ink to the 
more commonly used PCL. Issues with atmospheric moisture uptake and rapid 
dissolution of the hydrophilic scaffolds in water are also limiting factors.  
In order to render the hydrophilic scaffolds insoluble and overcome some of 
these limitations, crosslinking is required. Partial hydrolysis of PEtOx gives rise to 
PEtOx-EI, a copolymer with secondary amine groups that are suited to GA 
crosslinking. GA is typically used to fix tissue samples for histological analysis and 
is therefore found in most TE laboratories, representing an attractive and convenient 
crosslinker. This project demonstrated that PEtOx-EI can be melt-processed into 
films that can be crosslinked using GA solution and vapour. While GA solution 
provided the maximum crosslinking yield, vapour exposure caused the least 
deformation of the sample structure. Although this study showed for the first time 
that partially hydrolysed PEtOx films could be crosslinked using GA, 3D-printing 
and crosslinking of PEtOx-EI should be investigated in future work to examine strut 
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and structure morphology retention in aqueous environments. Exploring different 
crosslinking techniques and longer GA vapour exposure times are likely to render 
PEtOx-EI a new polymer ink for FDM techniques in TE applications.  
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Adipose tissue engineering aims to restore soft tissue defects and correct contour deformities by 
generating fat that is structurally and functionally equivalent to native tissue. Following trauma, 
replacement of lost subcutaneous fat would improve patient wellbeing by reduced scarring and 
preventing formation of adhesions. Therefore, the objective of this study was to investigate a 
novel approach to adipose tissue engineering that could have future applications in restoring 
subcutaneous fat tissue. A typical approach to tissue engineering involves seeding of cells onto 
porous scaffolds that provide a three-dimensional (3D) support structure. It is well recognised 
that 3D culture systems provide conditions that better mimic the in vivo environment. 
Accordingly, it has been shown that human adipose-derived stem cells (hASCs), a commonly used 
cell source for adipose tissue engineering, display improved adipogenic differentiation potential 
when cultured as 3D cell aggregates known as spheroids. Therefore, the aim of this study was to 
generate an organised and coherent adipose-like tissue by seeding hASC spheroids onto fibrous 
poly(ε-caprolactone) (PCL) scaffolds with box-shaped pores fabricated using a melt 
electrospinning writing (MEW) technique. As the sizes of the box pores and spheroids were 
required to be of a similar size to enable assembly, a preliminary study investigating the effect of 
seeded cell number on spheroid size and adipogenic differentiation was performed. Size 
measurements of the spheroids confirmed that spheroid size could be controlled by the number 
of seeded cells, however spheroids enlargement was not directly proportional to cell number. 
Histological analysis using Oil Red O staining revealed superior adipogenic differentiation in 
spheroids seeded with 0.1 x 104 and 0.5 x 104 hASCs, with large void spaces present in the larger 
spheroids. However, quantification of triglyceride (TG) content showed that spheroids seeded 
with 1.0 x 104 cells differentiated most efficiently, with the lowest accumulation of TGs measured 
in the 0.1 x 104 cell group. Therefore, spheroids containing 0.5 x 104 and 1.0 x 104 cells were 
deemed most optimal for scaffold seeding. Spheroids with these cell numbers, with diameters of 
approximately 337 µm and 420 µm, were seeded onto scaffolds with measured box widths of  
379 µm and 472 µm, respectively. Spheroids readily assembled in the boxes, and after 24 hours, 
had preferentially attached to the PCL fibres over the adhesive tissue culture plate. In this short 
time, the smaller spheroids had nearly completely dissociated, and hASCs almost entirely filled 
many of the box pores. This effect was less pronounced in the larger scaffolds, where spheroids 
had attached to the fibres but underwent less dissociation. In all scaffolds, inhomogeneous 
seeding patterns were observed as a result of the top-seeding technique used, where spheroids 
randomly fell into boxes. Nevertheless, spheroids in adjacent boxes did show signs of fusion, 
indicating that with optimisation of the seeding technique, this novel approach to adipose tissue 







2D   Two-dimensional 
3D   Three-dimensional 
ADD1   Adipocyte determination and differentiation factor 1 
AM   Additive manufacturing 
ANOVA   Analysis of variance 
ASC   Adipose-derived stem cell 
BAT   Brown adipose tissue 
BMSC   Bone marrow-derived stem cell 
c/EBP   CCAAT/enhancer binding protein 
CAD   Computer-aided design 
cAMP   Cyclic adenosine monophosphate 
CTS   Critical translation speed 
DAT   Decellularised adipose tissue 
DMEM   Dulbecco’s Modified Eagle Medium 
DMSO   Dimethyl sulfoxide 
DNA   Deoxyribonucleic acid 
ECM   Extracellular matrix 
EDTA   Ethylenediaminetetraacetic acid 
FCS   Fetal calf serum 
FDA   Food and Drug Administration 
FDM   Fused deposition modelling 
h…   Human 
ind   Induced 
IBMX   3-isobutyl-1-methylxanthine 
IGF-1   Insulin-like growth factor-1 
MEW   Melt electrospinning writing 






MSC   Mesenchymal stem cell 
NFs   Nanofilaments 
non   Non-induced 
PBM2   Preadipocyte Basal Medium 2 
PBS   Phosphate buffered saline 
PCL   Poly(ε-caprolactone) 
PEGDA   Poly(ethylene glycol) diacrylate  
Pen Strep  Penicillin streptomycin 
PET   Poly(ethylene terephthalate) 
PGA   Polyglycolic acid (PGA)  
PLGA   Poly(lactic-co-glycolic) acid 
PLLA   Poly(L-lactic) acid  
PPARƴ   Peroxisome proliferator-activated receptor ƴ 
PU   Polyurethane 
rpm   Revolutions per minute  
SD   Standard deviation 
SREBP-1c  Sterol regulatory element binding protein-1c 
SVF   Stromal vascular fraction 
TG   Triglyceride 








1. Introduction          
1.1 ADIPOSE TISSUE BIOLOGY 
1.1.1 Background 
In humans, two major types of adipose tissue are present: brown adipose tissue (BAT) and white 
adipose tissue (WAT). BAT is distributed throughout the body at birth and serves important 
thermoregulatory functions, however its presence decreases with age, with WAT most abundant 
in adults.1  WAT plays an important role in energy regulation in the body through controlled 
storage and release, and also acts as an endocrine organ by producing multiple adipose-derived 
hormones, including leptin and adiponectin, that regulate metabolic homeostasis.2  Furthermore, 
WAT has an important function in bodily aesthetics and providing mechanical protection to 
organs and bones.3  It is for these reasons that WAT is the main focus of the current adipose 
tissue engineering research, and accordingly will be the focus of this work.  
Adipose tissue is primarily composed of mature adipocytes tightly embedded in a  
three-dimensional (3D) network of extracellular matrix (ECM), with each cell containing a large 
lipid droplet that occupies the vast majority of its cytoplasm. Adipocyte sizes range from  
50–150 µm in diameter, and have a lifespan of approximately 10 years in humans.4  Due to its 
high metabolic rate, adipose is a highly vascularised tissue, with each adipocyte in contact with at 
least one capillary.5  Additionally, endothelial cells, preadipocytes, smooth muscle cells, pericytes, 
macrophages, and a population of mesenchymal stem cells (MSCs) are present in the stromal 
vascular fraction (SVF) of fat tissue.6, 7 Due to the terminally differentiated state of adipocytes, 
which are incapable of undergoing proliferation, the stem cell population contributes to adipocyte 
generation and regeneration during developmental growth, repair following injury or ischaemia, 
and hyperplasia in obesity.8   
1.1.2 Adipocyte differentiation 
Adipocyte differentiation from multipotent MSCs involves two main phases: determination and 
terminal differentiation. During the determination phase, MSCs are committed to the adipocyte 
lineage. These cells are known as preadipocytes, and are morphologically indistinguishable from 
MSCs but have lost the potential to differentiate into other cell lineages.9 During the second 
phase, known as terminal differentiation, preadipocytes develop into mature adipocytes 
accompanied by an increase in insulin sensitivity, synthesis and accumulation of lipids, and 
secretion of adipocyte-specific proteins.9 The cellular and molecular mechanisms of terminal 
differentiation have been more widely studied than the determination phase, largely due to the 
use of cell lines that have a restricted potential to differentiate into other lineages.9 Adipocyte 
differentiation is directed by a number of critical transcription factors that temporally regulate 
several gene expression events, including the CCAAT/enhancer binding protein (C/EBP)  
basic-leucine zipper family of transcription factors; the nuclear hormone receptor peroxisome 
proliferator-activated receptor ƴ (PPARƴ); and the sterol regulatory element binding protein-1c 






transcription factor. Studies in adipogenic cell lines have shown that following hormonal induction 
of differentiation, C/EBPβ and C/EBPδ are rapidly expressed, reaching a peak after a day and then 
beginning to decline as C/EBPα and PPARƴ rise.10, 11  C/EBPα and PPARƴ co-regulate one another 
using a positive feedback loop to maintain gene expression that promotes and maintains the 
differentiated state (Fig. 1). The important role of these factors in adipogenesis has been 
demonstrated by the stimulation of adipocyte differentiation in cultured fibroblasts by forced 
expression of PPARƴ or C/EBPα.12, 13 All aspects of mature adipocyte phenotype and the 
acquisition of insulin sensitivity are affected by the activation of PPARƴ.    
 
 
Figure 1. Regulation of adipogenesis by a cascade of transcription factors. Preadipocytes exposed to a cocktail of 
adipogenic inducers including insulin, glucocorticoids such as dexamethasone, and agents that raise cAMP (typically 
IBMX) activates expression of a transcription factor cascade that converges on PPARƴ. In turn, PPARƴ induces 
expression of C/EBPα, and in a positive feedback loop, these two factors induce terminal adipogenesis. Figure reprinted 
with permission from 14 (see Appendix H). 
In order to mimic the cytokine signals required for adipogenic differentiation in vivo, inducing 
hormonal factors are added to culture media to stimulate in vitro adipogenesis. The standard 
cocktail used for MSC differentiation to the adipogenic lineage contains dexamethasone, 
isobutylmethylxanthine (IBMX), and insulin or insulin-like growth factor 1 (IGF-1). While 
dexamethasone is an anti-inflammatory glucocorticoid that stimulates both osteogenic and 
adipogenic differentiation,15, 16 extended exposure or increased concentrations used in culturing 
of MSCs yields a higher number of adipocytes and inhibits osteogenic differentiation.17  IBMX is a 
phosphodiesterase inhibitor that raises intracellular cyclic adenosine monophosphate (cAMP) 
levels, and in combination with dexamethasone, regulates PPARƴ and promotes adipogenesis.18  
Additionally, dexamethasone and IBMX are both inducers of C/EBPβ and C/EBPδ.10 Insulin induces 
preadipocyte proliferation and adipogenic differentiation via numerous mechanisms, and at high 






Indomethacin, a non-steroidal anti-inflammatory drug, is often also added to the adipogenic 
cocktail and works as a PPARƴ agonist to sustain adipogenesis.6, 21     
1.1.3 The extracellular matrix 
Mature adipocytes contain a single fat droplet that occupies almost the entire cell volume, and is 
only separated from the cytosol by a lipid monolayer. In order to decrease the transfer of 
mechanical stress from the outside of the cell that could rupture the fragile lipid vacuole, 
adipocytes are surrounded by a thick ECM known as a basement membrane.22 To further 
minimise mechanical stress, forces are spread over a larger area of the tissue by linking of the 
basement membrane. Fibronectin, laminins, and collagen types I, IV and VI are all major ECM 
components of WAT.  
The differentiation of fibroblast-shaped preadipocytes into mature rounded-up adipocytes is 
accompanied by dynamic changes in the ECM structure and composition.23 During the terminal 
differentiation stage of adipogenesis that is accompanied with vast accumulation of triglycerides 
(TGs), the ECM develops from a fibrillar to laminar structure, and a strong upregulation of major 
basement membrane components collagen IV and laminin occurs.23, 24 Decreased synthesis of 
fibronectin and a gradual degradation of the fibronectin have also been observed during 
adipogenesis.25, 26 Remodeling of the ECM during adipogenic differentiation is not only a 
consequence of morphological changes in the cells, but also a necessary step in the differentiation 
process. Matrix metalloproteinases (MMPs) are one family of mediators involved in ECM 
remodeling, with inhibition of MMP-2 and MM-9 in 3T3-L1 preadipocytes shown to block 
adipogenesis.27  Therefore, in addition to providing an optimal environment for cell viability, ECM 
composition changes are also a requirement for adipogenic differentiation. 
1.2 ADIPOSE TISSUE ENGINEERING 
1.2.1 Background 
The reconstruction of soft tissue defects arising from trauma, tumour resections or congenital 
abnormalities remains a significant challenge in plastic and reconstructive surgery. The main goal 
of soft tissue reconstruction is to improve aesthetic function and subsequently minimise the 
anxiety and negative feelings that are commonly associated with disfigurement.28  Furthermore, it 
is important to restore the mechanical cushioning of muscles, tendons, and bones that is normally 
provided by adipose tissue.29  A number of approaches to repairing soft tissue defects have been 
explored. Small volume defects can be repaired using collagen injections or hyaluronic acid fillers 
and autologous fat grafting, however rapid degradation of fillers and 40–60 % loss of the graft 
volume over time due to resorption is commonly reported.30-32  As a result, repeated procedures 
are often required to maintain shape and volume.31  For treatment of larger soft tissue defects, a 
standard treatment option is autologous tissue transfer using vascularised flaps containing skin, 
adipose and muscle.30  However, this procedure requires considerable surgical skill and is 
associated with donor site morbidity and deformity. Other large volume reconstruction options 
include synthetic implants, however these materials can cause foreign body reactions and 






Adipose tissue engineering aims to address the growing clinical needs related to a number of 
adipose tissue defects and pathologies, by not only promoting volume regeneration but also 
restoring function.  
1.2.2 Acellular approaches  
A number of acellular approaches have been used in adipose tissue engineering to stimulate de 
novo adipogenesis. The main advantages of these techniques include a reduction in cost, avoiding 
issues associated with harvesting and expanding cells in vitro, and minimal immunocompatibility 
issues.34  One acellular approach to adipose tissue regeneration involves the implantation of a 
hollow support structure to provide mechanical protection to the developing fat tissue, often 
combined with a vascular pedicle to promote blood vessel development. In a rat model, de novo 
adipogenesis was achieved inside implanted silicone domes with a pedicled blood supply and 
filled with Matrigel, a basement membrane extract from Engelbreth-Holm-Swarm sarcoma, and 
bFGF.35 Plastic chambers partially filled with a fat flap and implanted into rats also generated 
spontaneous adipose tissue formation, with a higher volume of tissue formed inside perforated 
chambers.36  While these approaches utilise support structures to maintain shape and dimensions 
of the newly formed adipose tissue, implantation requires complex surgical procedures, and 
explantation is also necessary if non-degradable materials are used.6  A recent study by Rodríguez 
et al. reported de novo adipogenesis in mice after implanting fibrous-structured scaffolds 
composed of a biomaterial produced by telopeptide removal from natural collagen, known as 
atelocollagen.37 Tissue resembling adipose was observed 2 weeks after implantation and 





De novo adipogenesis has also been achieved without the use of support structures. An early 
study reported adipose tissue formation after subcutaneously implanting Matrigel and bFGF in 
mice.38  In situ development of adipose tissue has also been achieved in mice without Matrigel, 
using only microspheres containing adipogenic and angiogenic growth factors insulin, IGF-1 and 
bFGF.39 While these studies exploit the physiological mechanisms of adipogenesis, including 
recruitment of endogenous preadipocytes, angiogenesis, and adipogenic differentiation, they do 
not allow for precise control over shape and size of the newly formed tissue.6   
1.2.3 Cell sources  
The therapeutic applicability of adipose tissue constructs is largely influenced by the selection of 
an appropriate cell source that is autologous or non-immunogenic, obtainable in sufficient 
quantities either by direct harvest or expansion in vitro without loss of differentiation potential, 
and harvested using minimally-invasive procedures.6, 40, 41 Therefore, the use of post-mitotic 
mature adipocytes, which have lost their proliferative potential, is unfavourable.42  Furthermore, 
adipocytes are susceptible to mechanical trauma due to the fragility of the large lipid vacuole.42, 43  
Instead, MSCs have been utilised for the engineering of mesodermally derived tissues like 
adipose, as when treated with lineage-specific factors, MSCs demonstrate adipogenic 






While MSCs are commonly procured from bone marrow, known as bone marrow-derived stem 
cells (BMSCs), the procedure is typically associated with donor site pain and morbidity, and low 
cell yield.46  As previously mentioned, adipose tissue also contains a population of MSCs in the 
stroma.47, 48  These cells, termed adipose-derived stem cells (ASCs), can be readily isolated from 
surgical waste generated from routine elective procedures, including liposuctions.41, 47, 48 
Enzymatic digestion of this adipose waste enables isolation of the SVF, which can be cultured 
under conventional two-dimensional (2D) conditions to separate out the adherent ASC 
population.6, 48  One gram of adipose tissue can yield a population of 5 x 103 ASCs, which is 500 
times greater than that obtainable from equal amounts of bone marrow.49, 50  A study comparing 
BMSCs and ASCs harvested from the same patient revealed no significant differences in growth 
kinetics, multilineage differentiation capacity, cell senescence, or yield of adherent stromal cells.51  
Furthermore, a gene array analysis study revealed less than a 1 % difference in gene expression 
between BMSCs and ASCs, with ASCs proving superior at maintaining proliferative ability in 
culture.52 Combined with its abundance and relatively safe procurement, adipose tissue 
represents an attractive MSC source for the translation of adipose tissue engineering research 
into clinical applications. 
It is thought that ASCs perform a dual role in tissue engineering: as building blocks, and sources of 
trophic factors modulating the host response.53  Stem cells are known to actively secrete 
angiogenic and anti-apoptotic cytokines and growth factors that provide a stimulatory 
microenvironment for tissue development.6  A number of in vivo tissue engineering studies have 
demonstrated adipogenic differentiation of host cells at least partially promoted by implanted 
ASCs or BMSCs.54, 55 However, further research into the cytokine secretion of these cells after 
implantation is required to verify this dual role. 
1.2.4 Cell-encapsulated hydrogels 
Hydrogels present an attractive strategy for the translation of adipose tissue engineering to 
clinical applications due to their ability to fill irregularly shaped soft tissue defects.6 Fibrin 
hydrogels encapsulated with ASCs demonstrate good biocompatibility and successful engineering 
of adipose tissue.56, 57  In a study by Wittmann et al., stable fibrin hydrogels were combined with 
biodegradable poly(ε-caprolactone)(PCL)-based polyurethane (PU) scaffolds to generate volume-
stable adipose tissue constructs.58 In vitro adipogenesis has also been observed in collagen gels 
containing short fibres to reduce contraction and deformation.59 Alginate gels have also been 
utilised to differentiate encapsulated ASCs after implantation in mice.60 After 8 weeks of 
implantation, gels maintained approximately two-thirds of their original size. Studies 
encapsulating mature adipocytes in collagen61, 62 or methacrylated gelatin63 hydrogels have also 
demonstrated successful in vitro formation of adipose tissue.   
Hydrogels formed using synthetic polymers such as poly(ethylene glycol) diacrylate (PEGDA) have 
also been used in adipose tissue engineering studies. PEGDA gels encapsulating hBMSCs were 
implanted in athymic mice, and demonstrated 100 % volume retention after 4 weeks.64  However, 






of the implants.6  Pluronic F-127 hydrogels have also been used to differentiate BMSCs, with some 
differentiation observed even in the absence of adipogenic stimuli.65 
1.2.5  Porous scaffolds and sponges 
A major strategy in adipose tissue engineering involves the seeding of cells, most commonly ASCs 
or BMSCs, onto porous 3D scaffolds and subsequent implantation. For optimal soft tissue repair, 
scaffolds should possess biocompatibility, biodegradability, low immunogenicity, and mechanical 
stability. Furthermore, the construct must sufficiently mimic the in vivo environment to promote 
cell attachment, proliferation and differentiation. A prerequisite in the design of adipose tissue 
engineering constructs is pore sizes large enough to accommodate differentiating and mature 
adipocytes with diameters of approximately 10 and 100 µm, respectively.66 Pores must also be 
interconnected to allow effective diffusion of oxygen and nutrients throughout the construct.67 
Furthermore, volume and shape stability are of particular importance in adipose tissue 
engineering to ensure adequate filling of soft tissue defects, by matching the kinetics of tissue 
development and construct degradation.6  Structural support within the scaffold is also required 
to protect the fragile adipocytes and maturing cells from mechanical forces.42    
Porous scaffolds and sponges used in adipose tissue engineering have been fabricated using a 
range of natural or synthetic degradable biomaterials. Constructs made of natural materials offer 
advantages due to intrinsic promotion of cell attachment and low immunogenicity.68  Seeding of 
collagen sponges with hASCs and subsequent implantation into immunodeficient mice led to the 
formation of well-vascularised adipose-like tissue.69  Pore size plays an important factor in 
adipogenic differentiation, with a follow-up study determining that minimum pore size must be 
sufficient to allow for preadipocyte enlargement during differentiation, but no greater than 
approximately 100 µm.70 Similarly, in vitro hASC attachment and adipogenic differentiation has 
been reported in sponges made from hyaluronic acid modified by esterification,71, 72 and 3D 
porous silk-based fibroin scaffolds.73   
Scaffolds fabricated with synthetic biomaterials offer advantages in tissue engineering due to 
easier material scale-up and less batch-to-batch variations, enabling improved reproducibility of 
cell experiments.74  Furthermore, elasticity and hydrophilicity of scaffolds can be better adjusted 
to mimic the ECM.75  Patrick et al. first reported successful engineering of adipose tissue following 
the implantation of ASC-seeded porous poly(lactic-co-glycolic) acid (PLGA) scaffolds in rats.76 It 
was found that adipose tissue developed throughout the constructs and originated from the 
seeded ASCs. In a follow up publication, long-term observations revealed maximum adipose 
formation at 2 months and a complete resorption of the tissue and PLGA after 5 months.77  An in 
vitro study using porous PLGA scaffolds seeded with BMSCs reported adipose tissue formation in 
the outer areas of the scaffold after 4 weeks, with increased adipogenesis achieved with the 
addition of bFGF.78    
1.2.6 Fibre meshes 
Fibre meshes have also been utilised in adipose tissue engineering strategies to provide a cellular 






non-woven meshes with a fibre diameter of 12–14 µm and 96 % porosity were seeded with 
murine 3T3-L1 preadipocytes and differentiated in long-term culture.79  After 35 days of culture, a 
coherent and uniform tissue structure was formed that resembled native adipose (Fig. 2). 
Implantation of these constructs in mice yielded fat pads that were histologically comparable to 
native fat after 3 weeks. A follow-up study using the same model system observed that constructs 
cultured for up to 9 days after in vitro adipogenic induction formed well vascularised mature 
adipose tissues after implantation in mice.80  Needle-punched non-woven fibrous poly(ethylene 
terephthalate) (PET) meshes with a fibre diameter and porosity of approximately 20 µm and 87 %, 
respectively, have also been seeded with 3T3-L1 preadipocytes and differentiated.81 The cells 
acquired morphology and biological features characteristic of mature adipocytes, however the 
non-biodegradable nature of PET limits the clinical applicability of the study.     
 
 
Figure 2. Histological staining of developing 3D adipose tissue constructs over time. In vivo tissue development in the 
preadipocyte-seeded PGA fibre meshes was analysed by hematoxylin and eosin (H&E) staining for cellularity, and 
immunohistochemical detection of laminin, an ECM component. For comparison, native fat from rat femur is also 
shown. Blank spaces within the cells are due to the dissolution of lipids with organic solvents during the 
deparaffinisation process. Figure reprinted with permission from 79 (see Appendix H). 
 
1.2.7 Decellularised matrix 
Scaffolds derived from ECM have also been used in adipose tissue engineering. Adipose tissue 
obtained from liposuction that was washed and homogenised prior to freeze-drying was used to 
form ECM scaffolds that supported the adhesion and proliferation of hASCs in vitro.82  Using a 
more complex technique to remove cells and lipids from adipose tissue, Flynn demonstrated the 
intrinsic ability of decellularised adipose tissue (DAT) to induce expression of PPARƴ and CEBPα in 
seeded hASCs without exogenous differentiation factors.83  A more recent in vivo study by the 
same group showed that ASC seeding of DAT significantly enhanced adipogenesis and 






et al. reported formation of a thin adipose tissue later atop a commercially available acellular 
dermal collagen matrix (Permacol) that was seeded with hASCs and differentiated in vitro.85 In 
order to increase resistance to enzymatic degradation, cross-linking of decellularised matrix 
scaffolds has also been explored.86  Cross-linked ECM constructs seeded with hASCs and 
adipogenically induced showed characteristic adipocyte morphology. In vivo studies were 
performed by injection of decellularised matrix into rats, and revealed good integration with 
adipose tissue development at the periphery of the scaffolds. Incised adipose tissue has also been 
decellularised and combined with hASCs, with graft volume maintained for 8 weeks after 
implantation in Fischer rats.87   
1.2.8 Solution electrospun scaffolds 
Solution electrospinning is a scaffold manufacturing technique utilised in adipose tissue 
engineering due to its potential to produce non-woven meshes with nanofibres that mimic 
natural ECM. Poly(L-lactic) acid (PLLA) has been used to solution electrospin nanofibrous scaffolds 
with average fibre diameter and porosity of 400 nm and 90 %, respectively, for hBMSC seeding 
and adipogenic differentiation in vitro.88  Histologic analysis at day 21 of culture revealed typical 
adipocyte morphology. PLLA has also been combined with PCL to integrate its elasticity with the 
high degradation properties of PLLA. In a study by Liao et al., PLLA and PCL were blended in a 1/1 
ratio and electrospun into membranes with fibre diameters of approximately 780 nm.89  These 
scaffolds allowed multi-lineage differentiation of rabbit ASCs into osteocytes and adipocytes in 
vitro. A follow-up study by the same group demonstrated hASCs were also able to attach and 
differentiate on the nanofibrous scaffolds (Fig. 3).90  PCL has also been solution electrospun into 
nanofibrous scaffolds and seeded with murine embryonic stem cells, which demonstrated 
adipogenic differentiation following hormone induction.91  In a more recent study, rat ASCs were 
seeded on solution electrospun PCL scaffolds with fibre diameters ranging between 
approximately 580 nm and 3.9 µm, and an estimated porosity of 90 %.92  Adhesion of ASCs on the 
electrospun PCL fibres was found to be significantly higher than that of tissue culture plates. 
Mineralised PCL/gelatin core-shell nanofibers have also been produced using a co-axial 
electrospinning technique, and seeded with hASCs.93 The PCL/gelatin mats contained fibres with 
an average diameter of 680 nm, and promoted cell proliferation and osteogenic differentiation.  
 
Figure 3. The morphology of hASCs on PLLA/PCL (1/1 blend) nanofibrous scaffolds (NFS) over time. SEM micrographs 
were taken 1, 3, and 7 days after seeding. The hASCs showed round spots at day 1 due to release from culture flasks by 
trypsin. Irregularly shaped hASCs attached to surrounding fibres, and grew in number from day 3 to 7. Scale bars: 50 






Natural materials with compositions similar to native ECM have also been solution electrospun to 
fabricate nanofibrous scaffolds for adipose tissue engineering. Xu et al. used wheat glutenin, a 
highly crosslinked protein derived from wheat, to electrospin scaffolds with an average fibre 
diameter of around 5 µm.94  The scaffolds were intrinsically water-stable due to disulfide 
crosslinking of cysteine, withstanding 35 days incubation in PBS. Furthermore, hASC adhesion and 
adipogenic induction using hormone inducers were achieved. The same group also fabricated 
intrinsically water-stable electrospun scaffolds using soy protein isolated from soybeans.95  In vitro 
studies demonstrated uniform distribution and differentiation of ASCs within the scaffolds. 
1.3 3D CELL CULTURE 
1.3.1 Background 
In vivo, cells exist in a 3D microenvironment which consists of cell-cell and cell-matrix interactions, 
in addition to soluble growth factors, cytokines, and chemokines.96  There is growing evidence to 
support that this microenvironment plays an important role in determining the stemness 
properties of cells.97, 98  Conventional monolayer cell culture provides an environment that is not 
reflective of in vivo conditions, and as a result, cells typically dedifferentiate and lose  
tissue-specific characteristics.99 Therefore, a number of 3D culturing methods have been 
developed to preserve the stemness properties of stem cells by offering increased cell-cell 
interactions that better mimic physiological conditions. These techniques involve growing cells on 
3D scaffolds or embedding cells in gels, as previously discussed, or alternatively culturing cells as 
aggregates.  Aggregates are commonly known as spheroids, although the actual shape may not be 
perfectly spherical. Spheroids are an advantageous 3D culture model, because cells self-assemble 
and interact under native forces without any foreign materials, generating their own ECM.100   
1.3.2 Spheroid formation techniques 
A number of spheroid fabrication methods have been used. The earliest described cell 
aggregation technique utilised an inverted tissue culture plate lid with drops of cell suspension, 
where cells spontaneously aggregate at the bottom of the drop.101  Known as the hanging drop 
method, this technique has advanced into commercially available formats using 96- and 384-well 
plates to form smaller spheroids with increased control over size.102, 103 Spinner flasks and 
centrifugation are alternative techniques that promote spheroid formation.104, 105 The liquid 
overlay technique utilises non-adherent substrates to cause suspended cells to aggregate instead 
of adhering to the surface.106  This is commonly performed by coating 96-well culture plates with 
agarose prior to seeding with a determined number of cells. A high-throughput adaptation on this 
technique utilises microwell arrays, which have a high number of wells in the micrometer  
scale.107, 108 
1.3.3 ASC spheroids in tissue engineering 
When cultured in suspension or on non-adhesive surfaces, ASCs spontaneously aggregate into 
multicellular spheroids that have demonstrated improved differentiation potential,100 with 






against hypoxia and apoptotic cell death.110 It has also been shown that adherent ASCs derived 
from suspension-cultured spheroids retain the ability to differentiate into multiple cell types after 
serial, long-term culture expansions.111 Furthermore, spheroid-derived ASCs demonstrate 
increased expansion efficiency with less senescence, and express higher levels of pluripotency 
markers and angiogenic growth factors, thereby increasing the regenerative potential of ASCs for 
therapeutic applications.112   
In addition to utilising 3D culture as a strategy for preserving the stemness of ASCs, spheroids 
have been used as functional building units for adipose tissue engineered constructs. Large 
millimetre-sized rat ASC spheroids (Fig. 4) formed spontaneously from an adhered cell layer 
without trypsin treatment were shown to retain adhesion molecules such as fibronectin and 
laminin.113  Spheroids demonstrated superior tissue infiltrating abilities compared to single cells, 
which was thought to be influenced by the presence of these molecules on the surface. When the 
spheroids were seeded onto porous collagen membranes, cells infiltrated the structure and 
formed capillary-like lumen structures in the central region. However, spheroids exceeding 500 
µm in diameter required seeding within 3 days of assembly to avoid cell apoptosis in the core of 
spheroids, likely due to a lack of oxygen and nutrient supply. 
 
 
Figure 4. Large ASC spheroids and their tissue infiltrating properties. ASC spheroids (5.0 x 105 cells) inspected 24 h 
after spheroid formation (A), then sectioned and stained using H&E (B). 3 days after culturing ASC spheroids on 
collagenous tissue membranes, the constructs were sectioned and stained for ASCs (green) (C). Red arrows indicate 
capillary-like structures composed of spheroid-derived ASCs. Scale bars: A: 1 mm; B: 100 µm; C: 50 µm. Figure adapted 
with permission from  from 113 (see Appendix H).  
 
Biomaterials have also been integrated with hBMSCs to form composite multicellular spheroids 
for adipose tissue engineering. In 2012, Kim et al. reported the incorporation of biomimicking PLA 
nanofilaments (NFs) surface-immobilised with a cell adhesive peptide, Arg-Gly-Asp (RGD), into 
hBMSC spheroids.114 The composite spheroids contained hBMSCs surrounded with NFs, bearing 
resemblance to the 3D-mesh structure of natural ECM. The composite spheroids displayed 
increased cell proliferation and adipogenic differentiation. Possible reasons for this include 
enhanced initial cell-matrix interactions with the NFs, or a result of the nanometre-scale pores 
observed on the exterior of the composite spheroids, which could improve mass transport of 
nutrients, oxygen, and adipogenic induction factors. The composite spheroids were also seeded 
on PCL scaffolds with fibre diameters of 200 µm, and void spaces of 400 µm to match the 
diameter of the spheroids (Fig. 5). The spheroid-embedded scaffolds were used as modular 






PCL scaffolds were also functionalised to release bFGF after implantation. After 4 weeks, adipose 
formation and vascularisation were observed in all spheroid-embedded constructs, however more 
extensive capillary ingrowth occurred in constructs containing bFGF.  
 
Figure 5. 3D construct comprised of nanofilament/hBMSC composite spheroids and woodpile-like microfibrous PCL 
scaffold. (A) The composite spheroids were packing along the ordered array of void spaces of the scaffold.  
Scale bar: 1 mm. (B,C) Successive stacking of spheroid-embedded scaffold units to form a 3D cylindrical construct. Scale 
bar: 2 mm. Figure reprinted with permission from 114 (see Appendix H). 
Multicellular ASC spheroids can also be used as initiators of blood vessel formation in tissue 
engineered constructs. In a study by Laschke et al., porous polyurethane scaffolds dynamically 
seeded with murine ASC spheroids containing 5.0 x 103 cells induced a strong angiogenic host 
tissue response after implantation in mice, with significantly higher vascularisation observed 
when compared to scaffolds seeded with individual ASCs.115    
1.4 MELT ELECTROSPINNING WRITING 
1.4.1 Background 
Scaffold-based tissue engineering strategies require porous structural templates that ultimately 
form functioning tissue constructs by allowing cell attachment, invasion, proliferation, and 
excretion of ECM.116  Conventional technologies utilised for porous scaffold fabrication include 
solution casting, gas foaming, particulate leaching, freeze drying, and solution electrospinning.117  
The lack of control over scaffold pore size, geometry, and interconnectivity associated with these 
techniques has led to the adoption of additive manufacturing (AM) techniques more recently. 
AM, also known as rapid prototyping, refers to a group of techniques that enable fabrication of 
3D objects using a layer-by-layer approach according to computer-aided design (CAD).118  
Extensively used AM techniques in tissue engineering applications include selective laser 
sintering, stereolithography, and fused deposition modelling (FDM), as reviewed by Hutmacher et 
al.119  These techniques allow improved control over the structure and porosity of scaffolds, with 
the potential to design custom scaffolds for patients by integrating CAD principles and medical 
imaging.120  However, many of these AM techniques are unable to produce scaffolds with 
filaments small enough for all tissue applications. While nanofibres can be achieved with solution 






often limits cell infiltration.121  An emerging alternative technique for scaffold fabrication that 
allows for more precise control over fibre placement is known as melt electrospinning writing 
(MEW). Capable of producing microfibers in the 5–40 µm range, MEW can be used to fabricate 
scaffolds with fibre struts that are an order of magnitude smaller than FDM.121     
1.4.2 Melt electrospinning writing process 
Electrospinning is an electrohydrodynamic process capable of producing ultra-fine fibres from a 
diverse range of natural and synthetic materials. During electrospinning, a polymer solution or 
melt is pumped to the tip of a spinneret and held by surface tension. A high potential difference is 
applied between the spinneret and a collector, and when charge repulsion overcomes the surface 
tension of the polymeric fluid, a Taylor cone is formed and an electrified jet is ejected from the 
spinneret and drawn towards the collector.122  In the case of solution electrospinning, evaporation 
of solvent occurs as the jet travels towards the collector and solidifies. Melt electrospinning is 
inherently solvent-free, and accordingly solidification of the polymer melt instead occurs by 
cooling down in the air or on the collector.123  When the jet falls on a stationary collector, 
whipping and coiling occurs (Fig. 6). In MEW, whipping is reduced by using a moving collector 
plate, and linear fibres can be produced when the collector speed exceeds the jet speed, known 
as the critical translation speed (CTS).124, 125  In a publication by Brown et al., it was shown that 
straight fibres could be obtained with collector speeds ranging from 8.3–16.6 mm s-1.124  In a 
strategy adapted from AM methods, these fibres can then be laid on top of each other to build 3D 
scaffolds for tissue engineering applications. 
 
 
Figure 6. Schematic illustration of melt electrospinning writing with increasing collector speed. Melt electrospinning 
on a stationary collector results in jet bending instabilities and whipping (A); melt electrospinning on a slow translating 
collector reduces whipping (B); further increasing translational speed results in coiled fibres without whipping (C); linear 
fibres are produced from increasing the collector speed to the critical translation speed (D). Figure reprinted with 
permission from 125 (see Appendix H). 
 
A MEW device typically consists of a syringe containing polymer kept molten by two heaters and 
acted on by pneumatic pressure to feed the polymer towards a nozzle or spinneret which is 
surrounded by an electrode (Fig. 7). The electrode and collector plate are connected to voltage 
sources, generating an electric field that causes electrohydrodynamic jet formation. The jet is 






Y-directions, translating the scaffold design. Process parameters that affect scaffold morphology, 
particularly fibre diameter, have been extensively reviewed by Cipitria et al.122, and include: feed 
rate, viscosity, and conductivity of the material; distance between the spinneret and collector; 
voltages applied to the spinneret and collector; temperature of the polymer; and ambient 
temperature and humidity. MEW typically produces fibres in the micron scale, however 
submicron filaments have also been reported.126 
 
Figure 7. Schematic of a melt electrospinning writing device. The computer-controlled pneumatic feeding system (1) 
and electrical heating system (2), high voltage source (3), computer-aided moving collector plate (4), and syringe 
containing molten polymer and spinneret with electrode (5) are shown. Figure reprinted with permission from 126 (see 
Appendix H). 
1.4.3  Poly(ε-caprolactone)  
The most widely investigated polymer for MEW is poly(ε-caprolactone) (PCL), a biocompatible and 
bioresorbable synthetic polymer with a glass transition temperature of -62 °C and a low melting 
point of 59–64 °C depending on the degree of crystallinity.127  PCL has a very slow degradation 
rate of 2–4 years due to its semi-crystalline and hydrophobic nature.128, 129  PCL undergoes a two-
stage degradation process, wherein random hydrolytic cleavage of ester groups is followed by 
intracellular uptake and degradation of PCL fragments.127, 130  Due to its low cost and Food and 
Drug Administration (FDA) approval, PCL has been used clinically since the 1980s as a suture 
material and slow release drug delivery device.122 However, in scaffold-based tissue engineering 
applications, the hydrophobic nature of PCL typically necessitates surface modification of 
constructs to facilitate cell attachment. Nevertheless, PCL remains the most commonly used 
polymer for MEW of scaffolds due to its low melting point, good blend-compatibility, low cost and 
FDA approval. 
1.4.4 Melt electrospinning writing of scaffolds 
As mentioned previously, fibrous scaffolds are extensively used in tissue engineering research, 
providing necessary support and ECM-like structure for cell attachment, migration and 






controlling fibre deposition. A common AM scaffold design with a square porous geometry, 
known as a “woodpile” structure, is formed by printing a series of parallel fibres in one direction, 
then offsetting the fibre deposition by 90° in the next layer (Fig. 8 A).131 To achieve this with MEW, 
where deposition is performed with a continuous filament, a square wave pattern is typically 
utilised. Using this laydown pattern with multiple layers, it is possible to create box structured 
scaffolds (Fig. 8 B–D). In a recent study by Hochleitner et al., box structured scaffolds with a fibre 
diameter of 817 ± 165 nm and height of 80 µm were produced using the following parameters: 
accelerating voltage = 2.9 kV; collector distance = 1.5 mm; spinneret temperature = 84 °C; feeding 
air pressure = 2.8 bar; spinneret diameter = 33 G; velocity = 5500 mm min-1.126  It is important to 
note that MEW fibres are typically microscale, however this is still an order of magnitude smaller 
than attainable by FDM. Also, due to the smaller fibre diameter, MEW is able to produce scaffolds 
with higher porosity. In a study by Farrugia et al., PCL scaffolds fabricated by MEW with a 
thickness of 180 ± 40 µm were calculated to have a porosity of approximately 87 %,132 compared 
to the approximate 75 % porosity limit achievable by FDM.133, 134  However, unlike FDM, MEW is 
limited by a maximum achievable height of controlled fibre deposition, largely due to charge 
accumulation on the deposited polymer, which produced undesired Coulombic forces.124  This can 
be significantly improved by applying a negative voltage to the collector plate, which has been 
shown to increase the number of ordered layers achievable by MEW.135   
 
 
Figure 8. Schematic illustration of alternate deposition of fibres in 0° and 90° directions to form a “woodpile” structure 
(A); Scanning electron microscope (SEM) image of box structured PCL scaffold fabricated by MEW with submicron fibres 
(B); SEM images of the stacking (C) and weaving (D) of fibres in a melt electrospun PCL scaffold to form 1 mm x 1 mm x 
1 mm boxes. Panels A and B are adapted with permission from 126; panels C and D are adapted with permission from 124 






A recent study by Hochleitner et al. was published describing fibre pulsing instability, defined as 
the undesired sectional oscillation of the fibre diameter during MEW of PCL.136 While maintaining 
constant the spinneret diameter, polymer heating temperature, and collector distance, it was 
found that excessive feeding pressure (2.0 bar) and low acceleration voltage (5.25 kV) caused 
fibre pulsing. Furthermore, increasing the translational speed above the CTS not only resulted in a 
reduction in fibre diameter due to mechanical stretching, but also caused a growing lag of the jet, 
resulting in discrepancies between the computer-programmed movement and the path of fibre 
deposition. 
1.4.5  In vitro interactions with melt electrospun scaffolds 
In order for scaffolds fabricated by MEW to be applicable to tissue engineering, suitability for in 
vitro cell attachment and migration must be demonstrated. In a study by Farrugia et al., melt 
electrospun PCL scaffolds with a fibre diameter of 7.5 ± 1.6 µm and average inter-fibre distance of 
46 ± 22 µm were top-seeded with human dermal fibroblasts.132  ECM was evident throughout the 
scaffold after 7 days of in vitro culture, with full cell penetration achieved after 14 days. Murine 
3T3-E1 calvarial osteoblastic cells seeded on melt electrospun scaffolds with 90° cross-hatched 
fibre architecture and a fibre spacing of approximately 500 µm were observed to attach and 
spread on the scaffold fibres after 3 days in vitro (Fig. 9 A–B).135  Murine 3T3-E1 cells have also 
been grown on melt electrospun PCL scaffolds with 600 µm square pores.137  The cells were 
observed to initially adhere to the wall of the pores at day 6 of culture, forming a circular 
structure via cell-cell contact. However, by day 14 the pores were filled. Similar results were 
obtained in cell attachment studies performed on the aforementioned submicron fibre box 
structure scaffolds using hBMSCs (Fig. 9 C–D).126  Cells were observed adhering to and migrating 
along fibres, and were eventually able to fill the box pores. Combined, these studies show the 








Figure 9. Various in vitro interactions with melt electrospun box structured PCL scaffolds. Live/dead (A) and 
DAPI/Phalloidin (B) staining of murine 3T3-E1 cells seeded onto scaffolds with 500 µm fibre spacing after 3 days in vitro 
(DIV), demonstrating cell-fibre and cell-cell interactions. Hoechst/Phalloidin staining of scaffolds with 150 µm square 
pores seeded with hBMSCs after 4 (C) and 10 (D) DIV. Hoechst also stained the PCL fibres blue. Panels A and B reprinted 
with permission from 135; panels C and D reprinted with permission from 126 (see Appendix H). 






2. Project Goals 
Adipose tissue engineering aims to generate fat that is structurally and functionally equivalent to 
native tissue that can be used to aid in the repair or reconstruction of soft tissue defects arising 
from trauma, tumour resections, or congenital abnormalities. Particularly in trauma cases, 
reconstruction of the damaged subcutaneous fat layer would not only add volume, but also 
improve tissue elasticity and prevent the formation of adhesions to tendons, nerves and blood 
vessels, which is associated with restricted movement and disabling pain.138 
The ultimate goal of this project is to explore a novel approach to adipose tissue engineering by 
combining spheroids with melt electrospun box structure meshes or scaffolds. It is envisaged that 
these tissue constructs could generate a thin adipose tissue layer for the reconstruction of 
subcutaneous tissue, with the potential to deliver both functional and aesthetic results in future 
clinical applications. The support structure of these tissue-engineered cell sheets will be provided 
by PCL, which could offer advantages over natural ECM-derived alternatives do to its better 
stability, and enable easier handling. Furthermore, the slower degradation of PCL could prove 
advantageous for shape maintenance while the adipose tissue develops in vivo. While the project 
will be undertaken in an adipose tissue engineering context, it has the potential to establish a 
completely new general principle in tissue assembly. 
The success of this adipose tissue engineering strategy is dependent on close size matching of the 
spheroids and the box pores within scaffolds. MEW allows a high degree of control over box sizes, 
and will be used to fabricate the scaffolds out of PCL using existing optimised processing 
parameters. Spheroids will be formed using hASCs, which are an attractive cell source due to their 
easy procurement from byproducts of liposuction, and multilineage differentiation potential 
capacity. The technique for spheroid formation is well-established, and size can be controlled by 
cell seeding number. By combining spheroids and fibrous scaffolds with box-shaped pores, which 
appear as a natural match, it is hoped that an organised and coherent tissue structure will be 
formed. Adipogenic differentiation of the hASC spheroids could then be induced and studied in 
vitro. Alternatively, the construct could serve as a cell carrier for application of ASCs into 
subcutaneous tissue defect sites and facilitate in vivo adipogenesis, allowing for improved control 
over location compared with cell implantation alone.  
To achieve the goals outlined above, the specific aims include: 
1. Establishing an optimal spheroid size to seed in the box-shaped pores of PCL scaffolds, 
determined by ease of handling and adipogenic differentiation potential. 
2. Appropriately matching spheroid and scaffold box sizes to enable seeding of only one 
spheroid per box. 
3. Achieving homogeneous filling of box pores with spheroids to form a coherent tissue. 
4. Studying cell adherence and spheroid stability in the scaffolds. 
5. Investigating adipogenic differentiation of the spheroids within the scaffold. 




3. Chapter 1: Establishing the Optimal Spheroid Size 
3.1  EXPERIMENTAL DESIGN 
In order to effectively seed spheroids into box structured scaffolds, the dimensions of the boxes 
and spheroids must be closely matched. Therefore, the aim of this preliminary experiment was to 
generate data on a range of spheroid sizes, ultimately enabling selection of an optimal size for 
seeding experiments. To achieve this, spheroids were formed with 0.1 x 104, 0.5 x 104, 1.0 x 104, 
and 2.0 x 104 hASCs and differentiated into the adipose lineage, with diameter measurements 
recorded at regular intervals. It was hypothesised that a wide range of spheroid sizes would be 
generated, enabling evaluation of spheroid handling ease and providing insight on the 
relationship between spheroid dimensions and differentiation.  
3.2 MATERIALS AND METHODS 
3.2.1 Isolation and expansion of hASCs 
Abdominal lipoaspirate from a consenting healthy female donor was used to isolate and expand 
hASCs (see Appendix A). 
3.2.2 Generating hASC spheroids 
The liquid overlay technique was used to generate 3D spheroids (Fig. 10). This technique utilises a  
non-adherent culture surface to prevent cell adhesion, ultimately leading to the aggregation of 
cells into a 3D spherical structure. In this study, 96-well tissue culture polystyrene plates were 
coated with a 1.5 % agarose solution dissolved in DMEM/F-12 without supplementation. 50 µl of 
autoclaved agarose solution was pipetted into each well under sterile conditions and left to cure. 
Passage 2 hASCs were then centrifuged, resuspended in basal medium (PBM2 supplemented with 
10 % FCS and 1 % penicillin-streptomycin) and seeded in the coated well-plates with densities of 
0.1 x 104, 0.5 x 104, 1.0 x 104, or 2.0 x 104 cells/well. The outer rows of each plate were filled with 
100 µl of sterile PBS containing 1 % penicillin-streptomycin instead of cells, to reduce evaporation 
of the medium during culture. The well-plates were cultured on an orbital shaker (Heidolph, 
Schwabach, Germany) at 50 rpm at 37 °C and 5 % CO2.   
 
Figure 10. Generating hASC spheroids using the liquid overlay technique. After expansion in flasks, hASCs were seeded 
in agarose-coated 96-well plates with calculated densities. The agarose created a non-adherent surface, and following 
agitation on an orbital shaker, one spheroid was formed in each well. 
 
 




3.2.3  Adipogenic differentiation 
After culturing in basal medium for two days, adipogenic differentiation was induced in the 
spheroids. This time point was designated as day 0, and involved exchanging the basal medium 
for induction medium. Induction medium consisted of basal medium and hormonal inducers 
including dexamethasone, human insulin, 3-isobutyl-1-methylxanthine (IBMX), and indomethacin 
(see Appendix A).  
3.2.4 Imaging spheroids and measuring diameters 
Prior to each medium change at days 0, 2, 5, 7 and 9, spheroids were imaged in the well plates 
using an Olympus IX51 inverted microscope equipped with an XC30 digital camera (Olympus, 
Hamburg, Germany). For each group, 5 spheroids were imaged and measured at each time point. 
Due to the imperfect spherical shape of the spheroids, diameter was determined by measuring 
the area of the 2D image the freehand selection tool in ImageJ software and then using the 
following formula, where D is the diameter and A is the area: 
 
S
AD 4  
 
The theoretical volume of spheroids was then calculated using the following formula, where V is 
the volume, and r is the radius: 
3
3
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These volumes were then normalised to the number of cells seeded in each spheroid group. 
3.2.5 Cryosectioning and Oil Red O staining 
Spheroids were harvested from the well-plates at days 0 and 9, cryosectioned and then stained 
using Oil Red O and hematoxylin to visualise lipid content and nuclei, respectively (see Appendix 
B).  
3.2.6 Determining DNA and triglyceride content 
At days 0 and 9, induced and control spheroids were harvested from the well-plates for 
quantification of DNA content and intracellular triglyceride (TG) accumulation (see Appendix C).  
3.2.7 Statistical analysis 
GraphPad Prism 7 software was used to perform statistical analysis. All quantitative result values 
are expressed as mean ± standard deviation (SD). Analysis of variance (ANOVA) was used to 
assess statistical significance, with subsequent multiple comparisons according to Bonferroni 
post-hoc test. A value of p < 0.05 was considered statistically significant.  
 
 




3.3 RESULTS AND DISCUSSION 
3.3.1 Effect of cell number on spheroid size 
As expected, spheroid sizes at day 0 of induction increased with the increasing number of seeded 
cells (Fig. 11 A). The spheroid diameters varied from approximately 187 ± 12 µm (0.1 x 104 cells) to 
580 ± 23 µm (2.0 x 104 cells) (Fig. 11 B). Minimal variations in diameter were seen within each size 
group, as shown by the small error bars. This suggests spheroid size was well controlled and 
reproducible, which has important implications for seeding in MEW scaffolds with highly ordered 
and precise box dimensions.  
 
Figure 11. Spheroids formed with varying numbers of hASCs. A) Inverted microscope images were taken at days 0 and 
day 9 of adipogenic induction. Scale bar: 200 µm. B) Diameter measurements of spheroids formed with 0.1 x 104, 0.5 x 
104, 1.0 x 104 and 2.0 x 104 hASCs. Measurements were taken at days 0, 2, 5, 7, and 9 of adipogenic induction. Only the 
results from day 0 (white), day 5 (light grey), and day 9 (dark grey) are shown here. Measurements of non-induced 
(non) spheroids formed with 0.5 x 104 cells are also shown. * Statistically significant differences (p < 0.05) between day 
0, and days 5 and 9 in each group. c Statistically significant difference between day 5 and 9 in each group. Data 
represents mean ± SD (n = 5). 




Due to the 3D nature of spheroids, it is not accurate to compare size between the groups using 
diameter alone. Instead, theoretical volumes of the spheroids were calculated from measured 
diameters. When volume was normalised to the number of cells seeded, it was found that the 
increase in spheroid sizes between the 0.1 x 104, 0.5 x 104, 1.0 x 104 and 2.0 x 104 groups was 
larger than could be attributed to increased seeded cell number alone (see Appendix D). This 
effect was even more pronounced at day 9 of induction. As expected, adipogenic induction led to 
a significant increase in spheroid size in all groups between days 0 and 9, due to intracellular 
accumulation of lipids. In the non-induced control group, spheroid size decreased during the 9 
day culture period. It is interesting to note that in the 1.0 x 104 cell group, spheroid size peaked at 
day 5 of induction and then significantly decreased by day 9. Further investigation is required to 
determine if this the underlying cause of this. 
It is important to note that the rudimentary method for calculating spheroid volume assumed 
that the spheroids were perfectly spherical, which was not the case. However, because the 
ultimate goal of the experiment was to determine the optimal spheroid size for seeding into box 
structured scaffold, diameter was considered the most important parameter to measure, and 
volume calculations were only made to enable size comparisons between the groups. Accordingly, 
if more accurate spheroid volumes were required, other measurement techniques would have 
been utilised. 
3.3.2 Effect of spheroid size on cell differentiation  
The effect of spheroid size on hASC adipogenic differentiation was also investigated. Qualitative 
analysis was performed using Oil Red O staining of spheroid cryosections to visualise accumulated 
lipid droplets after 0 and 9 days of adipogenic induction. Hematoxylin was used to staining cell 
nuclei. As expected, adipogenic differentiation under induction conditions was observed by red 
staining of the accumulated intracellular lipid droplets in all spheroid groups (Fig. 12 A; e–h). At 
day 0 and under control conditions, no adipogenesis was evident in the spheroids (Fig 12 A; a–d, 
i). The void spaces present between cells at day 9 of induction, which enlarged accordingly with 
increased spheroid dimensions, were an unexpected observation. While further investigation is 
required to rule out sectioning and staining processing artefacts, this finding could explain the 
disproportionate enlargement of spheroids with increased cell number described in section 5.3.1. 
Alternatively, particularly in the two largest spheroid groups, these voids could be explained by 
necrosis and/or apoptosis of cells due to a lack of oxygen and nutrients. Other studies have 
reported that 500 µm is the upper diameter limit for viable spheroids.113, 139, 140  The 1.0 x 104 and 
2.0 x 104 cell-seeded spheroids had diameters that exceeded this at day 9, at 511 ± 4 µm and  
698 ± 12 µm, respectively. Iwai et al. recently reported minimal apoptosis in millimetre-sized rat 
ASC spheroids until culture exceeded 3 days.113 This could provide an explanation for the low 
prevalence of voids in day 0 spheroids, which were only cultured for 2 days. Histological analysis 
at earlier time points of adipogenic differentiation in addition to non-induced controls for all size 
groups are required to elucidate whether the voids are due to adipogenic induction, prolonged 
culture conditions, or both.  
Quantitative analysis of adipogenic differentiation was performed by measuring TG content  
(Fig. 12 B). These results confirmed the histological findings, with a significant increase in TG 
content in all induced groups compared to negligible values at day 0 (data not shown). 




Furthermore, all induced groups contained significantly higher TG content than the non-induced 
control group. However, as the TG content was normalised to DNA, which correlates to cell 
number, it is interesting to note that spheroid size appeared to affect adipogenesis. Contrary to 
what was indicated in the histological analysis, the 1.0 x 104 cell group was shown to most 
effectively differentiate, with a significantly higher content of TG than the 0.5 x 104 group. This 
could be interpreted as a density effect because spheroids containing more cells have increased 
cell-cell contacts, and the drop in TG content in the 2.0 x 104 cell spheroids could be due to 
counteracting of this effect by limited diffusion of oxygen, nutrients, and adipogenic inducing 
factors in the central region. However, further investigation is required to confirm this.  
3.4 CONCLUSION 
In this study, hASC spheroids with a range of sizes were produced by varying the number of cells 
seeded. Adipogenic differentiation was varied among all spheroid sizes, as determined by 
qualitative and quantitative methods. In order to determine the optimal spheroid size for scaffold 
seeding, a compromise must be reached between large spheroids that are easy to handle and 
require fewer units to generate a tissue construct of a given size, and smaller spheroids that 
differentiate more effectively and do not undergo apoptosis or necrosis in the central region. For 
these reasons, the smallest and largest spheroid groups were deemed impractical for initial 
seeding experiments. The 0.1 x 104 cell spheroids were the most difficult to handle due to their 
small size, and demonstrated the lowest adipogenic differentiation according to quantified TG 
content. While the 2.0 x 104 group performed better in the TG quantification assay and were the 
easiest group to handle, issues with cell viability in long term culture associated with the use of 
spheroids this size rendered the spheroids impractical for scaffold seeding. Therefore, it was 
decided that the mid-sized spheroid groups were optimal for scaffold seeding experiments. The 
0.5 x 104 group displayed optimal morphology in the histological analysis, but the larger 1.0 x 104 
cell spheroids were easier to handle, and quantification of TG content indicated significantly 
higher adipogenic differentiation. Scaffold seeding experiments will further clarify which size is 
most optimal.  





Figure 12. Adipogenic differentiation of hASC spheroids formed using varying cell numbers. A) Oil Red O staining at 
days 0 (a–d) and 9 (e–h) after induction (ind); nuclei were counterstained with hematoxylin. Spheroids formed with cell 
numbers of 0.1 x 104 (a, e), 0.5 x 104 (b, f, i), 1.0 x 104 (c, g) and 2.0 x 104 (d, h) are shown. Non-induced (non) spheroids 
formed with 0.5 x 104 hASCs served as a control (i). Scale bars: 50 µm. B) Triglyceride (TG) content of spheroids formed 
with 0.1 x 104, 0.5 x 104, 1.0 x 104 and 2.0 x 104 hASCs at day 9 of adipogenic induction. Quantitative analysis of 
differentiation was performed at days 0 and 9 of induction. Only the quantitative results of day 9 are shown here. Non-
induced (non) spheroids formed with 0.5 x 104 cells served as controls. TG content was normalised to the DNA content. 
* Statistically significant differences (p < 0.05) between induced samples and non-induced control. c Statistically 
significant difference between 1.0 x 104 group and 0.5 x 104 group. Data represents mean ± SD (n = 3). 





4. Chapter 2: Seeding Spheroids onto Melt Electrospun Scaffolds 
4.1 EXPERIMENTAL DESIGN 
The aim of this proof-of-concept study was to use MEW to fabricate PCL scaffolds with different 
box pore dimensions, and to establish whether these pores were of an appropriate size to enable 
seeding with hASC spheroids. To achieve this, scaffolds were printed using G-code for 400 and  
500 µm box sizes to match the diameters of 0.5 x 104 and 1.0 x 104 cell spheroids, respectively, 
measured in the previous study. The effectiveness of spheroid seeding technique was determined 
by monitoring spheroid attachment to the boxes. Homogeneity of box filling was also assessed, 
due to the ultimate goal of using spheroid-seeding to form a coherent adipose-like tissue. 
4.2 MATERIALS AND METHODS 
4.2.1 Fabrication of scaffolds 
A custom-built MEW printer was used to fabricate the scaffolds in this study (see Appendix D). 
Following stabilisation of the electrified polymer jet, box-structure scaffolds were melt 
electrospun by alternating deposition of layers by 0° and 90°. Four scaffolds measuring  
48 x 48 mm with box sizes of 400 µm (hereafter referred to as 400_10) were printed with a total 
of 10 layers (5 layers deposited in each direction). For the 500 µm box-structure scaffolds, 10 and 
20 total layers were printed (hereafter referred to as 500_10, and 500_20, respectively). 
Furthermore, due to the seeding of larger spheroids in these constructs, fibre thickness was 
increased to enable greater wall height in the boxes.  
4.2.2 Imaging of scaffolds 
Scaffolds were imaged using an Olympus IX51 inverted microscope fitted with an XC30 digital 
camera (Olympus, Hamburg, Germany). The straight line selection tool in ImageJ was used to 
measure the box width from these images. Measurements were repeated in 20 different regions 
of the scaffolds, and mean box width was calculated. 
4.2.3 Generating hASC spheroids  
Based on the results obtained in Chapter 5, it was decided that spheroids of 0.5 x 104 and  
1.0 x 104 cells would be formed and used for seeding of the 400_10 and 500_10 scaffolds, 
respectively. Passage 5 hASCs from the same donor were formed using the liquid overlay 
technique described in section 3.2.2. Spheroids were imaged immediately prior to seeding to 
ensure measurements were similar to those obtained in chapter 5.  
4.2.4 Seeding technique 
Scaffolds were cut into squares measuring approximately 12 x 12 mm, sterilised in EtOH, seeded 
with spheroids using a top-seeding technique assisted by rings, and cultured in basal medium (see 
Appendix E).  
 





4.2.5 Imaging of seeded scaffolds 
Spheroid-seeded scaffolds were imaged using an Olympus IX51 inverted microscope fitted with an 
XC30 digital camera (Olympus, Hamburg, Germany) immediately after seeding, and 24 hours later. 
4.3 RESULTS AND DISCUSSION 
4.3.1 Scaffold morphology 
PCL scaffolds were melt electrospun using G-code written to produce box-shaped pores with sizes 
of 400 µm and 500µm to match the spheroid sizes measured in chapter 5. As the G code did not 
factor in fibre thickness, actual box dimensions in the printed scaffolds are smaller. Box pore 
dimensions were measured from inverted microscope images using the line selection tool in 
ImageJ. It was found that the 400_10, 500_10, and 500_20 scaffolds had mean box widths of  
379 ± 4 µm, 472 ± 3 µm, and 452 ± 13 µm, respectively. The smaller pore size and increased 
variability in the 500_20 scaffolds was due to disorder of fibres in the upper layers (see Appendix 
G), and as a result, these scaffolds were deemed unsuitable for seeding with spheroids. 
Unfortunately, fibre diameter could not be accurately measured from the inverted microscope 
images, due to the 3D nature of the scaffolds and the inability to discern between layers of fibres 
in the images. In future, scanning electron microscopy will be performed to allow accurate fibre 
diameter measurements, in addition to determining scaffold height. However, a rudimental 
estimate of fibre diameter can be extrapolated by comparing the G code and measured box 
widths. Using this technique and qualitative assessment of the scaffolds, it was verified that fibres 
in the 500_10 scaffolds had a greater diameter than those in the 400_10 scaffolds. 
4.3.2 Spheroid-seeded scaffolds 
Scaffolds were cut into 12 x 12 mm squares, sterilised in 70% EtOH, and then top-seeded with 
hASC spheroids inside ring structures. Spheroid sizes were appropriately matched to box 
dimensions, and were readily organised in the box pores by gravity immediately after seeding 
without any need for manual manipulation (Fig. 13; a, b). Furthermore, no instances of multiple 
spheroids within one box were observed, indicating that the spheroids were not too small. While 
culture medium leaked out of the rings, spheroids remained inside but were carried to the 
periphery of the scaffolds by the moving liquid. After 24 hours, the scaffolds were transferred to a 
new well plate and imaged (Fig 13; c, d). Spheroids had preferentially attached to the PCL fibres 
over the adhesive tissue culture plate, as minimal cells remained in the original plate after 
transfer of the scaffolds. In the 400_10 scaffolds, with box widths and spheroid diameters of  
379 ± 4 µm and 350 ± 14 µm, respectively, hASCs grew out of the spheroids and almost entirely 
filled many of the box pores within this short time. Furthermore, cells were seen attached to 
fibres that were not immediately adjacent to spheroids, indicating migration of the hASCs along 
the fibres. This effect was less pronounced in the larger 500_10 scaffolds, with box widths and 
spheroid diameters of 472 ± 3 µm and 420 ± 17 µm, respectively. In these scaffolds, spheroid 
shape was still discernable after 24 hours, with less cell migration out of the spheroid and onto 





the walls of the box pores. Further investigation is required to determine if this was due to less 
accurate matching of box pore and spheroid size, or a result of the thicker fibres in the scaffolds.  
In all scaffolds, inhomogeneous seeding patterns were observed due to spheroids randomly 
falling into boxes during the top-seeding technique. This effect was exaggerated by the number of 
boxes in the scaffolds far exceeding the number of spheroids that were seeded. Nevertheless, 
spheroids that were located in adjacent boxes did show signs of fusing together, which is a 
promising indicator that this technique could have future applications in the formation of 
coherent adipose-like tissues.  
 
Figure 13. Inverted microscope images of hASC spheroid-seeded melt electrospun PCL scaffolds. Spheroids formed 
with 0.5 x 104 (a, c) and 1.0 x 104 cells (b, d) were seeded in scaffolds with 10 layers and box widths of 379.1 ± 4.2 µm 
and 472.3 ± 2.7 µm, respectively. Inverted microscope images were taken immediately after seeding (0 h; a, b) and 24 
hours later (24 h; c, d), after transferring the scaffolds to a new well plate. Scale bars: 200 µm. 
4.4 CONCLUSION 
In this proof-of-principle study, box structure PCL scaffolds were fabricated using MEW and 
successfully seeded with size-matched hASC spheroids. Despite issues with uncontrolled 
placement of spheroids in the box pores due to the rudimental and experimental seeding 
technique used, spheroids readily attached to the scaffold and showed signs of fusing with 
adjacent spheroids. The hASCs demonstrated preferential attachment to the PCL fibres over the 





tissue culture plate, and began to populate the mesh. However, the short space of time in which 
this occurred was unexpected, with an almost complete loss of spheroid structure in less than  
24 hours observed in some of the samples. Although this was not the desired effect of seeding the 
scaffolds with spheroids instead of using a conventional single-cell suspension, this could provide 
an alternative method for fast population of fibrous meshes. In an effort to preserve spheroid 
structure after seeding, it would be worthwhile to investigate the effect of increased culture time 
prior to seeding or fabricating scaffolds with increased layer height. Further experiments are also 
required to optimise the seeding technique and improve control over spheroid placement, in 






5.        Future Recommendations 
a) Improving seeding homogeneity 
Follow up experiments should be simplified by seeding with only one spheroid size until the 
technique is better established. Homogeneity of box-filling must also be improved to enable 
reproducible results, by either: 
x more closely matching the number of boxes available in the scaffold with the number of 
spheroids seeded, either by utilising smaller scaffolds, seeding an increased number of 
spheroids, or covering areas of the scaffold with a cell non-adhesive material like agarose 
x using a syringe pump, where spheroids and medium are the scaffold is used as a filter 
containing spheroids and medium 
b)  Adipogenic differentiation 
It is also important to investigate adipogenic differentiation of spheroids in the scaffold, by: 
x comparing the effect of differentiating spheroids pre- and post-seeding into the meshes 
x inducing the spheroids immediately after seeding, and 1 or 2 days later, when the cells 
have migrated out of the spheroid and started to populate the fibres, to determine if 
adipogenic differentiation has an effect on spheroid dissociation 
c) Analysis techniques 
Techniques used to analyse the seeded scaffolds also need to be investigated, including 
histological analysis using Oil Red O staining and immunohistochemistry, however techniques for 
sectioning the constructs must first be explored. While cryosectioning of scaffolds would enable 
visualization of intracellular lipid droplets, preliminary experiments have shown issues with 
adhesion of PCL onto glass slides. Paraffin sectioning could be used, however the technique 
results in loss of lipids. In order to quantify adipogenesis, cells could be digested off the scaffolds 
for DNA and TG analysis using previously described assay techniques.  
d) Scaffold design 
Scaffolds with a layer height more similar to spheroid diameter should be explored, to determine 
if this reduces spheroid dissociation. Additionally, other scaffold designs should be tested, 
including a gradient of fibre thickness such that fibres at the base are widest and become thinner 
in the upper layers. This would change the geometry of the pores to potentially better match with 
the shape of the spheroids. Additionally, a base could be printed on scaffolds by reducing fibre 
spacing in the lower layers, preventing spheroids from falling through. 
e) Other 
Surface modification of the PCL fibres could be explored to modulate cell attachment and 
therefore potentially also reduce or prevent spheroid dissociation. Furthermore, to rule out cells 






performed using non-adhesive or agarose coated plates. Another important experiment to 
perform would be a comparison of scaffolds seeded with spheroids, and scaffolds seeded with a 
comparable number of single cells, to determine if there is an advantage to spheroid seeding, in 
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Protocols for a) Isolation of SVF from Lipoaspirate; b) Expansion of hASCs in 
Culture; and c) Preparation of Induction Medium  
a) Isolation of SVF from Lipoaspirate 
Abdominal lipoaspirate from a healthy female donor was incubated at 37 °C for 2 h on an orbital 
shaker at 100 rpm in a collagenase buffer (pH 7.4; 0.1 M HEPES, 120 mM NaCl, 50 mM KCl, 1 mM 
CaCl2, and 5 mM glucose), containing 0.1 % collagenase NB4 from Clostridium histolyticum and 1.5 
% BSA. Following enzymatic digestion, the suspension was filtered through a 100 µm nylon mesh 
and then centrifuged at 311 x g for 10 min. Mature adipocytes floating atop the solution were 
then removed, and PBS was added prior to a further centrifugation step at 311 x g for 10 min. Any 
remaining floating adipocytes were then removed, and the solution was filtered again through a 
100 µm nylon mesh, and centrifuged for a third time at 700 x g for 10 min. The supernatant was 
then removed, and culture medium (DMEM/F-12 supplemented with 10 % FCS and 1 % penicillin-
streptomycin solution) containing 5 % DMSO was added to resuspend the cell pellet, termed the 
stromal vascular fraction (SVF). The SVF was then placed in vials and stored in isopropanol at -80 
°C overnight to facilitate slow freezing of the cells, and then cryopreserved in liquid nitrogen until 
required for culturing studies. 
b) Expansion of hASCs in Culture 
SVF was rapidly thawed and then seeded in T175 cell culture flasks with 25 ml of culture medium 
(DMEM/F-12 supplemented with 10 % FCS and 1 % penicillin-streptomycin) and 7.5 µl of bFGF to 
facilitate expansion of hASCs. After 24 h of incubation at 37 °C and 5 % CO2, culture medium was 
changed to remove DMSO and non-adherent cells. Culture medium was changed every 3–4 days 
until the cells were confluent. The hASCs were then passaged by washing with PBS and 
detachment from culture flasks using Trypsin-EDTA (0.25 %). Culture medium was added to stop 
the enzymatic reaction, and the suspension was centrifuged at 311 x g for 10 min. After the 
removal of supernatant and the addition of 10 ml of culture medium to resuspend the pellet, cell 
density was calculated using a hemocytometer. Cells were reseeded in T175 flasks and cultured 
until confluent again for further expansion. 
c) Preparation of Adipogenic Induction Medium 
Adipogenic induction medium was prepared using the following volumes of stock solution to 
achieve the required final concentration in the basal medium (Table 1). The non-induced control 
group was cultured in basal medium for the duration of the experiment. On days 0, 2, 5 and 7, 
induction or basal media was exchanged in the induced and control groups, respectively. In order 


























1 mM 1µl/1ml 
 
1 µM 
Human Insulin 1.7 mM 1µl/1ml 1.7 µM 
IBMX 25 mM 20µl/1ml 500 µM 
Indomethacin 
 








Appendix B  
Protocol for Cryosectioning and Oil Red O Staining of hASC Spheroids 
Spheroids were harvested from the well-plates on days 0 and 9, washed with PBS and then fixed 
with 3.7 % buffered formalin for 15 min. The spheroids were then washed with PBS again and 
stained with methylene blue to enhance visibility once embedded. Prior to embedding, the 
spheroids were washed three times with PBS and then dehydrated using a sucrose concentration 
gradient, wherein spheroids were exposed for 30 min to 10, 20, 30, and 40 % sucrose solutions. 
The dehydrated spheroids were then embedded in Tissue-Tek® using molds, snap frozen in liquid 
nitrogen, and cut into 8 µm sections using a Leica CM3050 S cryostat (Leica Biosystems, Wetzlar, 
Germany) and transferred onto slides. The microscope slides were then soaked in ddH2O for 30 
sec to dissolve residual Tissue-Tek®. Oil Red O working solution (0.5 g ORO, 100 ml isopropanol 
and 66.6 ml H2O) was filtered through a 0.2 µm filter, and then used to stain the sections for 6 
min. After washing with ddH2O, the slides were counterstained with Mayer’s Hematoxylin for 3 
min. The slides were washed under cold running water for 10 min and then coverslips were 
mounted with glycergel. Brightfield microscopy images were captured using an Olympus BX51 







Appendix C  
Protocols for DNA and Triglyceride Assays of hASC Spheroids 
Each assay was performed using three biological replicates for each sample group, with each 
replicate consisting of 20 spheroids. Spheroids were washed twice with PBS, and then stored in 
phosphate-saline-buffer (pH 7.4; 50 mM phosphate buffer, 2 mM Na2 EDTA · 2 H2O, 2 M NaCl) or 
0.5 % aqueous Thesit® solution for DNA or triglyceride (TG) quantification, respectively. The 
spheroids were then sonicated using an ultrasonic homogeniser (Sonopuls, Bandelin Electronic, 
Berlin, Germany).  
For the DNA assay, each sample was pipetted into two wells of a black 96-well plate to produce 
technical replicates. This process was also repeated with eight standard dilutions of double-
stranded DNA prepared from calf thymus (Table 2). To determine the DNA content of the 
samples, Hoechst 33258, an intercalating fluorescence dye, was used. A fluorescence 
spectrometer (Tecan GENios Pro, Tecan Dtl. GmbH, Crailsheim, Germany) was used to measure 
the fluorescence intensities at excitation and emission wavelengths of 365 and 458 nm, 
respectively. The measured fluorescence intensity of the standard DNA dilutions was correlated 
with the intensities of the homogenised spheroid samples to determine DNA content.  
Quantification of intracellular lipid accumulation during differentiation was performed using a 
Serum Triglyceride Determination Kit from Sigma-Aldrich (Steinheim, Germany) following 
manufacturer’s instructions. The assay works by enzymatic hydrolysis of intracellular TGs to 
glycerol and free fatty acids by lipase. Measurement of glycerol in the samples is then performed 
by coupled enzyme reactions that lead to the formation of a quinoneimine dye that has an 
absorbance maximum at 540 nm. Similar to the DNA assay, each sample was pipetted into two 
wells of a 96-well plate to generate technical replicates. This process was repeated with seven 
standard dilutions of a glycerol-standard (Table 2). The absorbance at 540 nm was then measured 
using a spectrophotometric MRX microplate reader (Dynatech Laboratories, Chantilly, Virginia, 
USA). The unknown TG concentration in the samples was then determined by correlating the 
measured absorbance with those of the glycerol-standard dilutions. The total TG content in each 








Table 2. Standard dilutions for DNA and triglyceride assays. 


















µg of glycerol in 
the  
well (in 20 µl) 
A 0 0  A 0 40 40 0 
B 2 98  B 3 40 37 0.195 
C 5 95  C 5 40 35 0.325 
D 10 90  D 10 40 30 0.65 
E 20 80  E 20 40 20 1.3 
F 40 60  F 30 40 10 1.95 
G 60 40  G 40 40 0 2.6 



































0.1 x 104 3.4 x 106 3.4 x 103 4.9 x 106 4.9 x 103   
0.5 x 104 2.3 x 107 4.5 x 103 2.8 x 107 5.6 x 103 1.6 x 107 3.3 x 103 
1.0 x 104 4.7 x 107 4.7 x 103 7.0 x 107 7.0 x 103   







Appendix E  
Protocol for Fabricating Scaffolds via Melt Electrospinning Writing 
A custom-built MEW printer was used to fabricate the scaffolds in this study (Fig. 14). A syringe 
containing PCL and fitted with a 22 G spinneret was heated to 85 °C inside a heating chamber 
regulated by a computer control system (Bosch Rexroth AG, Schweinfurt, Germany). Polymer 
feeding was controlled by a pneumatically assisted system. A positive high voltage source (PLS 
K003-20, Profector Life Sciences Ltd., Dublin, Ireland) was applied to the spinneret, and a negative 
high voltage source (PLS K011-20N, Profector Life Sciences Ltd., Dublin, Ireland) was applied to 
the stainless steel moving collector plate. Distance between the spinneret and collector plate was 
set to 4 mm. The collector plate was actuated in the X and Y directions by ball screw linear stages 
(PSK040-NN1, Bosch Rexroth AG, Schweinfurt, Germany) driven by servo motors (MSM019B-
0300, Bosch Rexroth AG, Schweinfurt, Germany). Printer parameters used to fabricate the 
scaffolds are shown in Table 4. 
 
Figure 14. Schematic illustration of melt electrospinning writing device used to fabricate scaffolds. Computer-
controlled movement of the collector in the X- and Y-axes enables fabrication of scaffolds. The printing head, including 
syringe, heater, spinneret and attached high voltage electrode, is mounted on a manually driven Z-axis for adjustment 
of the collector distance. Figure reprinted with permission from 136 (see Appendix H). 


























400_10 22 G 85 °C 500 mm/min 1.2 bar 4 mm -1.5 kV, +4.5 kV 
500_10, _15, _20  
 








Protocol for Seeding Spheroids onto Melt Electrospun Scaffolds 
400_10, 500_10, and 500_15 scaffolds were cut into squares measuring approximately  
12 x 12 mm using a sharp blade to minimise structural damage. The scaffold squares were then 
placed in sterile 12-well cell culture plates and sterilised with 70 % EtOH for 30 min. The scaffolds 
were then washed three times in the wells with sterile PBS, which was only removed immediately 
prior to seeding to prevent drying out. In order to hold the constructs in position inside the wells 
and to enable better control over spheroid positioning during seeding, a ring technique was used  
(Fig. 15). In brief, 10 ml serological pipettes were cut into ring sections measuring approximately 5 
and 10 mm in height, placed inside an ultrasonic cleaner and then sterilised in 70 % EtOH 
overnight. The 10 mm tall rings were then placed on top of the scaffolds inside the well plate.  
One day after seeding, spheroids were harvested from the well-plates for seeding onto the 
scaffolds. Spheroids were seeded into the centre of the pipette rings and onto the scaffolds with 
basal medium (PBM2 supplemented with 10 % FCS and 1 % penicillin-streptomycin). A further  
1 ml of basal medium was then added to each well. The next day, the scaffolds were transferred 
to a new well-plate with new basal medium, and a 5 mm tall ring was placed underneath each 




Figure 15. Serological pipette rings utilised for holding scaffolds in place for hASC spheroid seeding. Prior to seeding, a 
sterilised ring (~ 10 mm high) was placed atop each scaffold in a 12-well tissue culture plate (a). Spheroids suspended in 
medium were then pipetted inside the ring. The next day, the seeded scaffolds were moved to a new plate, and a 
shorter (~ 5 mm high) sterile ring was placed beneath to enable the underside of the mesh to receive medium (b). Scale 







Appendix G  
 
 
Figure 16. Microscope images of melt electrospun PCL scaffolds with box pores. Scaffolds printed with G code for 400 
µm pores with 10 layers (400_10; a, d), and 500 µm with 10 layers (500_10; b, e) and 20 layers (500_20; c, f) are shown. 








Permissions to Reprint Figures 
All materials used in this thesis not generated by the author were reused with permission of the 
copyright owners. These permissions were obtained under Creative Commons Attributions 
Licenses, or from the RightsLink Copyright Clearance Centre. The material was used either in its 
original form or with minor alterations, and the source was referenced appropriately in figure 
captions.  
Figure 1: Reprinted from Cell Metabolism, 4(4), Farmer, S.R., Transcriptional control of adipocyte 







Figure 2: Reprinted from Experimental Cell Research, 300(1), Fischbach, C., Spruß, T., Weiser, B., 
Neubauer, M., Becker, C., Hacker, M., Göpferich, A., and Blunk, T., Generation of mature fat pads 
in vitro and in vivo utilizing 3-D long-term culture of 3T3-L1 preadipocytes, p. 54-64, Copyright 








Figure 3: Adapted from PLoS ONE, 8(8), Chen, L., Bai, Y., Liao, G., Peng, E., Wu, B., Wang, Y., Zeng, 
X., and Xie, X., Electrospun poly(l-lactide)/poly(ε-caprolactone) blend nanofibrous scaffold: 
Characterization and biocompatibility with human adipose-derived stem cells, doi: 10.1371/ 









Figure 4: Adapted from Journal of Biomedical Materials Research – Part A, 104(1), Iwai, R., 
Nemoto, Y., and Nakayama, Y., Preparation and characterization of directed, one-day-self-
assembled millimeter-size spheroids of adipose-derived mesenchymal stem cells, p. 305-312, 








Figure 5: Reprinted from Advanced Functional Materials, 20(14), Kim, T.G., Park, S.H., Chung, H.J., 
Yang, D.Y., and Park, T.G., Hierarchically assembled mesenchymal stem cell spheroids using 
biomimicking nanofilaments and microstructured scaffolds for vascularized adipose tissue 








Figure 6: Reprinted from Materials Science and Engineering C, 45, Brown, T.D., Edin, F., Detta, N., 
Skelton, A.D., Hutmacher, D.W., and Dalton, P.D., Melt electrospinning of poly(ε-caprolactone) 
scaffolds: Phenomenological observations associated with collection and direct writing, p. 698-







Figure 7, Figure 8 (A, B), and Figure 9 (C, D): Reprinted from Biofabrication, 7(3), Hochleitner, G., 
Jüngst, T., Brown, T.D., Hahn, K., Moseke, C., Jakob, F., Dalton, P.D., and Groll, J., Additive 
manufacturing of scaffolds with sub-micron filaments via melt electrospinning writing, doi: 
10.1088/1758-5090/7/3/035002 with permission under the Creative Commons Attribution 3.0 









Figure 8 (C, D): Reprinted from Advanced Materials, 23(47), Brown, T.D., Dalton, P.D., and 
Hutmacher, D.W., Direct writing by way of melt electrospinning, p. 5651-5657, Copyright 2011, 








Figure 9 (A, B): Reprinted with permission from Biointerphases, 10(1), Ristovski, N., Bock, N., Liao, 
S., Powell, S.K., Ren, J., Kirby, G.T.S., Blackwood, K.A., and Woodruff, M.A., Improved fabrication of 
melt electrospun tissue engineering scaffolds using direct writing and advanced electric field 









Figure 14: Reprinted from BioNanoMaterials, 17(3-4), Hochleitner, G., Youssef, A., Hrynevich, A., 
Haigh, J.N., Jungst, T., Groll, J., and Dalton, P.D., Fibre pulsing during melt electrospinning writing, 
doi: 10.1515/bnm-2015-0022, 2016, with permission under the Creative Commons Attribution-




















Combination of 3D-printed microfibre  
scaffolds and multicellular spheroids for  
adipose tissue regeneration 
 
Rebecca McMaster 
BSc (Biomedical Science) 
 
Supervisory Team: 
Prof. Dr. Torsten Blunk 
Prof. Dr. Paul Dalton  
 
\ 
Submitted in partial fulfillment of the requirements for the degree of 
Master of Biofabrication 
Department of Trauma, Hand, Plastic and Reconstructive Surgery 
Universitätsklinikum Würzburg 
Department for Functional Materials in Medicine and Dentistry 
Julius-Maximilians-Universität Würzburg 
 




Table of Contents 
I Abstract  ....................................................................................................................................... V 
II Abbreviations  ............................................................................................................................. VI 
III List of Figures ............................................................................................................................. VIII 
IV Acknowledgements  .....................................................................................................................IX 
1. Introduction  .................................................................................................................................. 1 
2. Goals ............................................................................................................................................. 4 
3. Materials  ...................................................................................................................................... 5 
3.1  Laboratory equipment  .......................................................................................................... 5 
3.2  Consumable materials  .......................................................................................................... 5 
3.3  Solutions and buffers  ............................................................................................................ 6 
3.4  Chemicals  .............................................................................................................................. 6 
3.5  Adipogenic inducer stock solutions ....................................................................................... 7 
3.6  Cell culture media  ................................................................................................................. 7 
3.7  Kits ......................................................................................................................................... 7 
3.8  Oligonucleotides  ................................................................................................................... 8 
4. Methods  ....................................................................................................................................... 9 
4.1  3D-printing of microfibre box-structure scaffolds  ................................................................ 9 
4.1.1 Scaffold design  ....................................................................................................... 9 
4.1.2 Scaffold fabrication  ................................................................................................ 9 
4.1.3 Scaffold imaging and characterisation  ................................................................... 9 
4.2  Cell culture techniques  ........................................................................................................ 10 
4.2.1 Cell isolation and expansion  ................................................................................. 10 
4.2.2 Spheroid formation and measuring  ..................................................................... 10 
4.3  Seeding of 3D-printed microfibre scaffolds  ........................................................................ 11 
4.3.1 Seeding via pipette rings  ...................................................................................... 11 
4.3.2 Seeding via CellCrown™96 inserts  ....................................................................... 11 
4.4  Adipogenic differentiation  .................................................................................................. 11 
4.4.1 Adipogenic induction protocol .............................................................................. 11 
4.5  Analytical Techniques  ......................................................................................................... 12 
4.5.1 Imaging of seeded scaffolds  ................................................................................. 12 
4.5.2 Cell viability in the scaffold  .................................................................................. 12 
 III 
 
4.5.3 Whole sample histological staining ....................................................................... 12 
4.5.4 Cryosectioning and histological staining  .............................................................. 13 
4.5.5 Real time qRT-PCR ................................................................................................. 13 
4.5.6 Statistical analysis  ................................................................................................ 13 
5. Results  ........................................................................................................................................ 14 
5.1  Characterisation of 3D-printed microfibre scaffolds  .......................................................... 14 
5.1.1 Scaffold morphology  ............................................................................................ 14 
5.1.2 Scaffold dimensions  ............................................................................................. 15 
5.2  Spheroid morphology  ......................................................................................................... 15 
5.3  Characterisation of seeded scaffolds  .................................................................................. 15 
5.3.1 Establishing a seeding technique  ......................................................................... 15 
5.3.2 Spheroid positioning and retention in the scaffolds  ............................................ 17 
5.3.3 hASC behaviour in the 400_10 scaffolds  .............................................................. 18 
5.3.4 hASC behaviour in the 390_30 and 390_40 scaffolds  .......................................... 19 
5.3.5 Cell viability  .......................................................................................................... 22 
5.4  Adipogenesis in the seeded scaffolds  ................................................................................. 24 
5.4.1 Gross observations  ............................................................................................... 24 
5.4.2 Histological investigation of whole samples  ........................................................ 24 
5.4.3 Histological investigation of cryosections  ............................................................ 26 
5.4.4 Quantitative analysis  ............................................................................................ 26 
6. Discussion  ................................................................................................................................... 29 
6.1  Establishing a seeding technique ........................................................................................ 29 
6.1.1 Early experiments  ................................................................................................ 29 
6.1.2 Optimisation  ......................................................................................................... 30 
6.1.3 Suitability of 3D-printed microfibre PCL scaffolds for seeding  ............................ 30 
6.2  Spheroids as an alternative method for populating meshes  .............................................. 31 
6.2.1 Early observations  ................................................................................................ 31 
6.2.2 Spreading of hASCs on meshes  ............................................................................ 31 
6.3  Microfibre box-structure scaffolds as spheroid carriers  ..................................................... 32 
6.3.1 Spheroid behaviour in the scaffolds  ..................................................................... 32 
6.3.2 Formation of a continuous tissue layer in poorly seeded scaffolds  ..................... 33 
6.4  Differentiation towards the adipocyte lineage .................................................................... 33 
6.4.1 Cell morphology and behaviour  ........................................................................... 33 
6.4.2 Molecular investigation of terminal adipocyte differentiation ............................. 35 
6.5  Practicality for clinical translations  .................................................................................... 35 
 IV 
 
6.5.1 Potential for upscaling  ......................................................................................... 35 
6.5.2 Delivering spheroids to defect sites  ..................................................................... 36 
6.5.3 Forming higher order structures  .......................................................................... 37 
7. Conclusions and Future Directions  .............................................................................................. 38 
8. References  .................................................................................................................................. 41 
Appendix A ................................................................................................................................................ 46 
Appendix B  ............................................................................................................................................... 47 
Appendix C  ............................................................................................................................................... 48 








Three-dimensional (3D) multicellular spheroids have increasingly been used as building blocks in 
tissue engineering, offering an alternative to the conventionally used single cells. In adipose tissue 
engineering, which aims to produce structural and functional equivalents to native tissue, human 
adipose-derived stem cells (hASCs) have demonstrated improved differentiation potential when 
arranged in spheroids. However, the efficient delivery of spheroids to in vivo settings remains a 
challenge. In comparison to single cells, spheroids are relatively large and therefore most 
conventional tissue engineering scaffolds contain pores that are unsuitably sized for seeding with 
spheroids. Previous studies have addressed this issue by designing and fabricating macroporous 
scaffolds to accommodate spheroids, however the scaffolds contained thick polymer fibres, 
resulting in tissue constructs with a high polymer-to-cell ratio that is unfavourable for adipose tissue 
engineering. Here, using a custom-built melt electrospinning writing (MEW) device, microfibre  
poly(ε-caprolactone) (PCL) scaffolds were 3D-printed with box-shaped pores tailored to spheroid 
diameter. Microscopic analysis confirmed that fibre diameter and pore sizes were highly controlled 
and generally matched the original design. Regularly sized spheroids were formed with 5,000 hASCs 
using a liquid overlay technique and then loaded into the scaffold box pores using a top seeding 
approach. In situ imaging of the constructs at regular time intervals during culture enabled 
monitoring of spheroid behaviour in the scaffolds. Additionally, spheroid-seeded scaffolds were 
adipogenically induced for 14 days, and then harvested for qualitative and quantitative analysis via 
histological staining and quantitative reverse transcription-polymerase chain reaction (qRT-PCR), 
respectively. After establishment and optimisation of a seeding technique, it was demonstrated 
that PCL box-structure scaffolds could be seeded with spheroids at an efficiency approaching 100%. 
Spheroid structure was only partially maintained by the end of the culture period as cells at the 
periphery of the spheroids spread to fill the pores, forming a continuous tissue layer. Unseeded 
pores also became filled with cells, occasionally forming a spheroid-like arrangement. Adipogenesis 
was achieved within the spheroid-seeded scaffolds, with the cells displaying lipid accumulations. 
Adipogenesis was also confirmed at the mRNA level by significantly elevated expression of the 
major adipogenic transcription factors CCAAT/enhancer binding protein alpha (C/EBPα) and 
peroxisome proliferator-activated receptor gamma (PPARγ), and the late marker of adipogenesis, 
fatty acid binding protein-4 (aP2). It is envisioned that with upscaling, and surface modification of 
the PCL fibres to reduce cell adhesion and better preserve spheroid structure, the spheroid-seeded 
sheets could be used as patches to treat soft tissue defects, or even utilised as modular units for 
the fabrication of higher order structures. While this study was undertaken in the context of 
adipose tissue engineering, the technique lends itself to the generation of other tissue types by 
modification of the scaffold mechanical properties, cell type, and induction protocol. Altogether, 
this work reveals a new and exciting perspective in tissue assembly that combines the emerging 







2D   Two-dimensional 
3D   Three-dimensional 
ANOVA   Analysis of variance 
aP2   Fatty acid binding protein-4 
ASC   Adipose-derived stem cell 
bFGF   Basic fibroblast growth factor 
BMI   Body mass index 
c/EBPα   CCAAT/enhancer binding protein alpha 
Calcein-AM  Calcein acetoxymethyl ester 
CC96   CellCrown™96 
DMEM   Dulbecco’s Modified Eagle Medium 
DMSO   Dimethyl sulfoxide 
DNA   Deoxyribonucleic acid 
EDTA   Ethylenediaminetetraacetic acid 
EF1α   Elongation factor 1 alpha 
EthD-III   Ethidium bromide homodimer III 
FCS   Fetal calf serum 
FDM   Fused deposition modelling 
G   Gauge 
GLUT4   Glucose transporter type 4 
hASC   Human adipose-derived stem cell 
hBMSC   Human bone marrow-derived stem cell 
HMDS   Hexamethyldisilazane 
ind   Induced 
IBMX   3-isobutyl-1-methylxanthine 
MEW   Melt electrospinning writing 
MSC   Mesenchymal stem cell 
non   Non-induced 
PBM-2   Preadipocyte Basal Medium-2 
PBS   Phosphate buffered saline 
PCL   Poly(ε-caprolactone) 
PEG   Poly(ethylene glycol) 
Pen Strep  Penicillin streptomycin 
PET   Poly(ethylene terephthalate) 
PGA   Polyglycolic acid (PGA)  
PLGA   Poly(lactic-co-glycolic) acid 
PLLA   Poly(L-lactic) acid  
PPARγ   Peroxisome proliferator-activated receptor gamma 
PU   Polyurethane 
qRT-PCR  Quantitative reverse transcription-polymerase chain reaction 






RT   Room temperature 
SD   Standard deviation 
SEM   Scanning electron microscope 
SVF   Stromal vascular fraction 
TCPS   Tissue culture polystyrene 
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Figure 1. SEM images of 3D-printed microfibre scaffolds used for seeding in this study. 
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Figure 2. Spheroids formed with 5,000 hASCs show minimal variation in size and shape. 
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Figure 4. Microscopic images of spheroid- and cell-seeded 3D-printed microfibre 400_10 
scaffolds. 
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Figure 5. Microscopic images of seeded 400_10 scaffolds. 
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Figure 6. SEM images of spheroid-seeded 390_30 scaffolds, showing spheroid-scaffold 
and spheroid-spheroid interactions.  
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Figure 7. Microscopic images showing the progression of a non-induced (non) and an 
induced (ind) 390_30 scaffold with over 90% of boxes seeded with spheroids. 
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Figure 8. In situ microscopic images showing the progression of a non-induced (non) and 
an induced (ind) 390_30 scaffold with greater than 90% of boxes filled by spheroids, but 
poorer spheroid retention after 24 hours. 
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Figure 9. Live/dead staining of 390_30 scaffolds seeded with hASC spheroids. 
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Figure 10. Microscopic images showing the difference in cell morphology between non-
induced (A) and induced (B) spheroid-loaded 390_30 scaffolds. 
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Figure 11. Microscopic images showing adipogenic differentiation of 400_10 scaffolds 
seeded with hASCs as spheroids (A, B) or dispersed cells (C, D). 
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Figure 12. Macroscopic images of spheroid-seeded 390_40 scaffolds. 
 
25 
Figure 13. Microscopic images of cryosections from spheroid-seeded 390_30 scaffolds. 
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Figure 14. Relative expression of C/EBPα, PPARγ, and aP2 mRNA in hASC spheroid-
seeded 390_30 scaffolds. 
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Figure 15. Optical microscope images of 3D-printed microfibre scaffolds used for seeding 
in this study. 
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Figure 16. 24 hours after seeding 390_30 scaffolds with a dispersed cell suspension. 
 
48 
Figure 17. Whole sample histological staining of spheroid-seeded 390_40 scaffolds. 
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In plastic and reconstructive surgery, the restoration of soft tissue defects arising from trauma, 
tumour resections or congenital abnormalities remains a significant challenge, as discussed in 
section 1.2.1 of Annex 1. In addition to improving aesthetic function, soft tissue reconstruction aims 
to restore the mechanical cushioning of muscles, tendons, and bones that is normally provided by 
adipose tissue.1, 2 While autologous fat grafting or collagen injections can be used to repair small 
volume defects, these treatments are commonly associated with a significant loss of graft volume 
over time due to resorption, and often require repeated procedures to maintain shape and 
volume.3, 4 Significant drawbacks are also associated with the standard treatment option of 
autologous tissue transfer for larger soft tissue defects using vascularised flaps containing skin, 
adipose and muscle, such as deformity and donor site morbidity.3 Alternative treatment options 
such as synthetic implants can lead to foreign body reactions and infections.5 Therefore, the field 
of adipose tissue engineering aims to restore soft tissue defects by generating fat that is structurally 
and functionally equivalent to native tissue.  
A common approach to adipose tissue engineering involves the use of human adipose-derived stem 
cells (hASCs).6 An autologous cell source with the capacity to differentiate into the adipocyte 
lineage, hASCs can be readily isolated in large numbers from liposuctioned adipose tissue. 
Commitment of hASCs to the adipocyte lineage and subsequent full differentiation can be initiated 
by in vitro hormonal induction,7 as discussed in section 1.1.2 of Annex 1. It is recognised that  
three-dimensional (3D) cell culture more closely resembles the native tissue environment, due to 
the increased cell-cell and cell-matrix interactions compared to two-dimensional (2D) culture. 
Similarly, there is growing evidence to support that the 3D environment plays an important role in 
determining the stemness properties of cells.8, 9 In previous studies, this 3D environment has been 
provided by encapsulating ASCs in hydrogels,10-13 or alternatively, by seeding ASCs onto scaffolds. 
A study by Wittmann et al. combined these approaches, embedding a scaffold in a hydrogel and 
encapsulating hASCs to generate volume-stable adipose tissue constructs.14 Scaffolds fabricated 
using synthetic materials, which offer the advantage of easier scale-up and less batch-to-batch 
variations, have been used in adipose tissue engineering approaches. Fibre meshes fabricated using 
polyglycolic acid (PGA)15 and poly(ethylene terephthalate) (PET)16 have been seeded with ASCs and 
differentiated in vitro. Solution electrospun fibrous poly(L-lactic) acid (PLLA)-PCL blend17 scaffolds 
have also been seeded with ASCs in an adipose tissue engineering approach.  
An alternative approach to mimicking in vivo conditions is by culturing cells as self-assembling 
aggregates, commonly known as spheroids, wherein cells interact under native forces without any 
foreign materials.18 ASCs have demonstrated improved differentiation potential when cultured as 
spheroids,18 in addition to increased resistance against hypoxia and apoptotic cell death.19 
Spheroid-derived ASCs express higher levels of pluripotency markers and angiogenic growth 
factors,20 and demonstrate retained ability to differentiate after serial long-term culture 
expansions.21 However, while ASC spheroids have demonstrated superior regenerative capabilities 
to single suspended cells and thus are attractive units for the engineering of tissue constructs, 
delivery remains a challenge. Therefore, designing a suitable vessel to deliver the 3D spheroids is 






In comparison to single cells, spheroids are relatively large and therefore most conventional tissue 
engineering scaffolds contain pores that are unsuitably sized. In a study by Kim et al., PCL scaffolds 
with fibre diameters of 200 µm and void spaces of 400 µm were designed and fabricated for seeding 
with human bone marrow-derived stem cell (hBMSC) composite spheroids containing PLA 
nanofilaments.22 The scaffolds were then stacked to create a 3D biohybrid construct. However, due 
to the technique used to fabricate the scaffolds, the resulting constructs contained a high volume 
of polymer relative to spheroids. While this could be an appropriate strategy for load-bearing 
tissues in the body, the reinforcement from the thick fibres would likely prove excessive and 
disadvantageous for soft tissues such as adipose. In fact, it has been shown that adipogenesis is 
increased on surfaces mimicking the stiffness properties of adipose tissue when compared to 
harder surfaces.23  
Huang et al. were the first to report scaffolds that offer a microenvironment that is able to maintain 
MSC spheroid morphology.24 While the study showed that macroporous  
poly(D,L-lactide-co-glycolide) (PLGA) scaffolds formed using a liquid frozen deposition 
manufacturing technique were unable to maintain the spheroid structure, leading to disintegration 
and attachment to the scaffold with fibroblast-like morphology three days post-seeding, surface 
modification of the scaffolds with chitosan to reduce cell adhesion effectively sustained the 
spheroid structure. The authors also showed that maintenance of spheroid morphology within the 
scaffold was critical for chondrogenic differentiation. However, the study was performed in the 
context of cartilage regeneration, and the constructs contained a high volume of polymer due to 
the relatively thick PLGA fibres. Native cartilage, with a reported stiffness range of 4.6–7.1 MPa,25 
has vastly different mechanical properties to adipose tissue, which is much softer with a stiffness 
of around 2 kPa.26 Therefore, as previously mentioned, the scaffolds used in this study would likely 
not be suitable for applications in adipose tissue engineering. 
It has been shown that spheroids attach to electrospun matrices,27 which contain much thinner 
fibres in the nano- or micrometre range. In a study by Beachley et al., thin porous pre-stretched 
polyurethane (PU) solution electrospun meshes were seeded with ASC spheroids that attached and 
spread on the scaffold surface.28 Up to 7 closely placed spheroids underwent fusion after flattening 
to form a thick confluent tissue layer. However, greater numbers of spheroids were unable to form 
a continuous layer, with holes formed that could not be closed by the further addition of spheroids. 
Although this study demonstrated that microfibrous solution-electrospun scaffolds provide a 
surface that is permissive for spheroid adhesion, spheroid structure was not well-preserved and 
the study was more focused on monitoring fusion. The rapid loss of spheroid structure was likely 
due to the uncontrolled fibre deposition produced by solution electrospinning that prevented the 
spheroids from penetrating the scaffold, instead attaching superficially atop the scaffold surface 
which allowed fusion to occur.  
With the ability to control deposition of microscale fibres to produce macroporous scaffolds,  
melt electrospinning writing (MEW) can be seen as an intermediary between fused deposition 
modeling (FDM) and solution electrospinning techniques.29 As such, it is rational to assume that 
MEW scaffolds with tailored pore sizes may be particularly suitable for delivering relatively large 






box-structure, is fabricated by printing a series of parallel fibres in one direction, then offsetting the 
fibre deposition by 90° in each of the subsequent layers, producing a scaffold with regularly sized 
box-shaped pores. A recent study by Hochleitner et al. produced box-structure PCL scaffolds 
consisting of 50 stacked sub-micron fibres with box widths of 90 and 150 µm.30 While these 
scaffolds demonstrated hMSC adhesion and viability in vitro, with cells able to bridge the box pores 
and eventually fill them, it is envisioned that box-structure scaffolds could also prove suitable for 
accommodating spheroids. Due to the high control over fibre deposition, G-code could be written 
to produce box pores large enough to fit spheroids. Interaction between spheroids through and 
above the box walls may also be modulated by fibre deposition patterns and the number of layers 
stacked. The pairing of 3D-printed microfibre box-structure scaffolds and spheroids has not yet 
been reported, and will be the topic of this thesis. It is envisioned that these scaffolds will serve as 
a carrier for hASC spheroids, potentially allowing their enhanced regenerative properties to be 







ASC spheroids have shown superior regenerative properties over single cells, specifically enhanced 
differentiation potential,18 increased resistance against hypoxia and apoptotic cell death,19 higher 
expression of angiogenic growth factors,20 and retained ability to differentiate in long-term culture 
expansions.21 Therefore, spheroids have been proposed as a promising alternative to dispersed cell 
suspension in adipose tissue engineering. However, difficulties associated with maintaining the 3D 
structure during delivery currently limits the applicability of ASC spheroids in conventional tissue 
engineering approaches. When placed in a non-supportive environment, spheroids rapidly undergo 
disassembly and flatten, often fusing together to form a single unit. Furthermore, most 
conventional scaffolds used in tissue engineering contain pore sizes too small to allow for spheroid 
seeding. Custom-made supportive porous scaffolds surface-treated to minimise cell adhesion have 
successfully demonstrated maintenance of spheroid structure under in vitro conditions,24 however, 
the constructs contained a high ratio of polymer to cells due to the thickness of the fibres, which is 
not ideal for soft tissue engineering. Seeding of melt electrospun microfibrous scaffolds with 
spheroids has so far not been reported. For that reason, the primary aim of this study was to 
investigate, for the first time, if hASC spheroids could be seeded onto melt electrospun  
box-structure PCL scaffolds and, subsequently, adipogenically differentiated under in vitro 
conditions. It is envisaged that these scaffolds could serve as a carrier for hASC spheroids into 
subcutaneous tissue defect sites and aid in reconstruction, with the potential to deliver both 
functional and aesthetic results in future clinical applications. Furthermore, the support structure 
provided by the slow degradation of PCL could prove advantageous for shape maintenance for the 
adipose tissue in vivo. While the study was undertaken in the context of adipose tissue engineering, 
it has the potential to establish a completely new general principle in tissue assembly. 
In this study, a number of different scaffold designs were fabricated using MEW and seeded with 
spheroids to determine if architecture plays a role in maintaining 3D structure. Due to the novelty 
of the approach, a new seeding protocol was established and optimised throughout the study. For 
simplification, only one spheroid size was used for all experiments. First, simple mesh-like scaffolds 
were seeded with spheroids or a dispersed cell suspension to compare box pore filling and cell 
differentiation. Next, scaffolds were designed and fabricated with higher box walls and closer 
spaced fibres at the base, to maintain 3D structure and prevent spheroids falling through, 
respectively. In an effort to further optimise the filling of boxes, these scaffolds were secured in 
CellCrown™96 inserts while seeded with a more suitable number of spheroids. To gain an 
understanding of spheroid behaviour within the scaffolds, samples were monitored and imaged 
throughout the culture process. Differentiation along the adipogenic lineage was performed via a 
cocktail of hormonal inducers for 14 days. Through histological staining of whole samples and 
cryosections, adipogenic differentiation was investigated qualitatively. Quantitative measuring of 







3.1 LABORATORY EQUIPMENT 
Analytical balance      Ohaus, Zurich, Switzerland  
Ball screw linear stage PSK040-NN1   Bosch Rexroth AG, Schweinfurt, Germany 
Centrifuge Rotina 420 R     Hettich, Tuttlingen, Germany  
CO2 incubator       IBS integra biosciences, Fernwald, 
Germany Crossbeam 340 SEM     Zeiss Microscopy, Göttingen, Germany 
Cryostat CM 3050 S      Leica, Wetzlar, Germany  
Fluorescence spectrometer Tecan GENios pro   Tecan, Crailsheim, Germany  
Freezer       Liebherr, Biberach, Germany  
Fridges        Liebherr, Biberach, Germany  
High vacuum sputter coater EM ACE600   Leica, Wetzlar, Germany 
Melt Electrospinning Writing Machine (Blue)  Custom built, FMZ 
Microscope brightfield BX51     Olympus, Hamburg, Germany  
Microscope inverted IX51     Olympus, Hamburg, Germany  
Microscope SteREO DiscoveryV.20   Zeiss Microscopy, Göttingen, Germany 
Nanodrop 2000c spectrophotometer    Thermo Fisher Scientific, Waltham,  
        Massachusetts, USA 
Negative high voltage source PLS K011-20N  Profector Life Sciences Ltd., Dublin, Ireland 
Orbital shaker       Heidolph, Schwabach, Germany  
Pipettes       Eppendorf, Hamburg, Germany  
Pipette controller accu-jet® pro     Brand, Wertheim, Germany  
Positive high voltage source PLS K003-20   Profector Life Sciences Ltd., Dublin,    
        Ireland 
Real-Time PCR Detection System CFX96™   Bio-Rad, Munich, Germany  
Repetitive pipette      Brand, Wertheim, Germany 
Servo Motor MSM019B-0300    Bosch Rexroth AG, Schweinfurt, Germany  
Spectrophotometer, MRX microplate reader   Dynatech Laboratories, Chantilly, Virginia, 
USA TissueLyser     Qiagen, Hilden, Germany  
Water bath       Memmert, Schwabach, Germany  
3.2 CONSUMABLE MATERIALS 
Cell culture flasks T175      Greiner Bio-One  
CellCrown™96 inserts     Scaffdex Oy 
Combitips® Plus 2.5 ml      Eppendorf  
Glass pasteur pipettes      Brand  
Microtome blades      Feather  
Microscope cover glasses     Marienfeld  
Microscope slides Super Frost®     R. Langenbrinck  
Nunc® CryoTube® vials      Thermo Scientific  






Pipette tips 20 μl, 1000 μl     Sarstedt  
Pipette tips 200 μl, 300 μl, 1000 μl    Starlab  
Polypropylene tubes 15 ml, 50 ml    Greiner Bio-One  
Reagent reservoirs      VWR  
Safe seal micro tubes 1.5 ml, 2.0 ml    Sarstedt  
Serological pipettes 5 ml, 10 ml, 25 ml, 50 ml   Greiner Bio-One  
Terralin® liquid disinfectant     Schülke  
Tissue culture plate 96-well     TPP  
Tissue culture plate 24-well     Thermo Scientific  
Tissue culture plate 6-well, 12-well    Greiner Bio-One  
Tissue-Tek® O.C.T. compound    Sakura  
3.3 SOLUTIONS AND BUFFERS 
Hoechst 33258 stock solution  0.1 mg/ml in ddH2O  
Working solution: 0.1 μl/ml in 1 x TEN 
buffer 
Live/dead staining solution PBS + 4 µM ethidium bromide homodimer 
III + 2 µM calcein acetoxymethyl ester 
Oil Red O staining solution  0.5 g Oil Red O + 100 ml isopropyl alcohol  
+ 66.6 ml ddH2O (passed through a 0.2μm 
filter twice before using) 
Phosphate saline buffer     50 mM phosphate buffer + 2 mM Na2   
        EDTA · 2 H2O + 2 M NaCl → pH 7.4 
1 x PBS        10 PBS (Dulbecco A) tablets in 1 l ddH2O 
1 x TEN buffer       0.1 M NaCl + 1mM EDTA + 10 mM Tris →  
        pH 7.4 
3.4 CHEMICALS     
0.25% Trypsin-EDTA (1x), phenol red    Gibco® Life Technologies  
3-isobutyl-1-methylxanthine (IBMX)   Serva  
Agarose      Sigma 
Ambion RNaseZAP      Invitrogen  
Basic fibroblastic growth factor    BioLegend  
Collagenase NB4 from Clostridium histolyticum  Serva 
Dexamethasone     Sigma 
Dimethyl sulfoxide (DMSO)    Sigma 
Dulbecco’s Modified Eagle Medium/Ham’s F-12  Gibco® Life Technologies 
Ethanol absolute     Sigma 
Glycergel® mounting medium     Dako  






Isopropyl alcohol     Sigma 
Mayer’s hematoxylin     Sigma 
Hexamethyldisilazane (HMDS)    Sigma  
Human insulin      Promocell 
Indomethacin      Sigma 
Oil Red O      Sigma 
Phosphate buffered saline (Dulbecco A) tablets   Thermo Scientific  
Preadipocyte Basal Medium     Lonza 
Purasorb® PC 12 poly(ε-caprolactone)   Purac Biomaterials 
TRIzol® reagent      Life Technologies 
3.5 ADIPOGENIC INDUCER STOCK SOLUTIONS   
Dexamethasone      3.925 mg/ml in ethanol abs. (10 mM)  
        → diluted 1:10 with ethanol abs. (1 mM)  
Human insulin       10 mg/ml in 30 mM HCl (1.7 mM)  
        → sterile-filtered  
IBMX        5.55 mg/ml in ddH2O (25 mM) + one  
        spatula tip Na2CO3 → sterile-filtered  
Indomethacin       17.89 mg/ml in ethanol absolute (50 mM) 
3.6 CELL CULTURE MEDIA 
Cell expansion medium      DMEM/F-12 + 10% FCS + 1% Pen Strep  
        + 3 ng/ml bFGF 
Basal medium      PBM-2 + 10% FCS + 1% Pen Strep  
Adipogenic induction medium     PBM-2 + 10% FCS + 1% Pen Strep  
        + 1 μl/ml dexamethasone stock soln (1μM) 
        + 1 μl/ml human insulin stock soln (1.7μM) 
        + 20 μl/ml IBMX stock soln (500μM)  
        + 4 μl/ml indomethacin stock soln (200μM) 
3.7 KITS 
ImProm-II™ Reverse Transcription System   Promega 
Live/Dead Cell Staining Kit II    PromoKine 










Primer Catalogue # Target Sequence Manufacturer 
aP2 
(Hs_FABP4_1_SG) 




QT00203357 unknown QuantiTect® Primer Assay, 
Qiagen 
EF1α 
(EF1alpha_F and _R) 
00177869_0 
00177869_1 
Forward: ccc cga cac agt agc att tg 












4.1 3D-PRINTING OF MICROFIBRE BOX-STRUCTURE SCAFFOLDS 
4.1.1 Scaffold design 
Box-structure scaffolds were used for all seeding experiments. Preliminary experiments utilised a 
simple mesh-like scaffold design, where G-code was written to create 400 µm wide boxes with a 
total of 10 layers of fibres deposited, alternating the offset angle by 0° and 90°, hereafter referred 
to as 400_10. Therefore, each of the box walls consisted of 5 stacked fibres. In an effort to improve 
spheroid retention in the boxes, scaffold design was optimised in subsequent experiments. Fibre 
spacing was decreased to 390 µm to more closely match the 350 ± 15 µm spheroid diameter, as 
determined in section 3.3.1 of Annex 1. Also, wall height of the boxes was increased by depositing 
a total of either 30 or 40 fibre layers with alternating 0° and 90° offset angles, hereafter referred to 
as 390_30 or 390_40, respectively. Accordingly, the box walls in the 390_30 and 390_40 scaffolds 
consisted of 15 or 20 stacked fibres, respectively. Fibre density was also increased in the second 
layer by decreasing spacing to 130 µm to create a base for “catching” the top-seeded spheroids, 
preventing them from falling through the scaffold. Scaffolds were fabricated as 48 x 48 mm squares 
that were cut to size prior to seeding. 
4.1.2 Scaffold fabrication 
PCL with a molecular weight of 120,000 g/mol (Purasorb® PC12) was used for 3D-printing of all 
scaffolds with a custom-built MEW printer (see Annex 1, Appendix E). Briefly, PCL was loaded into 
a syringe fitted with a 22 G spinneret, and the heating controller was set to 85 °C. Positive and 
negative high voltage sources were applied to the spinneret and collector plate, respectively. The 
collector plate was actuated in the X- and Y-axes driven by servo motors in response to G-code. The 
printing head, including syringe, heater, spinneret and attached high voltage electrode, was 
mounted on a manually driven Z-axis for adjustment of the collector distance. Printer parameters 
used to fabricate the scaffolds are shown in Table 1. Scaffolds were 3D-printed following 
stabilisation of the electrified polymer jet. 


























       
400_10 
 




22 G 85 °C Walls: 1,000 mm/min 
Base: 1,500 mm/min 
Walls: 1.2 bar 
Base: 0.5 bar 
4 mm -1.5 kV, +4.5 kV 
       
 
4.1.3 Scaffold imaging and characterisation 
All scaffolds were imaged with a Zeiss SteREO DiscoveryV.20 stereo microscope. A Zeiss Crossbeam 
340 Scanning Electron Microscope (SEM) equipped with a GEMINI e-Beam column was also used to 






using a Leica EM ACE600 prior to SEM imaging. The straight line selection tool in ImageJ software 
was used to measure box size and fibre diameters. Measurements were taken at 20 random regions 
within the microscopic images, and mean values were calculated. 
4.2 CELL CULTURE TECHNIQUES 
4.2.1 Cell isolation and expansion       
 
 
Human adipose-derived stem cells (hASCs) were isolated from abdominal lipoaspirate samples from 
female donors aged 38–48 years with a body mass index (BMI) ranging from 27.5–29 who gave 
written consent. Stromal vascular fraction (SVF) cells were obtained following a series of enzymatic 
digestion, filtration, and centrifugation steps (see Annex 1, Appendix A). The SVF was resuspended 
in basal medium and 5% dimethyl sulfoxide (DMSO), then cryopreserved in liquid nitrogen after 
storing in isopropanol at -80 °C overnight to slow the freezing process of the cells. After rapid 
thawing of SVF, hASCs were plated with a density of 10,000–15,000 cells/cm2 in tissue-culture 
treated T175 flasks containing cell expansion medium (25 ml). To facilitate faster expansion of cells, 
basic fibroblastic growth factor (bFGF) was added to the medium (3 ng/ml). After 24 hours in a 
humidified incubator at 37 °C and 5% CO2, culture medium was replaced to remove DMSO and  
non-adherent cells. Culture medium was then changed every 3–4 days, and the cells were passaged 
using 0.25% Trypsin-EDTA once confluent (see Annex 1, Appendix A).  
4.2.2 Spheroid formation and measuring       
  
The liquid overlay technique was used to generate 3D spheroids containing 5,000 hASCs in passages 
3–5, as described in section 3.2.2 of Annex 1. Briefly, hASCs were harvested from confluent 
monolayers by treatment with 0.25% Trypsin-EDTA for 5 min in an incubator. After counting, the 
cell suspension concentration was adjusted to 50,000 cell/ml (5,000 cell/100 µl). 100 µl of cell 
suspension was then pipetted into agarose-coated wells of 96-well plates. The well-plates were 
cultured on an orbital shaker at 50 rpm at 37 °C and 5% CO2. The non-adherent culture surface 
prevented cell adhesion, ultimately leading to the aggregation of cells into a 3D spherical structure 
within 24 hours. Spheroids were imaged in the 96-well plate using an Olympus IX51 inverted 
microscope fitted with an XC30 digital camera prior to scaffold seeding for measuring. Due to the 
imperfect spherical shape, spheroid diameter was determined by measuring the area of the 2D 
image with the freehand selection tool in ImageJ software, and then using the following formula, 
where D is the diameter and A is the area: 













4.3 SEEDING OF 3D-PRINTED MICROFIBRE SCAFFOLDS 
4.3.1 Seeding via pipette rings  
Preliminary experiments were performed using 400_10 scaffolds and pipette rings to assist with 
seeding of spheroids and dispersed cells. Scaffolds were cut into squares measuring approximately 
12 x 12 mm using a razor blade and then sterilised in 70% ethanol for 1 hour, followed by 3 washes 
with sterile PBS. The scaffolds were then placed into separate wells of an agarose-coated 24-well 
plate, and a sterile plastic ring with an inner diameter of 8 mm was placed atop each scaffold. Basal 
medium (800 µl) containing 60 spheroids was seeded into the rings of some scaffolds. To enable 
comparisons with more conventional approaches to populating constructs with cells, the remaining 
scaffolds were seeded with a suspension containing an equivalent number of dispersed hASCs 
(300,000 in 800 µl) in suspension from the same donor and passage number. The spheroids or cells 
were allowed to attach to the scaffolds for 2 hours before a further 1.5 ml of basal medium was 
added. Two days after seeding, half of the spheroid- and cell-seeded scaffolds were adipogenically 
induced, and the other remaining scaffolds served as a non-induced control group. 
4.3.2 Seeding via CellCrown™96 inserts 
In an attempt to improve homogeneity, seeding with CellCrown™96 (CC96) inserts was explored. 
These structures allowed insertion of a circular sample with a diameter of 5 mm, however due to 
the placement of the inner ring, the area in which seeding could occur had a diameter of 2.7 mm, 
equating to approximately 32–34 box pores. 390_30 and 390_40 scaffolds were cut using a 5 mm 
biopsy punch and then placed in the holding cups of the CC96 inserts. The inner ring was firmly 
secured in place, and the entire construct was placed in 70% ethanol for 1 hour to sterilise the 
scaffold, then washed 3 times with sterile PBS. For the first attempt at seeding, 30 spheroids in 
basal medium (150 µl) were seeded into the centre of the CC96 inserts, which were situated in a 
96-well plate. For all subsequent seeding experiments, CC96 inserts were cut into rows of 2–4 and 
seeded in agarose-coated 6-well plates to minimise bubble formation and allow seeding in a greater 
volume of medium. To increase the seeding capacity, 40 spheroids were used for the second 
seeding attempt. Ultimately, it was observed that 34 spheroids was the optimal seeding number, 
which was used for all remaining experiments. 
For dispersed cell seeding studies, scaffolds were seeded in CC96 inserts with an equivalent number 
of hASCs (150,000–200,000, dependent on spheroid seeding number) in suspension from the same 
donor and passage number. The seeding was performed in an agarose-coated 96-well plate, with 
the CC96 inserts in direct contact with the agarose base. Medium was exchanged 5 hours after 
seeding, and the following day, the CC96 inserts were transferred to a 6-well plate coated with 
agarose.   
4.4 ADIPOGENIC DIFFERENTIATON 
4.4.1 Adipogenic induction protocol 
Adipogenic induction medium was prepared as described in section 3.2.3 from Annex 1. Briefly, the 






inducers dexamethasone, human insulin, 3-isobutyl-1-methylxanthine (IBMX), and indomethacin 
of 1, 1.7, 500, and 200 µM, respectively (see Annex 1, Appendix A). Basal medium was removed 
from the samples 1 day after seeding and replaced with adipogenic induction medium. This time 
point was designated day 0 of adipogenic induction. Non-induced control samples were cultured in 
basal medium for the duration of the experiment. Medium was replaced every 2–3 days, and 
samples were harvested for analysis at day 14 of adipogenic induction.  
4.5 ANALYTICAL TECHNIQUES 
4.5.1 Imaging of seeded scaffolds 
Seeded scaffolds were imaged in situ using an Olympus IX51 inverted microscope fitted with an 
XC30 digital camera at 0 and 24 hours after seeding, then at various time points during the culture 
period to monitor the progression of spheroid attachment and behaviour. SEM images were also 
taken of the scaffolds 24 hours after seeding. Samples were prepared for SEM imaging by rinsing  
4 times in PBS, then fixing in 6% glutaraldehyde for 15 min on ice. Dehydration was performed by 
a series of PBS, ethanol and hexamethyldisilazane (HMDS) incubation steps (see Appendix A), 
followed by drying of the samples overnight at room temperature. Prior to SEM imaging, the dried 
samples were sputter-coated with a 4 nm layer of platinum. 
4.5.2 Cell viability in the scaffold 
Cell viability in the spheroid-loaded scaffolds was assessed using the Live/Dead Cell Staining Kit II 
from PromoKine, according to the manufacturer’s protocol. Briefly, whole samples were washed in 
PBS for 20 min, then incubated with 2 ml of staining solution containing PBS, calcein acetoxymethyl 
ester (calcein-AM) and ethidium bromide homodimer III (EthD-III) for 1 hour on an orbital shaker at 
room temperature. Samples were then washed with PBS and visualised under an Olympus BX51 
fluorescence microscope. Calcein-AM passes through the membrane of living cells, where it is 
hydrolysed to green-fluorescent calcein. Conversely, EthD-III only penetrates the disrupted 
membrane areas of dead cells, intercalating with the DNA and emitting red light. The resulting 
images were overlaid using Olympus cellSens Imaging software. 
4.5.3 Whole sample histological staining 
Samples were harvested at day 14 of adipogenic induction for whole sample histological analysis. 
The scaffolds were washed with PBS and fixed by submersion in 3.7% buffered formalin for 20 min. 
After washing a further 3 times with PBS, samples were stored in PBS in the fridge until staining. 
The seeded scaffolds were stained with Oil Red O and hematoxylin to visualise lipid content and 
cell nuclei, respectively. Oil Red O working solution was used to stain the samples for 6 min. After 
washing with ddH2O, the scaffolds were counterstained with Mayer’s hematoxylin for 3 min. The 
samples were then rinsed 3 times in water and stored in PBS until immediately prior to imaging to 









4.5.4 Cryosectioning and histological staining 
Samples were harvested at days 0 and 14 of adipogenic induction. Non-induced control samples 
were harvested at the same time point. The spheroid-seeded scaffolds were fixed in 3.7% buffered 
formalin following the same protocol as described above in section 4.5.3. The scaffolds were then 
embedded in Tissue-Tek® in flat-bottom 2 ml Eppendorf tubes, and left overnight at room 
temperature to promote dehydration. The samples were snap frozen in liquid nitrogen the 
following day, and the embedded scaffolds were cut into 8 µm sections using a cryostat, and then 
transferred onto microscope slides. The slides were then soaked in ddH2O for 30 sec to dissolve 
residual Tissue-Tek®. Oil Red O working solution and Mayer’s hematoxylin were then used to stain 
the sections using the same protocol as in section 4.5.3. After staining, the slides were washed 
under cold running water for 10 min and then coverslips were mounted with glycergel. Brightfield 
microscopy images were captured using an Olympus BX51 microscope. 
4.5.5 Real-time qRT-PCR 
For gene expression analysis, real-time quantitative reverse transcription-polymerase chain 
reaction (qRT-PCR) was performed. Spheroid-seeded scaffolds were lysed prior to RNA isolation 
using a TissueLyser, and total RNA from cells was harvested using TRIzol® reagent according to 
manufacturer’s instructions. Total RNA was isolated from three biological replicates for each of the 
day 0, day 14 non-induced, and day 14 induced groups, with one replicate consisting of one scaffold 
seeded with 34 spheroids. The concentration of the isolated RNA was determined photometrically 
with a NanoDrop 2000c spectrophotometer. The ImProm-II™ Reverse Transcription System was 
used to perform first strand cDNA-synthesis from total RNA. Real-time quantitative PCR was 
performed using the CFX96™ Real-Time System with specific primers for the two most relevant 
transcription factors involved in adipogenesis, peroxisome proliferator-activated receptor gamma 
(PPARγ) and CCAAT/enhancer-binding protein alpha (C/EBPα), in addition to the late adipogenic 
marker gene, fatty acid binding protein (aP2). For detection, the MESA GREEN qPCR MasterMix Plus 
with MeteorTaq polymerase was used at the following cycling conditions: 95 °C for 15 min, followed 
by 40 cycles of 95 °C for 15 sec, 55 °C for 30 sec, and 72 °C for 30 sec. Subsequently, the melting 
curve was analysed from 74 °C to 89 °C. mRNA expression levels were normalised to elongation 
factor 1 alpha (EF1α) as a housekeeping gene. The 2-ΔΔCT method was used to determine the fold 
increase in expression levels. Afterwards, expression levels of day 14 samples were determined 
relative to day 0 conditions to enable easier comparison. 
4.5.6 Statistical analysis 
GraphPad Prism 7 software was used to perform statistical analysis. All quantitative result values 
are expressed as mean ± standard deviation (SD). Analysis of variance (ANOVA) was used to assess 
statistical significance, with subsequent multiple comparisons according to Bonferroni post-hoc 







5.1 CHARACTERISATION OF 3D-PRINTED MICROFIBRE SCAFFOLDS 
5.1.1 Scaffold morphology 
Microfibre scaffolds were fabricated using a custom-made MEW device. SEM and optical 
microscopy images confirmed well defined fibrous scaffolds with box-shaped pores that were 
generally matched to those of the original designs (Fig. 1; Appendix B). Scaffold thickness varied 
depending on the number of layers deposited in the 0° and 90° stack angles. 390_30 and 390_40 




Figure 1. SEM images of 3D-printed microfibre scaffolds used for seeding in this study. Box-structure scaffolds with  
390 µm fibre spacing and 30 (A, C, E) or 40 (B, D, F) fibre layers, referred to as 390_30 or 390_40, respectively, were 






5.1.2 Scaffold dimensions 
Fibre diameter and spacing were measured from microscopic images using the line selection tool 
in ImageJ software. Fibres comprising the box walls of the 390_30 and 390_40 scaffolds displayed 
regular diameters of approximately 13 µm and 14 µm, respectively (Table 2), while the wall fibres 
in the 400_10 scaffolds were around 15 µm in diameter. Fibres at the base of the 390_30 and 
390_40 scaffolds had average diameters of 8µm and 7 µm, respectively. As the G-code did not 
factor in fibre thickness, actual box dimensions in the printed scaffolds were smaller than in the 
original design. Regions of the 390_40 scaffolds displayed more variation in box size compared to 
the 390_30 scaffolds.  
Table 2. Microfibre scaffold measurements determined from optical or SEM images. 
 
       Scaffold 
 
              Box Width 
 
Wall Fibre Diameter 
 
         Base Fibre Diameter 
    
       390_30               362 ± 2.1 µm 13.4 ± 1.3 µm  8.5 ± 0.8 µm 
       390_40               357.3 ± 12.2 µm 14.2 ± 0.8 µm  7.5 ± 0.6 µm 
       400_10               379 ± 4 µm 15 ± 3 µm --- 
    
 
5.2 SPHEROID MORPHOLOGY 
Spheroids of spherical shape and standard size were repeatedly formed from a suspension of 5,000 
hASCs pipetted into agarose-coated wells of 96-well plates. Inverted microscope images were taken 
of the spheroids in the well-plate 48 hours after seeding (Fig. 2). From these images, the area of ten 
spheroids was measured using the freehand selection tool in ImageJ so that spheroid diameter 
could be calculated. It was found that the mean spheroid diameter was 352 ± 11 µm. Spheroid size 
calculated in Annex 1 was 350 ± 15 µm. Therefore, spheroid size was well controlled and 
reproducible, which has important implications for seeding in 3D-printed microfibre scaffolds with 
precise box dimensions.  
 
 
Figure 2. Spheroids formed with 5,000 hASCs show minimal variation in size and shape. In situ inverted microscope 
images were taken 48 hours after seeding of cells into an agarose-coated 96-well plate. Scale bars: 200 µm. 
 
5.3 CHARACTERISATION OF SEEDED SCAFFOLDS 
5.3.1 Establishing a seeding technique 
Due to the novelty of seeding microfibre box-structure scaffolds with spheroids, it was necessary 






inner diameter as a seeding guide, under which the 400_10 scaffolds were placed and basal medium 
containing 60 spheroids or an equivalent number of cells was pipetted into the centre of the rings 
(Fig. 3 A). While some leakage was observed, most of the spheroids and cells remained inside the 
ring and attached to the mesh within 24 hours. Although this protocol did provide rudimental 
comparisons between cell- and spheroid-seeding techniques, further improvements to the protocol 
were necessary to overcome issues including leakage, floating of the samples, and the need for an 
excessive number of spheroids to homogenously fill the large number of box pores inside the ring. 
Therefore, both the seeding technique and scaffold design were optimised for subsequent 
experiments.  
CC96 inserts were used in place of the rings in an attempt to better secure the scaffold in place and 
prevent floating, in addition to reducing the seeding area to approximately 32–34 box pores, 
dependent on the scaffold placement inside the CC96 holding cup. Furthermore, an optimised 
scaffold structure with higher box walls and the addition of base fibres was used in an attempt to 
improve spheroid retention in the scaffold. Initial experiments produced markedly improved filling 
of boxes with spheroids (Fig. 3 B), where 30 spheroids were seeded per scaffold. This led to a 
seeding efficiency, defined as the percentage of available boxes actually filled by a spheroid, of 
approximately 75% in all scaffolds. Although box pore and seeding number were nearly matched, 
this was possibly due to spheroids leaking out of the CC96 inserts, likely due to ruptures in the 
fragile base fibres or an imperfect placement of the scaffold in the CC96 holding cup. Also, air 
bubbles trapped in the medium caused disruption to spheroid placement, and were minimised by 
seeding in a bigger well-plate. To reach the goal of 100% seeding efficiency, the seeding number 
was increased to 40 to compensate for lost spheroids (Fig. 3 C). However, while this led to an 
improved seeding efficiency filling of approximately 84%, multiple spheroids were seeded into 
some boxes. Therefore, box wall height was slightly decreased with the 390_30 scaffolds, and only 
34 spheroids were seeded. This was determined to be the optimal seeding number, as it enabled 
an average seeding efficiency of at least 90% in the scaffolds, with some samples at 97 and 100% 
(Fig. 3 D), and minimal instances of spheroid stacking. 
Unfortunately, dispersed cell studies were unsuccessful using the CC96 inserts, due to the large 
pore sizes in the scaffolds. Despite resting the CC96 holding cup on agarose in the well plate, the 
cells congregated beneath the scaffold and formed a large floating aggregate on the agarose 
surface (see Appendix C). Some cells were observed attaching to the scaffold fibres, however it was 
not possible to compare these samples to those seeded by spheroids due to the subsequent 
significantly lower seeding density. Therefore, a different seeding technique must be developed 








Figure 3. Progress of hASC spheroid-seeding techniques on microfibre box-structure scaffolds. Initial experiments (A) 
involved seeding 400_10 scaffolds with spheroids using a ring (ø = 8 mm) as a guide. Subsequent experiments were 
optimised by using CellCrown™96 inserts (ø = 2.7 mm) and 390_40 (B, C) or 390_30 (D) scaffolds, and varying the spheroid 
seeding number (see text). Scale bars: 400 µm. Note: samples were imaged from beneath using an inverted microscope. 
The position of the spheroids appears to be offset from the boxes in panels B – D due to the angle of imaging, as the 
CellCrown™96 inserts could not be placed perfectly horizontal on the agarose-coated well plates. 
5.3.2  Spheroid positioning and retention in the scaffolds 
Due to the top-seeding approach that utilised gravity to populate the scaffolds, filling of the box 
pores was innately random and uncontrolled. Spheroids were appropriately size-matched and 
organised in the box pores of the 400_10 scaffolds without any need for physical guidance. No 
instances of multiple spheroids within one box were observed, indicating that the spheroids were 
adequately sized. However, the seeding was inhomogeneous due to the random filling of boxes, 
which was exaggerated by the number of box pores far exceeding the number of spheroids seeded. 
When using the CC96 inserts and 390_30 or 390_40 scaffolds, the spheroids could be guided into 
position by gentle shaking and tapping motions, however the spheroids were susceptible to later 
floating out of position with handling of the well-plate. As a result, while all boxes could eventually 
be filled with spheroids after optimising the seeding protocol, retention in the boxes remained a 
challenge for some samples. While the 390_40 scaffolds had higher walls that decreased the 
potential for spheroids to float out of position, this advantage was counteracted by the higher 
degree of difficulty associated with getting the spheroids to fall into the boxes, and issues with 






seeding as more homogeneous seeding could be achieved. In order to reduce spheroid movement 
and floating, minimal medium was used during seeding until spheroids had attached to the fibres.  
5.3.3 hASC behaviour in the 400_10 scaffolds  
Spheroids and dispersed cells attached to the 400_10 scaffolds within 24 hours, indicating its high  
bio-compatibility (Fig. 4). After 48 hours, the spheroids had completely spanned the box frames and 
started to lose the 3D spherical structure. The hASCs seeded onto the scaffolds as a cell suspension 
displayed a fibroblast-like morphology within 48 hours, and began to fill the pores.  
Figure 4. Microscopic images of spheroid- and cell-seeded 3D-printed microfibre 400_10 scaffolds. Scaffolds were 
seeded with spheroids containing 5,000 hASCs (A–C) or an equivalent number of hASCs (300,000) in a cell suspension  
(D–F). In situ images were taken immediately after seeding (A, D), and 24 (B, E) and 48 (C, F) hours later. Scale  
bars: 200 µm.   
 
The appearance of the seeded constructs differed between the two groups after 14 days of culture 
in basal medium (Fig. 5). As expected, a wider area was populated in the dispersed cell-seeded 
constructs, due to the number of seeding units greatly outnumbering the pores and the subsequent 
increased spreading during seeding. Cells had attached to fibres throughout the scaffold and 
started to fill the pores from the outside in, resulting in a ring-like pattern of boxes with an empty 
centre, as well as some completely filled boxes. In contrast, the spheroid-seeded samples had fewer 
filled pores, as expected with only 60 units seeded. While the 400_10 scaffolds failed to maintain 
the structure of the spheroids, the pores that had been seeded with a spheroid were completely 
filled. A complete loss of the 3D spherical shape was observed, with only a darker and denser area 
of cells remaining in each pore, indicative of the primary attachment point of the spheroid to the 
wall fibre. Spheroids that had randomly fallen into adjacent pores attached to the scaffold and 
appeared to undergo fusion to form a thicker and more confluent cell layer compared to the  






were observed attached to fibres distal to spheroid attachment sites. The ring-like pattern was not 
observed in the spheroid-seeded scaffolds. 
Interestingly, while both seeding techniques resulted in a mosaic of filled and unfilled box pores, 
the mechanism by which this was achieved differed for each group. In the dispersed cell-seeding 
study, hASCs attached to fibres throughout the scaffold and then filled the pores from the outside 
in. Conversely, in the spheroid-seeding study, the spheroids attached to one or two of the box walls 
and then filled the box from the inside out. 
 
Figure 5. Microscopic images of seeded 400_10 scaffolds. Scaffolds were seeded with 60 spheroids containing 5,000 
hASCs (A), or an equivalent number of hASCs (300,000) in a cell suspension (B). Images were taken in situ after 14 days 





5.3.4 hASC behaviour in the 390_30 and 390_40 scaffolds  
Spheroids were unable to fall through the 390_30 and 390_40 scaffolds suspended in the CC96 
inserts due to their size exceeding the spacing of the base fibres. SEM images revealed that the 
spheroids formed multiple attachment points to the scaffold fibres within 24 hours, and began to 
interact and form connections with neighbouring spheroids above and through the box walls  
(Fig. 6). However, the SEM images also displayed many drying artifacts from the sample preparation 
process, such as fractures in the spheroid-scaffold attachment regions and shrinkage of the 
spheroids.  
In spheroid-seeded samples with at least 90% filled boxes, in situ monitoring revealed minor signs 
of spheroid disassembly after 48 hours, referred to as day 1, in both the induced and non-induced 
control groups, with cells at the periphery of the spheroids displaying fibroblast-like morphology. 
In the non-induced group, spheroids had completely filled the box pores by day 3 (Fig. 7 A–F). A 
continuous layer of tissue was formed by day 14, however remnants of the spheroid structure 
remained as denser and darker areas in the centre of each box pore. It is also interesting to note 
that the empty pore shown in the sample in figure 7 started to become populated with cells after 
4 days, and was completely filled by end of the culture period. However, without the use of 
quantitative analysis techniques such as a DNA assay, it is impossible to determine whether this is 
a result of proliferation or cell migration in the sample, or a combination of both. Conversely, an 






scaffolds, with some holes remaining (Fig. 7 G–L). Similar to the non-induced group, spheroid 
structure was also still clearly discernable within each pore by day 14.  
 
 
Figure 6. SEM images of spheroid-seeded 390_30 scaffolds, showing spheroid-scaffold and spheroid-spheroid 
interactions. Images were taken 24 hours after seeding. Panel A provides an overview of the sample at 40-fold 
magnification, and panels B–D contain more detailed images at 200-fold magnification. Scale bars: A: 250 µm;  
B–D: 50 µm. Note: the sample preparation for SEM led to drying artifacts, such as spheroid shrinkage and fracturing of 
spheroid-scaffold attachments. 
 
Scaffolds that were initially seeded with at least 90% of boxes filled, but had poorer spheroid 
retention, displayed a different progression of scaffold population (Fig. 8 A–F). Accidental bumping 
of the samples or the formation of bubbles in the medium led to an accumulation of spheroids at 
the periphery of the scaffold after seeding, with only approximately 50% of boxes remaining filled 
after 24 hours. However, by the end of the culture period, the non-induced sample was similar in 
appearance to those that had started with over 90% seeding efficiency. Similar to the progression 
shown in figure 7, empty boxes began to fill with cells at around day 3. However, by day 14, some 
of the pores that were empty at day 0 were indistinguishable from those that were seeded with a 
spheroid. A dark and dense area was present in the centre of some of these pores, suggesting that 
the cells potentially formed a spheroid-like arrangement inside the box. This phenomenon was 
observed in the pores of a number of poorly seeded non-induced samples. This was not observed 
in the adipogenically induced sample that also had approximately 50% of boxes filled after 24 hours 






spheroids (Fig. 8 G–L). At day 14, some of the empty pores were incompletely filled with cells, and 
no new spheroid-like structures were observed.  
 
 
Figure 7. Microscopic images showing the progression of a non-induced (non) and an induced (ind) 390_30 scaffold 
with over 90% of boxes seeded with spheroids. In situ images were taken immediately after seeding (A, G), and at days 
0 (B, H), 1 (C, I), 3 (D, J), 7 (E, K), and 14 (F, L) of adipogenic induction. Arrows indicate a spheroid in the non-induced 
scaffold that dislodged after seeding and attached atop neighbouring spheroids. Scale bars: 400 µm. Note: images were 







Figure 8. In situ microscopic images showing the progression of a non-induced (non) and an induced (ind) 390_30 
scaffold with greater than 90% of boxes filled by spheroids, but poorer spheroid retention after 24 hours. Images were 
taken immediately after seeding (A, G), and at days 0 (B, H), 1 (C, I), 3 (D, J), 7 (E, K), and 14 (F, L) of adipogenic induction. 
The asterisk marks a box in the non-induced sample that was devoid of a spheroid at day 0, then became populated by 
cells, displaying a denser appearance in the centre by day 14. Scale bars: 400 µm. Note: images were taken of the 
underside of the scaffold using an inverted microscope. The dark ring-like structure in panel H is a bubble that formed in 




5.3.5 Cell viability 
Cell viability in the spheroid-seeded scaffolds was analysed via whole sample live/dead staining  
(Fig. 9). Living cells fluoresce green due to calcein-AM that passes through the membrane and is 
hydrolysed to calcein. Conversely, EthD-III enters dead cells via the disrupted membrane and then 






0 of adipogenic induction, the vast majority of cells that were visible from the surface of the whole 
sample were alive. Cell viability in the surface region of the constructs was slightly decreased after 
a further 14 days of culture in basal or adipogenic medium, with a greater number of dead cells 
observed. However, the majority of cells that could be viewed from the top surface of the scaffold 




Figure 9. Live/dead staining of 390_30 scaffolds seeded with hASC spheroids. Staining was performed 24 hours after 
seeding (A, B), and after a further 14 days of culture in basal (C, D) or adipogenic induction (E, F) medium. Viable cells 
appear green, and dead cells are stained red. Overview images at 4-fold magnification and more detailed images at  







5.4 ADIPOGENESIS IN THE SEEDED SCAFFOLDS 
5.4.1 Gross observations 
By day 14 of adipogenic induction, cells in the 390_30 scaffolds displayed a different morphology 
compared to non-induced controls. Lipid droplets were visible within the cells of the adipogenically 
differentiated samples, and the cell shape was more rounded compared to the fibroblast-like 
morphology of the non-induced samples (Fig. 10).  
 
 
Figure 10. Microscopic images showing the difference in cell morphology between non-induced (A) and induced (B)  
spheroid-loaded 390_30 scaffolds. Images were taken in situ at day 14 of adipogenic induction using an inverted 
microscope. Arrow indicates lipid droplets in the adipogenically induced sample. Scale bars: 200 µm. 
 
5.4.2 Histological investigation of whole samples 
Qualitative analysis of adipogenic differentiation was performed on whole samples using Oil Red O 
and hematoxylin staining to visualise accumulated lipid droplets and cell nuclei, respectively. 
However, light penetration and microscopic imaging was difficult due to the thickness of the 
samples. As expected, adipogenic differentiation was observed under induction conditions by red 
staining of the accumulated intracellular triglycerides in all scaffold groups. In the 400_10 scaffolds, 
both the spheroid- and cell-seeded samples displayed adipogenic differentiation by accumulation 
of lipid droplets inside the cells, however cell density in the spheroid-seeded samples was much 
higher (Fig. 11). Under non-induced control conditions, no adipogenesis was evident in the samples. 
PCL fibres were also rendered red by the Oil Red O staining. 
In the 390_40 scaffolds, sample thickness and cell density did not allow for clear microscopic images 
to be obtained (see Appendix D). However, from these images, red stained lipid droplets could also 
only be observed in the adipogenically induced group. Macroscopic images of the samples revealed 
that while spheroids in the non-induced control group remained within the box walls, the 
adipogenically induced appeared to grow upwards and above the box walls with a “fluffy” 
appearance atop the scaffold, as the outline of the wall fibres were no longer visible (Fig. 12). This 
is an interesting observation that could not be seen in the in situ images in figures 7 and 8, which 







Figure 11. Microscopic images showing adipogenic differentiation of 400_10 scaffolds seeded with hASCs as spheroids 
(A, B) or dispersed cells (C,D). Scaffolds were harvested at day 14 of adipogenic induction, then stained with Oil Red O 
and hematoxylin. Non-induced control (A, C) and induced (B, D) samples are shown. Triglycerides are stained red, and 
cell nuclei are stained purple. PCL fibres were also rendered red by the Oil Red O staining. Scale bars: 50 µm.  
 
 
Figure 12. Macroscopic images of spheroid-seeded 390_40 scaffolds. Samples were harvested and stained with Oil Red 
O and hematoxylin at day 14 of adipogenic induction. Non-induced (A) and induced (B) samples were imaged from above. 
Note: only a circular area (⌀ = 2.7 mm) in the centre of the scaffold was seeded with spheroids, due to obstruction of the 






5.4.3 Histological investigation of cryosections 
Due to the difficulties associated with imaging whole samples, a new protocol for cryosectioning 
the spheroid-seeded scaffolds was established. The cryosections were stained with Oil Red O and 
hematoxylin (Fig. 13). As seen in the whole sample staining, the PCL fibres in the cryosections were 
stained red during the process. However, the fibres did not remain fully intact during sectioning 
and failed to completely adhere to the slides during the staining and slide washing processes. 
Therefore, artifacts such as void spaces and fragments of red-stained PCL fibres, often in random 
locations, were observed in the sections.  
At day 0, the cells were similar in morphology and density to that observed in the sectioned 
spheroids from Annex 1, section 3.3.2.  The cells displayed no accumulated lipid droplets and had a 
rounded shape. Remnants of a denser outer shell of cells could still be seen around most spheroids. 
After 14 days of adipogenic induction, lipid vacuoles of various sizes were visible in the cells due to 
Oil Red O staining. Conversely, at day 14, the ASCs in the non-induced control samples displayed no 
lipid droplets, and were less dense compared with day 0.  
5.4.4 Quantitative analysis 
To complement the histological studies, real-time qRT-PCR was performed to quantitatively analyse 
the expression of adipogenic markers in the spheroid-seeded scaffolds. Differentiation was 
determined by measuring expression of C/EBPα and PPARγ, the two most relevant transcription 
factors involved in adipogenesis. As a late adipogenic marker, aP2 expression was also measured. 
Quantitative analysis of relative gene expression showed that the adipogenesis observed in the 
histological analysis was well reflected on the mRNA level (Fig. 14). Expression of these key 
adipogenic markers was low in the non-induced constructs, and no statistically significant 
differences were detected between the day 0 and 14 non-induced groups. Conversely, relative 
expression of all genes was elevated by adipogenic induction. Day 14 induced samples expressed 







Figure 13. Microscopic images of cryosections from spheroid-seeded 390_30 scaffolds. Sections were stained with Oil 
Red O and hematoxylin to visualise lipid content and cell nuclei, respectively. Samples were harvested for sectioning at 
day 0 (A, B) and day 14 (E, F) of adipogenic induction. Day 14 non-induced controls are also included (C, D). Overview 
images at 10-fold magnification and more detailed images at 20-fold magnification are shown. Arrows indicate PCL fibre 







Figure 14. Relative expression of C/EBPα, PPARγ, and aP2 mRNA in hASC spheroid-seeded 390_30 scaffolds. Total RNA 
was isolated for expression analysis at day 0 (d0) and 14 days (d14) after adipogenic induction (ind). Non-induced (non) 
seeded scaffolds served as controls. Expression of C/EBPα (A), PPARγ (B), and aP2 (C) were normalised to EF1α as a 
housekeeping gene. Gene expression levels are expressed relative to d0. * Statistically significant difference (p < 0.05) 
between d14 ind and d0. c Statistically significant differences (p < 0.05) between d14 non and d14 ind. Data represents 








In plastic and reconstructive surgery, the restoration of large soft tissue defects still represents a 
significant challenge. While it has been shown that ASC spheroids possess superior regenerative 
capabilities compared to single cells, which are conventionally used in adipose tissue engineering, 
delivery to in vivo settings is still a challenge. Previous studies have used various scaffold designs as 
spheroid carriers or models for studying spheroid fusion. A promising study by Huang et al. was the 
first to report scaffolds that provide a microenvironment capable of maintaining MSC spheroid 
morphology.24 However, the study was performed in the context of cartilage regeneration, and with 
fibre diameters of 200 µm, the constructs contained a high polymer-to-cell ratio that may not be 
ideal for adipose tissue engineering. Therefore, the intention of this study was to investigate, for 
the first time, if microfibre box-structure scaffolds fabricated by MEW could be seeded with hASC 
spheroids, and if these spheroids could undergo adipogenic differentiation under in vitro 
conditions. 
6.1  ESTABLISHING A SEEDING TECHNIQUE    
6.1.1 Early experiments 
Due to the novelty of the study, a new seeding technique was established and optimised. In order 
to simplify the experimental process, only one spheroid size was used. Determining the optimal 
spheroid size for scaffold seeding necessitated a compromise between the easier handling of larger 
spheroids that also required fewer units to generate a tissue construct of a given size, and smaller 
spheroids that differentiated more effectively and avoided apoptosis or necrosis in the central 
region. It has been reported that 500 µm is the upper diameter limit for viable spheroids.31-33  
Therefore, from the spheroid sizes measured in Annex 1, it was decided that all experiments would 
be performed using spheroids formed with 5,000 hASCs, as the diameter of these spheroids was 
below the upper limit of viability, and homogeneous differentiation was observed.  
Scaffolds were 3D-printed by MEW using G-code that was written with a 90° offset of fibre 
deposition in each layer, resulting in vertical square-prism shaped pores. Within the context of 
spheroid seeding, pore size within the scaffolds is a measurement of the maximum diameter of a 
sphere that is able to fit in the void space, and is therefore equivalent to fibre spacing in the X and 
Y directions. The first and most basic scaffold type used in this study was a PCL mesh designed using 
G-code for 10 fibre layers, with 5 layers deposited in each of the X and Y directions, and fibre spacing 
of 400 µm, referred to as 400_10. Measuring at around 379 µm, the inner width of the box pores 
was actually smaller because of the fibre thickness, and potentially also jet instability or fibre 
pulsing, which affect fibre placement.34 The meshes were placed beneath a ring structure with an 
inner diameter of 8 mm for seeding, resulting in approximately 300 boxes in the seeding area. 
However, due to the long time required to generate such a large number of spheroids using the 
liquid overlay technique in 96-well plates, and the proof-of-principle nature of the experiment, a 
much lower number of spheroids were seeded on the meshes. The spheroids were appropriately 
size matched to the boxes and were readily seeded in a random pattern without any manual 






number of dispersed cells, all pores were immediately homogeneously filled. This is to be expected, 
due to the number of cells far exceeding the number of pores positioned inside the seeding guide.  
6.1.2 Optimisation 
Optimisation of seeding efficiency was undertaken by varying a number of parameters. Firstly, the 
seeding area was minimised to 32–34 boxes by using CC96 inserts, because this was a practical 
number of spheroids that could be generated and seeded per sample using the liquid overlay 
technique. Furthermore, the CC96 inserts better secured the samples during seeding and medium 
changes. Due to the CC96 inserts requiring suspension of the sample during seeding, a base was 
added to the scaffold design via the addition of closer spaced fibres in the third layer, in order to 
catch and retain the top-seeded spheroids. Furthermore, pore size was slightly decreased, and wall 
height raised by increasing the number of layers to 40, referred to as 390_40. By increasing wall 
height and reducing pore size to more closely match spheroid dimensions, it was anticipated that 
spheroid structure would be better maintained. Measurements taken from SEM images of the 
scaffolds revealed that actual box size was smaller than written in the G-code, with box widths in 
the 390_30 and 390_40 scaffolds of 362 ± 2 µm and 357 ± 12 µm, respectively. These values are 
smaller than expected when fibre diameter is accounted for. As previously mentioned, this is likely 
due to small inaccuracies with fibre placement resulting from jet instability or fibre pulsing, which 
could have also caused the increased variation in box size in the 390_40 scaffolds.34 Nevertheless, 
the box sizes were still adequately sized for spheroid seeding. In the first seeding attempt using the 
CC96 inserts, 390_40 scaffolds were seeded in a 96-well plate, as per the CellCrown™ 
manufacturer’s instructions. Each scaffold was seeded with 30 spheroids, and while the seeding 
efficiency was improved from the 400_10 scaffolds, only approximately 75% of boxes were filled. 
Due to the formation of bubbles in the small wells that disrupted spheroid placement, and the 
insufficient ratio of medium volume to cell number, it was decided that larger well plates would be 
more appropriate for future experiments. To increase the seeding efficiency, 40 spheroids were 
seeded in the 390_40 scaffolds in 6-well plates, but this resulted in multiple spheroids in some 
boxes. Additionally, difficulties were encountered with manipulating spheroids into the boxes due 
to the higher walls on the boxes. Therefore, wall height in the scaffolds was slightly decreased by 
10 layers, referred to as 390_30. These scaffolds provided optimal results, and when 34 spheroids 
were seeded, an average of 90% seeding efficiency was achieved in each sample, with some 
samples at 100%. Importantly, instances of multiple spheroids stacking in the boxes were 
minimised. It was found that gentle tapping and shaking motions of the well plate encouraged 
spheroids to disperse in the medium above the scaffold and then fall into the boxes, leading to 
improved homogeneity of box filling.   
6.1.3  Suitability of 3D-printed microfibre PCL scaffolds for seeding 
The hASCs attached within 24 hours in all scaffold groups, indicating good compatibility with the 
PCL scaffolds. This is to be expected, as the high affinity for cell attachment in melt electrospun 
microfibre PCL scaffolds has been reported in a number of studies. Murine calvarial cells (MC3T3-
E1),35, 36 hBMSCs,30, 36 human osteoblasts,37, 38 human mesothelial cells (Met-5A),37 and human 
dermal fibroblasts39 have all demonstrated good attachment and spreading on PCL fibres in 






have also been shown to support ASC attachment and growth.40-42 Furthermore, a study where 
hASCs were successfully attached to nanofibrous PCL scaffolds demonstrated enhanced viability 
and proliferation rate compared with conventional tissue culture polystyrene (TCPS).43  
6.2 SPHEROIDS AS AN ALTERNATIVE METHOD FOR POPULATING MESHES 
6.2.1 Early observations 
While the 3D structure of the spheroids was not properly maintained by the 400_10 scaffolds, the 
technique could serve as an alternative method for populating meshes with cells. Therefore, 
comparisons with the conventional technique of populating scaffolds using dispersed cells are 
important to consider. In the meshes, the spheroids initially attached to one wall or corner of the 
square pores. After 24 hours, cells at the periphery of the spheroids had elongated, changing to a 
fibroblast-like morphology, and formed attachments to the other walls of the pore. By 48 hours, 
some of the pores had completely filled with cells as the spheroids underwent further disassembly. 
After approximately 5 days of culture, pores seeded by spheroids were completely filled and the 
spheroid structure was not well preserved. This was faster than that observed in the dispersed cell 
experiment, where after 5 days, few pores were completely filled, and inside most of the squares, 
the cells had formed a circular structure via cell-cell contacts after initially attaching to the walls.  
6.2.2 Spreading of hASCs on meshes 
At the end of the culture period, both groups had a mosaic of filled pores, however there was a 
marked difference in appearance. The spheroid-seeded samples had a much higher cell density in 
the pores, and cells had migrated along the fibres to surrounding squares and accumulated in the 
corners. This result can be attributed to the general tendency of spheroids to spread on cell-
interacting surfaces, such as the PCL fibres. Conversely, where cells had spanned the pores in the 
cell-seeded scaffolds and completely filled them, the cell density was much lower, and a number of 
ring-like structures remained in the other pores. This ring-like structural formation was only present 
in the cell-seeded samples, and is thought to be due to the process of pore filling. Square pores 
containing spheroids were filled from the inside out, with the spheroid occupying a large space 
inside the pore at seeding, compared with cell-seeding which occurred from the outside in, wherein 
cells attached to the fibres and formed cell-cell contacts and proliferated in order to span the pore. 
The ring-like structure formation has been reported in a number of studies involving seeding of 
dispersed cells onto box-structure microfibre scaffolds. In melt electrospun PCL scaffolds with pore 
sizes of 600 µm, MC3T3-E1 cells formed a circular structure inside the pores after 6 days.36 However, 
the pores were all eventually filled via cell proliferation after 14 days. With the smaller pores in the 
400_10 scaffolds, it was expected that a continuous layer of cells would be formed in a shorter 
period of time, however this was not achieved, likely due to a lower seeding density and different 
cell type. Similarly, PCL box-structure scaffolds with pore sizes of 90 and 150 µm seeded with 
hBMSCs showed a similar ring-like structure after 4 days in vitro, with the cells taking on a fibroblast-








6.3 MICROFIBRE BOX-STRUCTURE SCAFFOLDS AS SPHEROID CARRIERS 
6.3.1  Spheroid behaviour in the scaffolds 
With increased layer height and the addition of base fibres, the 390_30 and 390_40 scaffolds 
contained proper 3D box-structure pores more tailored to spheroid dimensions. As expected, this 
resulted in improved maintenance of spheroid structure compared to the 400_10 meshes, likely 
due to the more stable and supportive environment provided by the higher walls, and the reduced 
void space around the spheroids able to be filled by migrating cells. Optimisation of the seeding 
technique led to marked improvements in seeding efficiency, allowing at least 90% of boxes to be 
occupied by a spheroid.  
Unlike in the 400_10 meshes, all spheroids formed more than one point of contact with the scaffold 
when initially seeded. Due to the scaffolds not sitting perfectly horizontal in the CC96 inserts, 
gravity forced the spheroids to make contact with not only the base fibres, but also one wall or 
corner of the box pore. Within 24 hours, many of the spheroids were no longer in the centre of the 
pores, as the outer cells in the spheroid had attached to the wall fibres and tethered the spheroid 
off centre. SEM images revealed that the spheroids also interacted with neighbouring spheroids 
above and through the box walls. However, drying artifacts such as fracturing and spheroid 
shrinkage limited the observations that could be made from the images. As such, optimisation of 
the sample preparation protocol should be explored in future experiments. Encouragingly, cell 
viability tests showed that the majority of cells in the spheroids survived the seeding process, 
despite the pipetting steps and reduced volume of medium used during seeding. However, only 
cells near the top surface of the samples could be analysed, and further experiments involving 
cutting of the sample or an MTT assay are required to confirm if cells in the central region remained 
viable.  
Minor signs of spheroid disassembly were observed 48 hours after seeding, and the empty spaces 
in the boxes began to fill with cells. After 4 days, each spheroid was completely surrounded by a 
network of fibroblast-like cells inside its box pore. Empty boxes within the scaffold also began to fill 
with cells, likely due to a combination of proliferation and cell migration from neighbouring 
spheroids. While it is known that proliferation is reduced in spheroids, it has also been shown that 
ASCs migrate out of spheroids and proliferate upon transferring to another adherent growth 
surface.44 Furthermore, spheroids with diameters over 200 µm are known to exhibit a 
heterogeneous architecture, with mostly viable and proliferating cells in the outer layers,45 which 
are highly exposed to the medium, and an inner hypoxic and quiescent cellular core.46 Therefore, it 
is probable that cells in the outer layer of the spheroid underwent proliferation to fill the void 
spaces, however quantitative analytical techniques such as a DNA assay are needed to confirm this. 
The relatively quick population of the empty pores with cells was also likely assisted by the base 
fibres bridging the pore and providing a path for the cells to spread across. By the end of the culture 
period, previously empty pores were completely filled with cells, however the density was lower 
than those occupied by spheroids. Spheroid structure was not completely preserved, however a 
darker and denser circular shaped area remained inside each pore. Similar to the results reported 






would enable the box-structure scaffolds to not only accommodate the spheroids, but also provide 
a microenvironment for preserving spheroid structure.   
6.3.2 Formation of a continuous tissue layer in poorly seeded scaffolds 
While the aforementioned issues with bubbles forming inside the CC96 inserts and accidental 
disruption of samples resulted in multiple spheroids floating out of the boxes and accumulating at 
the periphery of the scaffolds, in situ imaging of these samples at regular time intervals provided 
an interesting insight into cell behaviour and migration. Unexpectedly, a thick continuous layer of 
cells that closely resembled the samples seeded with at least 90% efficiency was often formed by 
the end of the culture period. Many of the spheroids that floated out of the boxes accumulated 
above the scaffold and fused to form a dense mass of cells within 24 hours, which underwent 
further compaction by 48 hours. However, after 7 days, the appearance was markedly different. 
Many of the previously empty pores had become densely populated with cells, and by the end of 
the culture period, a dark circular-shaped mass of cells was present in the centre of some unseeded 
boxes that were indistinguishable in appearance from those seeded with spheroids. This was an 
unexpected result, and further investigation is required to determine if the dense area of cells is 
spherical or 2D, and if the internal structure is similar to that of the spheroid-seeded pores. There 
are a number of logical explanations for this phenomenon, including that the cells congregated on 
the closely spaced base fibres and formed a denser aggregate at the base of the scaffold, which is 
the surface from which the samples are imaged, giving the illusion of a 3D structure. Alternatively, 
self-aggregating to form a spheroid-like arrangement would allow the cells to maximise cell-cell 
contacts and minimise contact with the PCL fibres, ultimately leading to an environment more 
similar to physiological conditions. Unfortunately, due to the large pore sizes and the requirement 
for suspension of the sample in the CC96 inserts during seeding, it was not possible to observe 
whether this phenomenon occurred with scaffolds seeded with dispersed cells. Modification of the 
seeding technique is required before single cell studies can be performed, possibly by the addition 
of a non-adhesive sheet in the CC96 insert beneath the scaffold to prevent the cells from falling 
through. However, as the scaffolds were ultimately designed as spheroid carriers, modifying the 
seeding technique to suit dispersed cell seeding could be considered counterintuitive, and must not 
affect spheroid seeding efficiency.   
6.4 DIFFERENTIATION TOWARDS THE ADIPOCYTE LINEAGE 
6.4.1 Cell morphology and behaviour 
Spheroids and cells successfully underwent differentiation in the 400_10 meshes, as determined by 
histological investigation. While spheroids are known to differentiate more effectively than cells 
cultured in monolayer, this result was not expected in this study due to the disassembly of the 
spheroids and the 3D environment provided by the mesh. Unfortunately, due to the high cell 
density, it was difficult to image and analyse the samples, and adipogenic comparisons between 
the cell- and spheroid-seeded samples could not be accurately made.  
Similar to the 400_10 meshes, hASCs in the spheroid-loaded 390_30 and 390_40 scaffolds 






Importantly, cell viability did not appear to be affected by adipogenesis, however, as previously 
mentioned, only cells in the superficial layer of the construct were able to be analysed. In the first 
few days of induction, spheroids behaved similarly to those in the non-induced control group. 
Spheroid structure was still discernable by day 14 of adipogenic induction, however a coherent 
layer of tissue was not formed as some void spaces remained around the spheroids and in the 
unseeded pores. This is to be expected, as it is known that proliferation and differentiation are 
opposing processes in ASCs.47 In order for adipogenic differentiation to occur, ASCs must be 
withdrawn from the cell cycle,48 and studies have shown that ASCs in PCL scaffolds differentiated 
towards the adipocyte41 or chondrocyte49 lineages is correlated with a reduction in proliferation. 
However, as previously mentioned, analysis of total DNA content or a similar measure of 
proliferation is necessary to confirm that proliferation was reduced in the induced samples, as cell 
migration was likely also affected. Macroscopic imaging of the top scaffold surface revealed that 
cells in the adipogenically induced samples had expanded up and above the box walls, unlike the 
non-induced samples. This is likely due to the large increase in cell volume that occurs with lipid 
accumulation during adipogenesis. 
Accumulation of lipid droplets in the differentiating cells could be seen from day 5 with the inverted 
microscope, and the cells took on a rounded and swollen appearance. Oil-Red-O staining of lipid 
droplets is considered a gold standard for histological visualisation of adipogenesis. Red stained 
lipid-containing vacuoles inside cells could be seen with a brightfield microscope in the whole 
specimens, however as in the 400_10 samples, thickness and density limited light penetration and 
image quality. Therefore, sectioning of the spheroid-loaded PCL constructs was necessary for 
histological investigations. Due to the chemicals used in standard paraffin sectioning that strip 
adipose tissue of lipids, cryosectioning of the scaffolds was trialed instead. Due to the thinness of 
the PCL fibres, cutting of the samples with the cryostat was easily achieved. However, the fibres 
were broken during the process and, as expected, did not remain fully attached to the slides during 
the staining process. As a result, small void spaces were formed and only fragments of PCL remained 
on the slides. Further experimentation with surface coated microscope slides may yield improved 
results. Nevertheless, Oil Red O and hematoxylin staining of the cryosections enabled evaluation of 
lipid accumulations, cell morphology, and density. At day 0, cell morphology and density was similar 
to spheroids prior to seeding, as investigated in Annex 1, with a rounded cell shape and no lipid 
droplets. The higher density of cells at the periphery typically seen in spheroids was still discernable 
but reduced in thickness. By day 14, cells in the adipogenically induced samples displayed 
intracellular lipid droplets, however these were smaller and fewer in number than that observed in 
the sectioned spheroids in Annex 1, which were induced for 5 fewer days. Further experiments are 
required to determine whether this was a result of seeding into the scaffolds, or donor variability. 
However, cells in the denser regions of the spheroid-seeded scaffold appeared to have accumulated 
more triglycerides. While it has been suggested that a limitation in space for cells to proliferate is 
beneficial for adipogenesis of preadipocytes,50 improvements to the sectioning quality and further 
analysis must be performed before this can be confirmed in the spheroid-seeded samples. As 
expected, no lipid droplets were observed in cells in the non-induced group, which appeared similar 







6.4.2 Molecular investigation of terminal adipocyte differentiation 
To further prove adipogenic differentiation in the 390_30 and 390_40 scaffolds, real-time qRT-PCR 
analysis was conducted for typically expressed adipogenic genes. Differentiation of preadipocytes 
is directed by a number of critical transcription factors that temporally regulate several gene 
expression events, including the C/EBP and PPAR families. Studies in adipogenic cell lines have 
shown that following hormonal induction of differentiation, C/EBPβ and C/EBPδ are rapidly 
expressed, reaching a peak after a day, and then begin to decline as C/EBPα and PPARγ levels rise 
during the intermediate phase of terminal differentiation.51, 52 Using a positive feedback loop, 
C/EBPα and PPARγ co-regulate one another to maintain gene expression that promotes and 
maintains the differentiated state. The important role of these factors in adipogenesis has been 
demonstrated by the stimulation of adipocyte differentiation in cultured fibroblasts by forced 
expression of PPARγ or C/EBPα.53, 54 All aspects of mature adipocyte phenotype and the acquisition 
of insulin sensitivity are affected by the activation of PPARγ. During the late stage of terminal 
differentiation, PPARγ and C/EBPα drive the expression of adipocyte-specific and lipogenic genes, 
including fatty acid-binding protein 4 (aP2), leptin, adiponectin, glucose transporter type 4 (GLUT4), 
and others.55, 56 Therefore, expression of C/EBPα and PPARγ were measured as markers of early 
differentiation, while aP2 served as a marker of late adipogenesis. Consistent with the histological 
data, elevated gene expression of PPARγ, C/EBPα, and aP2 in induced samples confirmed at the 
molecular level that 3D-printed microfibre PCL scaffolds were suitable for supporting adipogenesis 
of ASC spheroids in vitro. However, these values are lower than those typically measured by our 
group in adipogenically induced spheroids, and in hASCs encapsulated in fibrin/PU constructs. This 
correlates with the histology results, which showed poorer adipogenic differentiation than 
previously seen in spheroids. As previously discussed, further experiments are required to 
determine whether this was a result of the scaffold interfering with differentiation, or donor 
variability. Additionally, the large variations in the data, particularly in the induced samples, was an 
unexpected result. The experiment must be repeated in future to determine whether this was due 
to inhomogeneous seeding of the scaffolds that subsequently affected cell density, which is known 
to influence adipogenesis.  
6.5 PRACTICALITY FOR CLINICAL TRANSLATIONS 
6.5.1 Potential for upscaling 
As this study was performed in the context of adipose tissue engineering, which aims to repair soft 
tissue defects, the potential for upscaling of the technique is a necessary consideration. The 
constructs produced in this study were small, with a diameter of only 2.7 mm, but considered 
sufficient for the proof-of-principle experiments in this thesis. Box-structure scaffolds can be  
3D-printed in clinically relevant sizes using MEW. While ASCs are readily obtained from liposuction 
aspirates manually and can be expanded to large numbers in culture, commercially available cell 
sorters that enable rapid (1–2 hours) isolation of ASCs from adipose, such as Celution® developed 
by Cytori Therapeutics in collaboration with Olympus, would enable automation of this process. 
Furthermore, the use of bioreactors to increase stem cell propagation over conventional static 
culture conditions would improve scalability. In this study, the limiting factor in generating sizeable 






technique is most suitable for small- to mid-scale experiments, as the platform does not allow 
formation of large numbers of spheroids in a time efficient manner. Therefore, it was decided that 
CC96 inserts would be most practical for this study, as the CellCrown™48 inserts would have 
required seeding each sample with around 360 spheroids to fill every box. CellCrown™6 inserts with 
a seeding diameter of 28 mm are available for generating larger constructs, although even larger 
custom-made seeding guides could be fabricated via rapid prototyping. Therefore, it is envisioned 
that seeding of larger constructs would be possible if a high throughput technique for spheroid 
formation was utilised, and issues with bubble formation during seeding would also likely be 
minimised. As spheroids are considered such a promising tool in tissue engineering and 
regenerative medicine, strategies for upscaling and automating the formation of spheroids and 
other cell aggregate types have been given considerable attention in the literature. A promising 
method for scalable fabrication of cell aggregates is micromolded wells on non-adherent surfaces, 
wherein cells seeded in a suspension assemble in the microwells and conform to its geometry due 
to gravitational and hydrodynamic forces.57-62 Therefore, to generate reproducibly  
spherical-shaped aggregates, the microwells must have a rounded bottom. In a study by Napolitano 
et al., spheroids with controlled size and shape were formed in polyacrylamide and agarose 
hydrogels micromolded with an array of cylindrical recesses with round bases.57 A follow up study 
by the same group presented an optimised version of the micromolded agarose gel that could be 
autoclaved and reused, and was capable of creating hundreds of uniform spheroids with one 
pipetting step.58 This system has been commercialised by Microtissues®, a Brown University  
start-up company.63 Similar micro-patterned AggreWell™ plates for spheroid formation are 
manufactured and distributed by STEMCELL Technologies. Micromolded hydrogels made with 
chitosan59 and poly(ethylene glycol) (PEG)60 have also been developed as high throughput 
techniques for forming large numbers of spheroids. To further improve scalability, Mehesz et al. 
employed a robotic system for seeding of microrecessions in an agarose gel with an ASC 
suspension.61 Close to 6000 uniformly sized spheroids were formed in one 96-well plate, requiring 
only 12 pipette movements using an eight-channel dispensing tool attached to an automated 
system. Other scalable techniques for generating spheroids include modified hanging drop 
methods, with companies such as InSphero and 3D Biomatrix™ producing plates suitable for pairing 
with robotic cell dispension,61 for example, with the epMotion® automated pipetting systems by 
Eppendorf. Therefore, adoption or modification of one of these high throughput techniques would 
enable a sufficiently large number of spheroids to be generated in a time efficient manner, suitable 
for top seeding onto large box-structure scaffolds. 
6.5.2 Delivering spheroids to defect sites 
When arranged in spheroids, ASCs demonstrate improved differentiation potential18 and express 
higher levels of angiogenic growth factors,20 both of which are important for the regeneration of 
adipose in defect sites. However, delivery of spheroids without loss of the 3D structure must be 
overcome before these benefits can be translated to clinical applications. While the scaffolds used 
in this study as a potential spheroid carrier did maintain some of the 3D structure after 15 days in 
vitro, the challenge remains to fully preserve spheroid morphology. As mentioned previously, 
spheroid structure may be better preserved by treating the surface of the scaffold fibres to 






changes and handling of the scaffolds, some level of cell attachment must occur. It is known that 
the disassembly and spreading of spheroids is determined by competing cell-substrate and cell-cell 
interactions.64 If the cell-scaffold interactions are weaker than the cell-cell interactions, the result 
is the formation of a tethered but not spread spheroid.65 Conversely, when strong cell-scaffold 
adhesion forces override cell-cell interactions, complete spreading to the level of a cell monolayer 
has been observed.66 Therefore, it is likely that modification of the surface to allow only weak  
cell-scaffold interactions would tether the spheroid while preserving the 3D structure. 
Alternatively, to prevent spheroids from dislodging from the surface-modified scaffolds and floating 
away during medium changes and handling of the construct, fibres could be directly melt 
electrospun onto the spheroid-seeded scaffolds to form a lid. In vitro MEW has previously been 
reported by Dalton et al. with maintained cell vitality, however issues with fibre quality and fibres 
lifting off the cells with the addition of medium were encountered.67 Therefore, optimisation of the 
technique and modifications of the existing MEW device configuration would be required for this 
approach to be feasible.  
A different approach to achieving the delivery of well-preserved spheroids would be to shorten the 
culture period within the scaffolds. As the spheroids attached to the PCL scaffolds within 24 hours, 
when spheroid morphology was still well maintained, the constructs could be implanted at this time 
point. In this case, the spheroids could be partially or fully adipogenically differentiated prior to 
seeding. However, surface modification of the fibres would likely be required to slow spheroid 
disassembly after implantation. Alternatively, because it is known that spheroid-derived cells show 
improved differentiation ability over cells cultured in conventional monolayer conditions, the 
spheroid-seeded constructs may even prove advantageous at tissue regeneration when spheroid 
structure is not well preserved. Furthermore, the constructs could provide an alternative technique 
for studying spheroid-derived cells without the need for an enzymatic digestion step. 
6.5.3 Forming higher order structures 
It is envisioned that the PCL box-structure scaffolds loaded with spheroids could serve as adipose 
tissue sheets or patches with suitable physical handling properties for the reconstruction of 
subcutaneous tissue. To improve the versatility of this tissue assembly technique, the  
spheroid-seeded scaffolds could also be utilised as modular hybrid building units to fabricate higher 
order 3D structures. Indeed, this approach would not be limited to adipose tissue engineering 
applications. Successive stacking of the sheets would enable thicker tissues to be formed, with the 
high porosity of the scaffolds enabling continuous and direct cell-cell contacts between layers. 
There is also the potential to incorporate layers containing spheroids formed from different cell 
types, for example endothelial cells, to possibly introduce vasculature into the construct. Offering 
further flexibility in hierarchical 3D construction, spheroid-seeded sheets could also be rolled for 
regenerating tendons, blood vessels, and tubular organs. 





7. Conclusions and Future Directions 
The main intention of this work was to investigate, for the first time, if 3D-printed microfibrous PCL  
box-structure scaffolds could accommodate hASC spheroids and enable differentiation along the 
adipocyte lineage. Previous studies involving seeding of spheroids onto fibrous scaffolds either 
resulted in a loss of spheroid structure, or produced constructs with a large volume of polymer and, 
subsequently, mechanical properties that are unsuitable for soft tissue engineering. While it is 
known that ASCs cultured as spheroids provide enhanced regenerative capabilities, surprisingly, 
studies exploring suitable carriers for spheroids in the context of adipose tissue engineering are so 
far missing from the literature. Therefore, in this study, PCL microfibre box-structure scaffolds were 
designed and 3D-printed using MEW, and a spheroid seeding technique was established. Spheroid 
behaviour in the scaffolds was monitored by in situ imaging, and adipogenic differentiation was 
induced using a hormone cocktail. Cell viability and adipogenesis were investigated using live/dead 
and histological staining, respectively. For all analyses, comparisons were made with non-induced 
control samples. 
It was demonstrated that hASC spheroids and box pores in microfibre scaffolds fabricated by MEW 
could be size-matched, allowing seeding that was eventually optimised to at least 90% efficiency. 
Scaffold architecture was found to affect spheroid disassembly, with higher box walls most 
successfully preserving spheroid morphology. Spheroids seeded into the boxes readily attached to 
the PCL wall and base fibres, and likely due to a combination of migration and proliferation of cells 
at the periphery of the spheroids, completely filled the pore spaces by the end of the culture period. 
However, further quantitative analyses such as a DNA assay are required to confirm proliferation 
was involved in this process. It was found that after 15 days of culture, spheroid structure was still 
visible within the pores, however it is hypothesised that future experiments involving surface 
modification to reduce cell adhesion would improve preservation of the 3D structure. Adipogenesis 
of the hASCs was also achieved in the spheroid-seeded scaffolds, as seen in the histological sections 
and confirmed at the mRNA level by real-time qRT-PCR. Typical changes in cell morphology were 
observed in the adipogenically induced samples, including accumulation of lipids that was not 
present in the non-induced group. Indeed, significantly elevated relative expression of C/EBPα and 
PPARγ, the two most relevant transcription factors involved in adipogenesis, and aP2, a late 
adipogenic marker, were only found in the induced group. Furthermore, cell viability in the 
superficial layer of the samples was apparently unaffected during the seeding, culture, and 
adipogenic induction processes. 
Despite the promising results obtained in this study, a number of further experiments are suggested 
to improve maintenance of spheroid structure and facilitate upscaling towards clinical translations. 
Firstly, modification of the PCL fibres to reduce or prevent cell adhesion is expected to better 
preserve the 3D structure of the spheroids, in line with results obtained in other studies. Seeding 
of pre-differentiated spheroids would also provide interesting insight on the migratory behaviour 
of cells already committed to the adipocyte lineage. However, pore sizes may need to be enlarged 
to accommodate the spheroids, which increase in diameter due to the engorgement of cells with 
lipids, as investigated in Annex 1. Additionally, issues have previously been encountered with 
adipogenically differentiated spheroids floating in medium due to the lipid contents, which may not 





be compatible with the gravity-assisted top seeding technique used in this study. Nevertheless, if 
these issues were overcome by modifying spheroid architecture and the seeding technique, 
interesting results could be obtained. Alternatively, differentiating the spheroids for only a short 
period of time prior to seeding would lead to only a minor increase in size, and could potentially 
also decrease spheroid disassembly inside the boxes. 
Additional analytical techniques should be established for future experiments to provide a more in-
depth investigation of cell behaviour and adipogenesis. Firstly, histological processing of the 
spheroid-loaded constructs should be improved. A cryosectioning protocol was modified in this 
study to section the samples, however the results were not optimal. Paraffin sectioning would be 
worth exploring, despite the associated loss of lipid content in the sections, as construct structure 
may be better preserved. Similarly, surface coated microscope slides may improve cryosectioning 
results. Additionally, optimisation of the SEM sample preparation protocol to minimise drying 
artifacts, and imaging of spheroid-seeded samples at different time points during the culture 
process should be explored. Most importantly, additional quantitative analytical techniques should 
be utilised in future experiments. DNA and triglyceride assays, as described in Annex 1, would 
provide useful insight on cell proliferation and differentiation, respectively. The inability to 
consistently generate samples with the same seeding efficiency in this study rendered these tests 
unsuitable, as due to the different buffers used for each assay, triglyceride content is normalised to 
DNA content from a different sample. Therefore, real-time qRT-PCR was used instead, as the values 
are normalised within each sample, however large variations in the data were still found. 
Nevertheless, with further optimisation of the seeding technique, consistent seeding efficiency 
should be achievable. Sampling of the medium during the culture process and analysis of proteins 
would also likely provide an interesting insight into the culture and adipogenic processes.  
Furthermore, sample dimensions should be increased to enable easier handling and provide more 
clinically relevant results. As the liquid overlay technique used in this study was not developed for 
generating such large numbers of spheroids, its time inefficiency was the limiting factor for sample 
size. Therefore, the use of high throughput spheroid fabrication techniques would enable seeding 
experiments to be performed in much larger scaffolds. In this setting, the most suitable approach 
would be micromolded non-adhesive hydrogel surfaces, which are available commercially or could 
be made cost-effectively using a 3D printed mold and agarose hydrogels in well plates. In an effort 
to increase the versatility of this new approach to tissue assembly, future experiments involving 
stacking of spheroid-seeded scaffolds to form higher order structures would be an interesting and 
logical progression. Rolling of the scaffolds could also lend itself to applications in the engineering 
of tubular organs, tendons, and blood vessels. 
Overall, this work contributes not only to the field of adipose tissue engineering, but also suggests 
a new approach to tissue assembly. As it was shown that spheroids and 3D-printed microfibre  
box-structure scaffolds are a suitable match, this study provides a basis for future work focused on 
improving scaffold design to provide a suitable microenvironment for sustaining 3D structure for 
implantation in clinical applications. Alternatively, the work described here could be adapted and 
used as a faster and more efficient technique for populating scaffolds compared to the conventional 
method using a dispersed cell suspension. The successful differentiation of cells within the scaffolds 





further proves the suitability of the technique for adipose tissue engineering applications. In 
conclusion, this study reveals a new perspective in adipose tissue engineering, combining two 
common 3D culture approaches, spheroids and scaffolds, to produce a novel construct that could 
serve as a tissue sheet for repairing soft tissue defects, or be utilised as a modular hybrid building 
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Preparation of spheroid-seeded scaffolds for SEM  
The spheroid-seeded 390_30 scaffolds were removed from the CC96 inserts and then rinsed 4 times 
with PBS. Fixation and dehydration were performed using a series of glutaraldehyde, ethanol, and 
HMDS incubation steps (see Table 3). The samples were then dried overnight at room temperature 
(RT) prior to sputter-coating and SEM imaging. 









     
 6% glutaraldehyde 15 min On ice  
 PBS 10 min On ice  
 PBS 10 min On ice  
 50% ethanol 10 min RT  
 50% ethanol 10 min RT  
 70% ethanol 10 min RT  
 70% ethanol 10 min RT  
 90% ethanol 10 min RT  
 90% ethanol 10 min RT  
 100% ethanol 10 min RT  
 100% ethanol 10 min RT  
 HMDS 15 min RT  


















Figure 15. Optical microscope images of 3D-printed microfibre scaffolds used for seeding in this study. Box-structure 
scaffolds with 390 µm fibre spacing and 30 (A, D) or 40 (B, E) fibre layers, referred to as 390_30 or 390_40, respectively, 
were imaged from above (A, B), and below (D, E) to show the supporting base fibres. A microfibre mesh with 400 µm 








Dispersed cell studies were unsuccessful using the CC96 inserts, due to the large pore sizes in the 
scaffolds which allowed the cells to fall through and congregate on the agarose surface below  
(Fig. 16). Therefore, a different seeding technique must be developed before comparative 
dispersed cell-seeding studies can be performed. 
 
 
Figure 16. 24 hours after seeding 390_30 scaffolds with a dispersed cell suspension. Cells had failed to attach to the PCL 
fibres of the scaffold, instead forming a large floating aggregate on the agarose surface beneath the scaffold. Images were 








In the 390_40 scaffolds, sample thickness and cell density did not allow for clear microscope images 
to be obtained (Fig. 17). However, from these images, red stained lipid droplets could only be 
observed in the adipogenically induced group. 
 
 
Figure 17. Whole sample histological staining of spheroid-seeded 390_40 scaffolds. Non-induced (A) and adipogenically 
induced (B) samples were stained with Oil Red O and hematoxylin to visualise triglycerides and cell nuclei, respectively. 
Scale bars: 400 µm. 
